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A comparative study of four anaesthetic drugs has been
undertaken with the object of improving the understanding of their
neuropharmacology. Pentobarbitone, ketamine (Vetalar*), alphaxalone
(Saffan*) and metomidate have been selected to represent the types
of compound currently in clinical use. With a more extensive
knowledge of the drugs at their disposal clinicians will be better
able to exploit the different properties of individual drugs.
Intracellular recordings have been made from identified bulbar
reticulo-spinal (M'uller) cells in the medulla of lamprey
ammocoetes. Responses to iontophoretically applied transmitters
have been measured as changes in membrane potential and input
resistance. Bath application of anaesthetics resulted in dose-
dependent alterations in the responses to #-aminobutyric acid
(GABA), glycine and glutamate. These amino acids are transmitters
thought to be of major importance in central nervous mechanisms.
The suitability of the lamprey preparation for a pharmacol¬
ogical study of this nature is discussed. All four drugs have been
tested and shown to anaesthetise lampreys; although pentobarbitone
was effective only when administered by injection.
Anaesthetic effects on the spontaneous synaptic activity
recorded from M'uller cells have been measured: EPSPs were decreased
in frequency by pentobarbitone (1CT<,"M) and, after a transitory
increase, by alphaxalone (1-3 x lCT^M). Sub-anaesthetic
concentrations of ketamine (<10-S*M) stimulated activity in the one
preparation tested. High concentrations (c.lCf^M) of all drugs
suppressed all spontaneous activity: below this concentration
metomidate had little effect. IPSPs were more labile than EPSPs:
they were reduced in frequency by all drugs at anaesthetic or supra-
anaesthetic concentrations, and this reduction was longer lasting
than that of EPSPs.
GABA responses were potentiated by pentobarbitone (1-3 x 1CT4M)
and prolonged by ketamine (3.7 x 10~4M); but depressed by high
concentrations (1CF3M) of all drugs, as well as by anaesthetic
concentrations of alphaxalone (1-3 x lCT^M) .
Glycine responses were depressed by alphaxalone (1-3 x lCf^M)
and by supra-anaesthetic concentrations of ketamine (3.7 x 10~4M)
and metomidate (1.8 x 10-3M). No drug potentiated the glycine
responses.
Anaesthetic effects on glutamate responses were more variable
and much less striking than were those on GABA and glycine
responses. Only pentobarbitone and ketamine had consistent dose-
dependent inhibitory effects. No potentiation of glutamate
responses was observed.
In the absence of an effect common to the four anaesthetics, it
is concluded that neither potentiation nor inhibition of all GABA,
glycine or glutamate responses is an essential feature of
anaesthesia. However, effects comparable to those described here
may contribute to the overall clinical picture during anaesthesia of
higher vertebrates. Attention is drawn to the difficulty of
predicting the consequences of effects observed on a single
component of a polysynaptic pathway. The findings do not support
the notion that all anaesthetic agents act on biological membranes
by a single mechanism.
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Introduction
...and as there is no greater inconvenience to any
Arteficer, than not to know his tools that he must work
with...
Porta (1561)
Porta referred to the necessity of botanical knowledge to the
practising magician, but the thought is equally applicable to the
modern anaesthetist, who can practise his art efficiently and safely
only if he has a good understanding of the drugs at his disposal.
With this in mind, I present here the initial results of a
comparative study of the neuropharmacology of some injectable
anaesthetic agents. The study falls into three sections:
i) investigation of the capability of each anaesthetic to induce
anaesthesia in lamprey ammocoetes (Section III); a necessary
screening experiment;
ii) measurements of anaesthetic-induced changes in the spontaneous
synaptic activity recorded from reticulo-spinal cells (Section IV);
iii) observations of the effects of anaesthetics on the responses of
identified cells to inhibitory (Section V) and excitatory
(Section VI) amino-acid neurotransmitters.
Four drugs have been considered in detail: these were
selected to represent the wide range of compounds currently
available for intravenous administration. The project was designed
rather to further the understanding of those drugs currently in
clinical use in order that they may be used more effectively, than
to study the mechanisms of anaesthesia. Closely related but non-
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anaesthetic compounds have therefore not been included, nor have
racemic mixtures been separated to investigate the different
properties of their components.
Evidence of interactions between the anaesthetics and three
putative amino-acid neurotransmitters has been sought. These amino
acids are thought to be of major importance in central nervous
mechanisms; although they are numerically but a small sample of
current transmitter candidates, and represent only one category of
such substances.
A single preparation has been used throughout: bulbar reticulo¬
spinal cells in the brain-stem of a simple chordate, the lamprey.
Insofar as they are understood, neurotransmitter mechanisms in the
lamprey seem similar to those in mammalian brains, so the simpler
animal is acting in this study as a model for the more complex.
It should be stressed at the outset that the bulbar reticulo¬
spinal cells are not directly involved in the control of
consciousness although they are located in the reticular formation,
and therefore no conclusions can be drawn as to the mechanisms by
which anaesthesia is induced. Secondly, although two of the amino
acids used, glycine and L-glutamate, are good candidates for the
roles, the natural transmitters acting on these cells have yet to be
positively identified (Matthews & Wickelgren, 1979a,b; Gold &
Martin, 1982b). However, comparison of the effects of the drugs on
the cells' responses, and correlation with their effects on
spontaneous synaptic activity, enable comment to be made on the side
effects reported by clinicians. The question then arises as to
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whether the results cast any light on the management or medication
most likely to lessen the impact of these side effects in the peri¬
operative period. Any such extrapolation from the lamprey to higher
vertebrates assumes comparability of the cell systems studied, and
of individual cell responses to the drugs used. No major




General Anaesthetics: an historical preamble
...and the Lord God caused a deep sleep to fall upon
Adam, and he slept: and he took one of his ribs,
and closed up the flesh instead of thereof...
Genesis 11:21
This, probably the first reference to a surgical operation
performed under some form of anaesthesia, testifies to the
prevalence of the concept of anaesthesia at the time the book of
Genesis was compiled. Anaesthesia does not, as many modern writings
imply, date from the mid-19th Century (although its widespread
application probably does) as further quotations also illustrate:
...il donnait au malade une preparation de chauvre (Ma¬
yo) , et, au bout de quelques instants, il devenait aussi
insensible que s'il eut £t6 plong£ dans l'ivresse ou
prive de vie. Alors, suivant le cas, il pratiquait des
ouvertures, des incisions, des amputations, et enlevait
la cause du mal; puis il rapprochait les tissus par des
points de suture et y appliquait des liniments. Apres un
certain nombre de jours (au bout d'un mois, suivant les
Annales des Han post6rieurs), le malade se trouvait
retabli sans avoir eprouv6, pendant l'operation, la plus
legere douleur...
Biography of Hoa-tho, eminent physician in the Wei
dynasty, 220-230 A.D., in a 16th Century Chinese
account of medicine ancient & modern.
Transl. Stanislas Julien, (1849)
The historical accuracy of this account is uncertain because
the biography is undated, but the idea of anaesthesia must have been
current in the 16th Century. (Ma-yo was an extract of the leaves
of Cannabis indica taken with wine.)
...some persons boil down the roots in wine to a
third,strain it, and put it away, using one cyanthus in
the case of persons suffering from insomnia or severe
pain, or those about to be cut or cauterised, when they
wish to produce anaesthesia...
...wine is also made from the bark of the root without
boiling; for this purpose put three minae into one
metretes of sweet wine. Three cyathi of this should be
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given to persons about to be cut or cauterised...They
do not feel the pain on account of the ensuing stupor...
Dioscorides, a herbalist and physician of the 1st Century A.D.,
here used the term "anaesthesia" in its modern sense (it was coined
independently by Holmes in 1846) . The two extracts from his
writings were cited by Randolph (1905) in an exhaustive study of
ancient references to Mandragora. Randolph concluded after
examining the available sources that mandragora, whose active
ingredients include atropine, hyoscine and hyoscyamine, was the
principal, indeed almost the only anaesthetic of antiquity, and that
it was used by physicians at least as early as the 1st Century A.D.
However, there is only presumptive evidence that mandragora was in
fact used; Randolph found no mention of it in any description of a
specific operation. The reason why anaesthesia was not more widely
practised must be a matter for conjecture, but it is pertinent that
the dangers attendant on the use of available agents were well
recognised. Other agents mentioned in the ancient literature
include tears of poppy (opium), Hyoscanthus, Morum (mulberry)
and Lactuca silvestris (wild lettuce) (Tallmadge, 1946).
Interestingly, although the mandrake has become associated with
a wealth of legends (some of them, such as the various digging
ceremonies, probably transferred from other plants), two species of
mandragora have been identified and shown to have genuine
anaesthetic properties. Richardson had some success in reproducing
the ancient wine of mandragora:
...the wine of the mandragora is a general anaesthetic of
the most potent quality. The action no doubt depends on
the presence of an alkaloid which is like, if not
identical with, atropine, and from it an alkaloid could
be extracted which might be used medicinally, and which
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would, I have no doubt, be one of the most active
anaesthetics we have yet discovered. From the
circumstance that the heart continues to beat after the
respiration has ceased we may infer that as a general
anaesthetic the alkaloid might, under necessity, be once
more employed, as in the olden time, to deaden the pain
of a surgical operation, and that, too, with
comparatively little risk to life...
Richardson (1888)
It is notable that all the agents mentioned so far were to be
administered orally or per rectum rather than by inhalation. The
first mention of gaseous anaesthesia was in Davy's account of the
properties of nitrous oxide:
...as nitrous oxide in its extensive operation appears
capable of destroying physical pain, it may probably be
used with advantage during surgical operations in which
no effusion of blood takes place...
Davy (1800).
However, not only did Davy fail to exploit this observation,
he also frustrated Hickman's attempts in 1826 to introduce carbon
dioxide anaesthesia. In like manner, his patron Beddoes failed to
exploit ether although he recorded its anaesthetic properties in
1818. Both ether and nitrous oxide were used only frivolously for
their stimulant properties until the 1840's.
Intravenous techniques followed later, but the first
intravenous injection of a narcotic drug had been made two centuries
previously by Sir Christopher Wren:
...the most considerable experiment I have made of late,
is this; I injected Wine and Ale into the mass of blood
in a living dog, by a vein, in good quantities, till I
made him extremely drunk, but soon after he pissed it
out...it will be too long to tell you the effects of
opium, scammony, and other things which I have try'd this
way. I am in further pursuit of the experiment, which I
take to be of great concernement, and what will give
great light to the Theory and Practice of Physick...
Wren (1656).
No description of the effects of opium followed but Boyle, an
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eye-witness to this the first documented intravenous injection,
later described the effects of the injection of a warm solution of
opium in sack:
... (Wren) conveyed a small dose of the solution or
tincture into the opened vessel, whereby getting into the
mass of blood (some quantity of which it 'tis difficult
to avoid shedding in the operation) it was quickly, by
the circular motion of that, carried to the brain, and
other parts of the body: so that we had scarce untied the
dog (whose four feet it had been requisite to fasten very
strongly to the four corners of the table) before the
opium began to disclose its narcotick quality, and almost
as soon as he was on his feet, he began to nod with his
head, and faulter and reel in his pace, and presently
after appeared so stupified, that there were wagers
offered his life could not be saved...
Boyle (quoted in a memoir Parentalia compiled by
Wren's son and published by his grandson: Wren, 1750).
The dog however was saved by dint of being "whipped up and down
a neighbouring garden until he came to himself", and was
subsequently used for further experiments until, being a notoriety,
he was stolen. From this "invention" developed the technique of
blood transfusion (King & Lower reported a successful transfusion
from sheep to human in 1667), but routine intravenous administration
of medicinal substances did not immediately follow. Wren's
technique entailed exposing and ligaturing a large superficial
vein, before slitting it and inserting a quill or other slender
pipe by which the solution was injected. The description is of
quills fastened to a bladder "in the manner of clyster pipes".
Is it coincidence that the development of intravenous




...it would be easy to form theories referring the action
of blood impregnated with nitrous oxide, to its power of
supplying the nervous and muscular fibre with such
proportions of condensed nitrogene, oxygene and light or
ethereal fluid, as enabled them more rapidly to pass
through those changes which constitute their life: but such
theories would be only collections of terms derived from
known phaenomena and applied by loose analogies of language
to unknown things...
Davy, Researches on nitrous oxide (1800)
The literature concerning anaesthetics and the mechanisms by
which they may act is voluminous, and has been comprehensively
reviewed at intervals during the past century (recent reviews
include Seeman, 1972; Kaufman, 1977; Richards, 1978; Roth, 1979;
Gage & Hamill, 1981; Franks & Lieb, 1982) . By this brief
introduction I aim to set the scene for the present investigation,
not to retell a story which has been told many times before and at
far greater length than is appropriate here.
Bernard (1875) was the first to propose a unitary theory
whereby the actions of all agents depressant to the central nervous
system might be explained; and thereby set a trend for many
subsequent theories. The philosophical desire for a unitary theory
was based partly on the recognised diversity of compounds with
anaesthetic actions (these even including the chemically unreactive
rare gases xenon and krypton), and partly on the assumption that
there was a single anaesthetic state induced by all anaesthetic
drugs. Because of the chemical diversity of the drugs a non¬
specific mechanism was sought rather than a specific "anaesthetic
receptor". Anaesthetic research has proceeded on more than one
level, and only recently has it begun to be possible to assimilate
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the many strands into a single picture. This picture is as yet far
from complete and will remain so until such time as mechanisms of
consciousness are much better understood.
Overton in 1899 and Meyer in 1901 independently were the first
to correlate the anaesthetic potencies of a series of alcohols with
their partition coefficients between water and olive oil. This was
the first statement of the "lipid theory", a theory which has
remained current in a refined form to the present day. However, its
limitations have been recognised. For example Butler (1950),
despite admitting Ferguson's argument (1939) that the correlation
was considerably better, as well as more appropriate, if the
thermodynamic activities of the drugs in the various phases in
equilibrium were used in place of their concentrations, was at pains
to show that such correlations could do no more than suggest that
the site of action of anaesthetics was in an apolar region of the
cell, be it a protein molecule or a membrane lipid, and offered no
mechanism by which the depressant effect was exerted. Butler also
pointed out that Meyer (1936) had applied the lipid theory only
to "indifferent narcotics" or the "alcohol group", a fact that was
sometimes overlooked, and that he had recognised the possibility
that other compounds may depress brain function by different means.
The lipid theory assumed the status of a hypothesis of
anaesthesia only when Mullins (1954) proposed that anaesthetics act
by expanding the surface membrane lipid, so disordering its
structure that the functioning of enzymes, ion channels and
receptors was compromised. A more recent general hypothesis
concerns the demonstrable ability of many anaesthetics to increase
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the "fluidity" of lipid membranes; by this was meant the freedom of
movement of the apolar lipid chains which are usually aligned in a
plane normal to the membrane surface. An increase in fluidity can
be detected by magnetic resonance techniques (see Metcalfe, Hoult &
Colley, 1974; Kaufman, 1977), and there is some evidence that
anaesthetic steroids and barbiturates can be distinguished from
their non-anaesthetic relatives by their ability to cause such an
increase (e.g. Lawrence & Gill, 1975; Novak & Swift, 1976).
Alterations in fluidity must alter the constraints on the protein
molecules that constitute the membrane ion "channels", and are
therefore likely to affect their physical properties: the ion
permeabilities and the kinetics of opening and closing the
channels. It has however yet to be demonstrated that an increase in
membrane fluidity is either necessary or sufficient for anaesthesia
to occur; and any evidence for the various mechanistic possibilities
is lacking.
Recently the lipid interacting with a local anaesthetic has
been identified less with the bulk of the surface membrane than with
the annulus immediately surrounding the sodium channel (Lee, 1976).
Application of this concept to general anaesthetics has the
attraction that there is the potential to incorporate stereo-
specific effects of a drug, and tissue-specific effects (see
Metcalfe, Hoult & Colley, 1974). As Gage & Hamill (1981) made clear
however, no distinction can confidently be made between an effect on
the lipid annulus and one on a hydrophobic part of the protein
constituting the ion channel. The effect of an anaesthetic molecule
on a particular membrane protein or lipid will depend on the
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latter's composition; insufficient is known as yet about the detail
of either. Arguments have raged as to the most appropriate lipid to
use in such studies (see Kaufman, 1977) but the crucial effect of
the environment of the lipid has often been ignored. It is likely
that a lipid that forms an integral part of the cell membrane is so
constrained by the cell architecture and by the adjacent cytoplasm
that its properties differ from those of the same lipid either in
bulk phase or as a thin "black" membrane.
At this point the proponents of the modified lipid theory met
h
the neurophysiologists and neurojojarmacologists on common ground.
There had been a parallel development of anaesthetic theories
concerned with events at the cellular rather than the molecular
level, springing from Sherrington's observation (1906) that spinal
reflexes were more readily depressed by anaesthetics (by a factor of
10) than was impulse conduction in peripheral nerves. Attention was
thus directed to the synapse as the likely site of action, and
detailed studies have been performed on accessible synapses: notably
the neuro-muscular junction, invertebrate neural ganglia, autonomic
and dorsal root ganglia. Latterly the development of brain slice
preparations has allowed extracellular studies on mammalian brain
cells. Well controlled intracellular studies have been carried out
on cultures of mammalian brain and spinal cord.
The mechanism of the selective effect of anaesthetics on
synaptic transmission has yet to be fully elucidated. Larrabee &
Posternak (1952), showing the diverse effects of different agents on
transmission through sympathetic ganglia, suggested anaesthetic
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blockade of conduction in the fine presynaptic nerve terminals as an
economical unitary mechanism. Current opinion is that there is no
good evidence for such a theory (Richards, 1978, 1982) . There is no
reason to suppose that all anaesthetic agents must act by a single
mechanism, and it has long been known that some differ in their
pharmacological effects. For example, Derbyshire et al (1936)
reported that ether and pentobarbitone had different effects on the
cortical electro-encephalogram (EEG). The accumulating evidence for
both pre- and postsynaptic effects is considered more fully in
connection with pentobarbitone (p.20) and in Sections V & VI.
Although most theories assume that the surface membrane is that
principally affected by the anaesthetic process, an apolar site is
also provided by the extensive intra-cellular membranes. Krnjevic
(1975) emphasised this when proposing that anaesthesia resulted from
a reduced mitochondrial uptake of calcium: the consequent rise in
free intracellular calcium should promote transmitter release at
synapses and hyperpolarise the postsynaptic membrane by increasing
the membrane permeability to potassium. The possible role of
calcium in the anaesthetic process has been a continuing thread
running through anaesthetic research, and from time to time has been
invoked to explain experimental findings (e.g. Morris, 1978).
Should intracellular accumulation of free calcium be an intrinsic
part of the mechanism, it would be expected to have also quite other
and far-reaching consequences.
An anaesthetic-dependent calcium-induced loss of respiratory
control in mitochondria has been reported, associated with
anaesthetic concentrations (10-s' to lCf^M) of alphaxalone (Smith,
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Sweetman & Esmail,1974; Esmail, Smith & Sweetman, 1974).
Sweetman & Esmail (1975) , found that mitochondrial uptake of radio-
labelled calcium was reduced after treatment with either alphaxalone
(Althesin) or hexobarbitone. Nonetheless, Pennefather, Puil &
Quastel (1980) measured a reduction in depolarisation-secretion
coupling at the mouse neuro-muscular junction during exposure not
only to alphaxalone and other anaesthetic steroids (such as
progesterone), but also to the non-anaesthetic isomer /y ~
alphaxalone. Whilst this effect may not therefore be relevant to
mechanisms of anaesthesia, it must be taken into account in
considering the results of Section IV. Calcium has also been
implicated in the presynaptic actions of pentobarbitone (Krnjevic,
1975) and ketamine.
A unitary theory of this type goes part-way towards fulfilling
the requirement that anaesthetic depression be greater at synapses,
but it does not explain the different susceptibilities shown by
different synapses. Other theories have attributed anaesthesia to
drug actions at specific membrane receptors for neurotransmitters.
Some of this evidence is considered in Sections V & VI. Such
theories, whilst they may account for differences in drug effects,
do not propose any molecular mechanism that has adequate
experimental support (Gage & Hamill, 1981) .
Reviewing the more recent studies, Franks & Lieb (1982) have
suggested that the various lipid theories are less than
satisfactory. This was not recognised previously because earlier
studies employed anaesthetic concentrations greater than those
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encountered during surgical anaesthesia. Clinically relevant
concentrations have only small effects on membrane dimensions, and
no detectable effect on the membrane fluidity. Franks & Lieb have
pointed out that most of the experimental data, such as that
concerning the influence of temperature and the reversal of
anaesthesia by pressure, can be explained equally well by a simple
model in which an anaesthetic binds to a functional membrane
protein.
Many have now abandoned the concept of a truly unitary
mechanism of anaesthesia. Not only are there recognised differences
between drugs in the progression of clinical states, but
anaesthetics differ in their effects on the EEG and at the level of
individual synapses. Furthermore, some mixtures of anaesthetics
have been shown to have non-additive effects on sleeping times in
mice (Richards & White, 1981). Insofar as the lamprey preparation
can be considered an appropriate model of the mammalian CNS, the




A Sleeping Apple: for it is made of opium, Mandrake, juice
of Hemlock, the seeds of Henbane; and adding a little Musk,
to gain an easier reception of the smeller: these being
made up into a ball, as big as a man's hand can hold, and
often smelt to, generally close the eyes, and bind them
with a deep sleep.
Porta (1561)
Four drugs were selected to represent the types of compound
currently in veterinary clinical use for the induction of
anaesthesia by intravenous injection. The drugs are chemically very
different and although they share the ability to induce anaesthesia,
the resultant clinical states show differences, as do the side
effects reported. In this initial survey the compounds used were:
pentobarbitone sodium - a barbiturate,
*
ketamine hydrochloride - a phenylcyclohexylamine,
alphaxalone/alphadolone - a mixture of two derivatives of the
steroid pregnanedione,
metomidate hydrochloride - an imidazole derivative.
It was expected that the drugs would differ in their effects on
the reticulo-spinal cells. These cells have essentially a motor
function (p.39), and marked differences are reported by clinicians
in the degree of muscle tone retained during anaesthesia and in the
incidence of excitatory motor effects such as twitching, myoclonus
and convulsions, according to which drug has been used.
Barbiturates
The barbiturates were among the earliest drugs to be developed
for intravenous anaesthesia. The parent compound, barbituric acid,
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itself had no anaesthetic activity, but its 5:5 diethyl derivative
was introduced into medicine as a hypnotic by Fischer & von Mering
in 1903. Pentobarbitone (Figure 1-1) was introduced into medical
practice in 1930 and to veterinary practice in 1931 (Kreutzer,
1931). Since then it has been extensively used both in clinical
practice (e.g. Wright, 1934, 1938) and as an anaesthetic for
experimental animals, but it has now been superceded for most
purposes by shorter acting barbiturates such as thiopentone and
methohexitone, or by non-barbiturate anaesthetics. Because of the
widespread use of pentobarbitone in experimental studies there is a
wealth of information available concerning its neuropharmacology,
and this was the main reason for its selection in the present
investigation. A comprehensive review of the published work
relevant to this study is not realistic, but some of the more
important points will be considered briefly. This will serve also
to trace the development of ideas about anaesthetic actions on
synaptic transmission.
EEG studies The onset of sleep has long been known to be
associated with a change in the EEG pattern from one of low voltage
fast waves, when cortical neurones are firing out of phase, to
slower synchronised waves of greater amplitude. Brazier &
Finesinger (1945) reported a similar change a few minutes after
barbiturate administration had induced unconsciousness. They also
noted a transient period during both induction and recovery, when
there was high voltage fast EEG activity. Derbyshire et al (1936)
had earlier reported few changes in the spontaneous and evoked
cortical potentials following administration of pentobarbitone,
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Figure 1-1

































Barbifuric acid Pentobarbit one
although the cortical waves increased in amplitude, implying some
synchronous activity of cells. During anaesthesia the spontaneous
waves were infrequent but sciatic stimulation evoked a big
electrical response. Schlag, Quadens & Kridellca (1956) observed
that pentobarbitone (15-30mg/kg), unlike ether and oC-chloralose,
depressed the spontaneous activity of the somatosensory cortex, the
hippocampus and the reticular formation without affecting evoked
activity in the cortex. Sparing of the sensory paths has been
observed repeatedly with techniques that have looked at different
parts of the pathway (e.g. Forbes & Morison, 1939; Mark & Steiner,
1958; Morris, 1978). The latter measured transmission in the
cuneate nucleus, one of the relay stations en route to the sensory
cortex.
The reduced spontaneous activity and the more synchronised
EEG waves indicated cortical depression. More recent observations
of reduced responsiveness of cortical neurones to the excitatory
transmitters glutamate and acetylcholine (Richards, 1972, 1974;
Richards & Smaje, 1976; Smaje, 1976) have provided supportive
evidence.
Effects at synapses Not all early experiments recorded increased
or spared synaptic transmission: Brooks & Eccles (1947) found that
all components of the monosynaptic reflex path through the spinal
cord were blocked by pentobarbitone, but they were using supra-
anaesthetic doses (30-120mg/kg), concentrations sufficient to block
axonal impulse conduction although not to prevent generation of a
large synaptic potential. Larrabee & Posternak (1952) in classic
and oft quoted experiments showed that pentobarbitone concentrations
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equivalent to those known or calculated to obtain in blood during
surgical anaesthesia, blocked transmission in sympathetic ganglia
but were not sufficient to block axonal conduction. The extent of
this selectivity varied between anaesthetics. Exley (1954) also
found autonomic ganglionic depression, especially from amylo-
barbitone, but noted in comparing three barbiturates that there was
no correlation between this effect of the drugs and their potencies
as anaesthetics. This was an early indication that ganglionic
blocking action may not be relevant to the anaesthetic effect of the
barbiturates. It is interesting that although ganglionic
transmission is cholinergic, inhibitory receptors for )(-aminobutyric
acid (GABA) are present on ganglion cells. Pentobarbitone has been
shown to potentiate or even to mimic GABA effects on a variety of
preparations, including sympathetic ganglia, but whereas the peak
effect occurs at around 8 x lCF^M pentobarbitone (Bowery & Dray,
1978), a slightly higher concentration (lCT^M) has been measured in
the blood on the recovery of consciousness (Richards, 1972). This
observation therefore casts doubt on the role of the GABA-
potentiation in pentobarbitone anaesthesia.
Anaesthetic effects on synaptic transmission having been
established, the possible sites of action were examined in more
detail. Somjen & Gill (1963) found reduced excitatory postsynaptic
potentials (EPSPs) in ventral spinal roots and in single motor-
neurones after peripheral stimulation, but no change in the resting
membrane potential. However, they did not distinguish between the
possible presynaptic and postsynaptic effects. Eccles, Schmidt &
Willis (1963) reported increased and prolonged presynaptic
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inhibition at low concentrations whereas inhibition was reduced by-
higher doses (reduced 50% by 30mg/kg). These authors were using
cats and it should be noted that a dose of 30mg/kg induces surgical
anaesthesia in this as in many other species.
Weakly (1969) was among the first to distinguish between
presynaptic and postsynaptic effects: both pentobarbitone and
thiopentone reduced the mean quantal content of an EPSP whilst
leaving the amplitude of the unit potential unaltered. An
anaesthetic-induced change in the input resistance of the
motoneurone membrane was ruled out as a possible explanation and
Weakly concluded that the barbiturate action was confined to
inhibition of transmitter release from the presynaptic nerve
terminal. These experiments also were carried out on cats, this
time with sub-anaesthetic doses of pentobarbitone (lOmg/kg).
In contrast, Thomson & Turkanis (1973) recorded an increase in
the mean quantal content of EPPs at the neuro-muscular junction
together with a reduction in the mean amplitude of miniature EPPs
(MEPPs). The increase was the more remarkable because the external
magnesium concentration was lOmM: magnesium and calcium are known to
be antagonistic in their effects on transmitter release at the neuro¬
muscular junction (del Castillo & Engbaek, 1954). It is possible
that this blocking effect of magnesium unmasked a second mechanism
postulated for some anaesthetics; whereby they inhibit mitochondrial
uptake of calcium, and so by increasing the intracellular
concentration of free calcium, promote transmitter release
(Krnjevic, 1975). Under normal circumstances it may be that this is
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masked by an effect of the anaesthetic to reduce the depolarisation-
linked entry of calcium from the extracellular fluid. Such a
reduction in the uptake of radio-labelled calcium by synaptosomes
has been demonstrated (Blaustein & Ector, 1975). However, Thomson &
Turkanis used phenobarbitone and a convulsant barbiturate, so their
findings may relate more to excitatory than to anaesthetic actions
of the barbiturates.
Haycock, Levy & Cotman (1977) showed that pentobarbitone
(2 x 10_5"m to 2 x lCT^M) reduced the calcium-dependent efflux of
radio-labelled nor-adrenaline and GABA from synaptosomes. Their
observation, that no such effect of pentobarbitone could be
demonstrated when a calcium ionophore was incorporated in the
system, localised the site of pentobarbitone's action to the
depolarisation-linked entry of calcium. A similar reduction in GABA
release was found when cortical slices were used. Waller & Richter
(1980) extended this observation, showing that pentobarbitone
(5 x 1CTVM) reduced only the calcium-dependent potassium-evoked
release of endogenous GABA, glutamate, aspartate and acetylcholine
from rat mid-brain slices, leaving the resting release unaltered.
This reduced the likelihood that the results of experiments using
radio-labelled exogenous transmitters were spurious, reflecting only
the transmitters' uptake and release from neuro-glia (which also
have a pronounced GABA uptake system). A comparable calcium-
dependent potassium-evoked release of glycine has also been found,
but so far only in the spinal cord.
Thomson & Turkanis' result was supported by that of Procter &
Weakly (1975): both pentobarbitone and phenobarbitone in
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concentrations up to 5 x lCT^M progressively reduced the amplitudes
of MEPPs and increased the quantal content of the EPP. The former
effect was quantitatively the greater, especially with pento¬
barbitone, because the EPP amplitude was, if anything, reduced. A
bathing solution with high magnesium (9-10mM) and low calcium
(0.6-0.7mM) content was again used.
Meanwhile, Richards (1972, 1974) also had interpreted the
results of his experiments with pentobarbitone in terms of a pre¬
synaptic effect. He measured evoked field potentials in slices of
olfactory cortex, and found that pentobarbitone at 5 x lCf^M to
6 x lCT^M reduced the EPSP in a dose-dependent manner without
affecting the compound action potential in the lateral olfactory
tract. Since there was no change in the threshold for electrical
stimulation of olfactory tract fibres nor for the synaptic
excitation of post-synaptic cells, and post-tetanic potentiation
and frequency potentiation were either unchanged or enhanced by
2-3 x lCT^M pentobarbitone, he concluded that a reduced transmitter
output from presynaptic terminals was likely.
Other studies have been concerned with inhibitory synapses.
Recurrent inhibitory postsynaptic potentials (IPSPs) in cat moto-
neurones were prolonged by hexobarbitone (Larson & Major, 1970).
This was not the result of a protracted Renshaw cell discharge. A
range of anaesthetics has been shown to reduce the synaptic
excitation of granule cells in the olfactory bulb, and to prolong
the post-synaptic inhibition of mitral cells (Nicoll, 1972). A wide
dose range of anaesthetics was effective. Reduced break-down of
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GABA was ruled out as a possible explanation of the latter effect.
Scholfield (1980) has recently shown that the inhibitory after-
depolarisation recorded intracellularly from cells of the olfactory
cortex was prolonged by all general anaesthetics he tested,
including three barbiturates (among them pentobarbitone), but not by
the local anaesthetic lignocaine. The effect was dose-related and
was already considerable at concentrations that were still sub-
anaesthetic. At higher concentrations (e.g. 2 x lCT^M to lCT^M
pentobarbitone) he recorded depression of the early EPSP component
of the response to stimulation of the lateral olfactory tract, and
also a reduction in the input resistance of the neurones.
Barbiturates have thus already been shown to have more than one
action relevant to synaptic transmission. Perhaps the best
documented effects are those on the postsynaptic responses to GABA
and glutamate. These will be considered in greater detail in
Sections V (GABA) and VI (glutamate). Suffice it to say now that
potentiation of GABA responses seems to occur in a variety of
preparations, but is maximal at sub-anaesthetic doses. The
depressant effects on glutamate responses occur with rather higher
doses of barbiturates.
Phenylcyclohexylamines
These compounds are derivatives of phencyclidine (Figure 1-2),
whose properties typify those of the group. Pharmacological effects
of the parent compound (1-(1-phenylcyclohexyl)piperidine HC1) were
described by Greifenstein et_al (1958) in their report on the
clinical trials, and by Chen et al (1959). Tests in mice and rats
showed a quietening effect of low doses, but induction of a
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Figure 1-2
Structures of phencyclidine and its derivative ketamine
Phencyclidine
Ketamine
cataleptoid state or of general anaesthesia by high doses: this
state progressed to convulsive seizures in some species. Non-toxic
doses had few autonomic effects and, despite phencyclidine's having
local analgesic activity approximately twice that of procaine, no
depressant effect on skeletal muscle.
Thus it was apparent from the outset that here was a compound
which, unlike the barbiturates or the volatile anaesthetics,
produced a state of agitation or convulsions in high doses (0.5-
lmg/kg); a lower dose (0.25mg/kg) allowed surgical incision and
sometimes a complete operation. Amnesia occurred even though an
element of consciousness remained during the operation. Muscle
relaxation and cardiovascular depression were notable by their
absence, but some respiratory stimulation was reported. However,
disturbing psychotic side effects also occurred: in the clinical
trials 10 out of 64 patients were unmanagable during the post¬
operative period, showing manic behaviour. Although the violent
reactions could be controlled by opiates such as pethidine or
morphine, phencyclidine was subsequently withdrawn from use in man.
It has however been retained for use in non-human primates.
Ketamine, the representative drug used in this investigation,
was developed during a search for a phencyclidine-like drug that was
shorter acting and had no psychotic effects. First reports of its
use in monkeys (McCarthy et al, 1965) and in man (Domino, Chodoff
& Corssen, 1965) were favourable although some psychotic changes
were recorded, usually vivid dreams or even hallucinations (Corssen
& Domino, 1966). In appropriate dose, approximately 5 times that
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of phencyclidine, ketamine produced similar analgesia, but the
anaesthetic effect was of shorter and more controllable duration. A
to
broad range of doses produced immobilisation, and su^jequent tests
showed that anaesthesia was induced in some species (monkeys, mice
and pigeons) in which phencyclidine caused convulsions. The
features of this type of anaesthesia which have led to its continued
use are the good analgesia coupled with the maintenance of
protective reflexes and the lack of depressant effects on the
cardiovascular system: the latter makes it particularly suitable for
use in poor-risk patients. However cardiovascular stimulation,
thought to be central in origin, somtimes constitutes a contra¬
indication (White, Way & Trevor, 1982) .
After its introduction into medical practice, ketamine was
evaluated in several species of domestic animals including non-human
primates (Beck & Dresner, 1972); cats (Beck, Coppock & Ott, 1971) ,
pigs (Thurmon, Nelson & Christie, 1972) and dogs (Kaplan, 1972).
More recently it has been used successfully in horses, in
conjunction with xylazine premedication, and in birds. Excitatory
side effects have been noted, particularly in pigs during recovery,
but were controlled with thiopentone sodium or halothane.
Excitement occurred more frequently in older animals and in animals
that had been roughly handled. Convulsions reported in 3.4% of dogs
were of the tonic-clonic type, all occurring between 2 and 7 minutes
after the injection of ketamine and all responding to thiamylal.
The routine premedication in Kaplan's study consisted of atropine,
which partially countered the stimulation of salivation, acetyl
promazine, to control hypertension, and thiamylal, which was found
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to reduce muscle rigidity and make the results of anaesthetisation
more predictable.
There were varying degrees of muscular hypertonus and
purposeful movements occasionally occurred despite the level of
anaesthesia's being such as to suppress motor responses to noxious
stimuli. Interestingly, although interference with calcium binding
or fluxes has been proposed to account for the biphasic effect of
ketamine on the twitch response when muscle is stimulated directly
(initial potentiation succeeded by a blockade), ketamine has been
used safely in patients suffering from myopathies or known to be
susceptible to malignant hyperthermia (White, Way & Trevor, 1982).
The latter condition, which is triggered by certain anaesthetics and
muscle relaxants, is thought to be related to an abnormality of
calcium regulation in muscle cells (Hall, Lucke & Lister, 1980).
Any general effect of ketamine on calcium metabolism is likely also
to have repercussions on synaptic function.
Effects on the central nervous system (CNS) Much of the abundant
literature concerning ketamine relates to attempts to define and
explain the anaesthetic state produced. Corssen & Domino (1966)
pointed out early on that although the reactivity of the CNS was
altered, there was no true sensory blockade and the motor reflexes
were not only intact but often hyperactive. The term "dissociative
anaesthesia" was coined by Miyasaka & Domino (1968) to describe the
state induced by ketamine. However, as Winters etjal^ (1972)
remarked, the former authors used doses of ketamine (l-16mg/kg) that
were lower than those required to permit surgery (usually 20-
40mg/kg). Winters suggested that ketamine be classified rather as
- 26 -
an excitatory agent capable of inducing a state of cataleptic
anaesthesia; because surgical procedures could be performed only
after doses that induced a cataleptic state that was accompanied by
seizure activity in the hippocampus. This slow wave seizure
activity, described also by Mori et al (1971) and Manohow, Maxwell
& Winters (1972), was likened by Kayama & Iwama (1972) to the
seizures of petit-mal epilepsy, and the two have since been shown to
respond in a similar manner to the anti-epileptic drugs
trimethadione and diphenyl hydantoin (Kayama, 1982). Kayama
concluded however that the seizures could not, as had previously
been supposed, be related to the hypnotic effects because whilst
trimethadione inhibited seizure activity it did not alter the
behavioural responses of cats to ketamine. It should be noted that
Kayama, too, used sub-anaesthetic dose rates (2-6mg/kg i.v.).
Seizure waves were confined to sub-cortical levels and Reder, Trapp
& Troutman (1980), showing that ketamine (10-100mg/kg) protected two-
day old White Leghorns against convulsions produced by pentylene
tetrazole, concluded that ketamine has anti-convulsant activity in
areas of the CNS which it does not stimulate. They also recorded
that a dose of lOOmg/kg, which was fully protective against
convulsions, itself induced "bike-pedalling" activity in all birds
tested.
There is general agreement that it is principally the
association areas of the brain that are depressed by ketamine. It
might therefore be predicted that in the simpler brain of the
lamprey ammocoete (see p.38) ketamine would have little effect.
However, ketamine has been used to induce anaesthesia in fish
- 27 -
(Oswald, 1978); although the dose required (13Qng/kg) caused
respiratory depression such that Oswald considered the drug contra-
indicated. This dose is considerably greater than that used in
mammalian species (20-40mg/kg) and it is possible that lower
vertebrates are relatively insensitive to ketamine. It is
interesting that much lower doses have been used clinically in man
(l-5mg/kg i.v.; 7-13mg/kg i.m.): this, in view of the greater
development of the association areas in the human brain, suggests
that a different pharmacological action is important to the
anaesthetic effect in different species. An alternative explanation
may be that there are species differences in the permeability of the
blood-brain barrier to ketamine.
Optical isomers of ketamine differ in their properties
A patent application for ketamine and related compounds, to be used
as cataleptic agents in humans and animals, was filed in the U.S.A.
in 1962 by Stevens on behalf of Parke Davis & Co.. Subsequently two
optical isomers were separated and patented by Hudyma et al on
behalf of Bristol-Myers Co.. Both isomers were anaesthetic and anti¬
convulsant, but pharmacological studies have since shown that the
(+) isomer has greater potency (Ryder, Way & Trevor, 1978). At equi-
analgesic doses in mice the (+) isomer caused less locomotor
stimulation and had less hypnotic activity than did the (-) isomer,
which suggests that the underlying mechanisms of these actions are
distinct. Loss of the righting reflex was used as the index of
hypnosis, and the "phenyl quinone writhing test" to assess the
analgesic effect. These differences were quantitative: Meliska,
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Greenberg & Trevor (1980) have since described qualitatively
different effects of the isomers in behavioural tests in mice. Few
studies have attempted to distinguish between the properties of the
enantiomers, the majority using, as here, the racemic mixture.
Steroids
Interest in steroid anaesthesia began with the observation that
intraperitoneal injection of several steroid hormones to mice and
rats caused a reversible loss of consciousness (Selye, 1941).
Subsequent investigation revealed pregnanedione as the most potent
steroid tested, and as one without detectable hormonal effects
(Selye, 1942). A derivative of pregnanedione, hydroxydione, was
introduced into clinical practice in 1955, but was found to have
certain disadvantages including a slow onset and long duration of
action in comparison to thiopentone. More seriously, pain on
injection and post-anaesthetic thrombosis were common, and the onset
of side effects was delayed in the same way as was the anaesthetic
effect.
The objective in developing steroid anaesthetics had been to
find an intravenous induction agent which had a greater therapeutic
index than the barbiturates and whose effect was terminated by some
factor other than redistribution in the body. In many respects the
steroids were promising: induction and recovery from anaesthesia
were pleasant, surgical conditions were good (Sutton, 1972) and the
action was terminated by detoxification in the liver. Attempts to
resolve the problems of undesirable side effects and low water
solubility were therefore continued.
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Solubility had been reported by Selye (1942) to be an important
factor limiting the anaesthetic effect of steroid hormones, and
measures such as dissolving the steroid in a surface active agent,
polyoxyethylated castor oil (Cremophor EL), have been used. Rapid
induction and high potency were associated with a free 3ot-OH group
in the steroid molecule, and in a screening programme in which
compounds were administered intravenously to mice, 3o(-OH-5ocpregnane-
11,20-dione (alphaxalone, Figure 1-3) was the most potent
tested. It was originally tested as an aqueous suspension (the
British patent application in 1970 was for a sterile aqueous
suspension or redispersed lyophilised solids) but was later marketed
dissolved in Cremophor EL. Addition of a second steroid,
alphadolone acetate (Figure 1-3) further increased the solubility
(by a factor of 3) whilst adding a lesser anaesthetic activity to
the solution. A more concentrated solution could thus be prepared
and the volume of an injection reduced by a corresponding amount.
This product, known originally as CT 1341 and since marketed as
Saffan for veterinary, and Althesin for medical use, has been used
throughout the present study. Its composition is:
Alphaxalone 9mg/ml
Alphadolone acetate 3mg/ml
Cremophor E.L. (B.A.S.F.) 20Qmg/ml
Sodium chloride (AR) 2.5mg/ml
Water for Injection B.P. to 100%
no antibacterial agent is included.
In the ensuing Sections this product is referred to as alphaxalone
because concentrations are expressed in terms of this: the principal
Figure 1-3
Structures of pregnane and its anaesthetic derivatives
Potent anaesthetics are produced by making simple substitutions on
the pregnane molecule (left). In alphaxalone (right) "R" = H.
In other anaesthetic derivatives "R" may be H, OH or an ester
(usually succinate or phosphate).
 
active constituent.
There has been a continued search for a water-soluble
anaesthetic steroid that is also acceptable in other respects: one
promising contender, minaxolone, has been withdrawn pending long term
toxicity studies. Other side effects remain a problem and
adverse reactions occur rather more frequently with Althesin than
with the barbiturates, sometimes leading to cardiovascular collapse.
These reactions appear to be of two types: one, involving
Complement, occurring on first exposure in subjects who frequently
have previously shown atopic phenomena, and the other, a hyper¬
sensitivity reaction, occurring on repeated exposures (e.g. Radford,
Lockyer & Simpson, 1982).
Child et al (1971) reported on anaesthetic tests using
CT 1341 in a variety of mammalian species, and the drug then passed
into clinical trials. Early clinical experiences were described by
Campbell et al (1971) and Clarke et al (1971). Both groups
reported muscle movements or tremors in some patients, excitatory
effects that were dose-related. However, whereas the latter found
the incidence of excitement to be 5% at 30^1/kg, 50% at 100^1/kg
and 75% at 200 j^l/kg; the former claimed that involuntary movements
occurred more frequently at their lower dose rate (100 ywl/kg as
opposed to 150 ^1/kg) and when the patient was stimulated.
Comparing CT 1341 with other available induction agents, Clarke et
al found the incidence of excitatory effects second only to that
after methohexitone administration. These effects occurred soon
after injection and subsided spontaneously.
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Subsequent studies evaluated the new drug for use in domestic
animals including cats (Child et al, 1972; Evans, Aspinall &
Hendy, 1972), horses, sheep and pigs (Hall, 1972). Apart from
hyperaemia, there was said to be a low incidence of side effects in
cats, but those reported included muscle twitching and occasional
emergence excitement. Excitement constituted a more serious problem
in horses when paddling and galloping movements alternated with mild
trembling and contractures of isolated muscle groups during the
recovery period. These effects, reduced by acetyl promazine and
almost abolished by xylazine, are of particular interest in relation
to the lamprey study, as are the occasional excitatory reactions
reported in other species. Hall did not comment on excitement in
pigs or sheep, but reported a low incidence in cats (3 out of 71).
The low water solubility was a particular problem in the larger
species because of the volume of injection necessitated. Histamine
release caused by Cremophor E.L. rendered the product useless in
dogs unless an anti-histamine drug was incorporated in the
premedication.
Modifications of the alphaxalone molecule, such as the
introduction of substituents and double bonds, alter its anaesthetic
activity. Rearrangement of the molecule as in -alphaxalone,
can lead to the loss of anaesthetic activity. Richards & Hesketh
(1975) showed that -alphaxalone (5 x 10_5"m) depressed the
population EPSP measured in the olfactory cortex by only 10-15%,
whereas the depression due to alphaxalone was 30-60%. In contrast,
both compounds reduced the depolarisation-secretion coupling as
assessed by measurement of MEPPs at the mouse neuro-muscular
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junction (Pennefather, Puil & Quastel, 1980). Lawrence & Gill
(1975) found that the isomer both was inactive as an anaesthetic
and produced less disordering of phospholipid/cholesterol bilayers;
perhaps because, being a planar structure, it could more readily be
incorporated into the membrane without causing disruption of its
structure. Comparison of the properties of the various isomers
should assist the identification of effects important to
anaesthesia.
Effects on the CNS The neuropharmacology of alphaxalone is not
well documented. However, the effects on the EEG seem to be
excitatory as are those of )(-0H butyrate (Bimar & Lepouleuf, 1973;
Timrns, 1976). Alphaxalone has been reported to precipitate
epileptic convulsions in susceptible individuals (Uppington, 1973),
an action also reported for hydroxydione and methohexitone, but not
for thiopentone. Anti-convulsant activity of alphaxalone has also
been demonstrated: against generalised convulsions induced by
pentylene tetrazole (Bimar & Lepouleuf, 1973) or exposure to
hyperbaric oxygen; and against focal seizures produced by local
application of penicillin (de Riu, Susini & Ruju, 1982). Cases of
benzodiazepine-resistant status epilepticus have been successfully
treated with alphaxalone. The apparent conflict may stem from the
doses used: de Riu et _al gave a dose of 0.9mg/kg alphaxalone
(O.lml/kg Althesin) to rabbits, whereas the anaesthetic induction
dose in this species is about 18mg/kg. Also, the focal convulsions
were induced by the application of penicillin to the pia of rabbits
already anaesthetised with ether. The only major discrepancy
Gyermek & Soyka (1975) reported between the central actions of
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hydroxydione and those of the barbiturates was that the latter
depressed monosynaptic reflexes unaffected by the steroid and caused
a more complete block of polysynaptic reflexes. A direct comparison
between alphaxalone and barbiturates was not made but the EEG
changes were similar: spindles appeared and progressed to
hypersynchrony. The main effect of alphaxalone was on the sensory
and limbic systems; evoked potentials in the reticular formation
were unchanged or depressed.
In contrast to the 5^- steroids, alphaxalone does not seem to
cause hyperaesthesia. Smaje (1976) and Richards & Smaje (1976),
recording spike activity extracellularly, have shown that 5 x ICT^M
alphaxalone reduces the sensitivity of guinea-pig prepyriform
cortical neurones to both acetylcholine and glutamate.
Imidazole derivatives
Following reports of the use of the imidazole derivative
"methoxymol" for the anaesthesia of birds (Marsboom, Mortelmans &
Vercruysse, 1965; Cooper, 1970), Janssen et al (1971) published
the results of animal tests with a new derivative, etomidate.
These, and subsequent experimental studies and clinical trials,
suggested that here was a successful short-acting hypnotic with a
rapid onset of action and minimal effects on the circulation.
Etomidate was first used in man in 1972 under ECG and EEG control.
It is the ethyl ester of l-(l-phenylethyl)-lH-imidazole-5-carboxylic
acid (Figure 1-4), and is generally marketed as the more soluble
hydrochloride. Detoxification is by hydrolysis probably mainly in
the liver (Ghoneim & van Hamme, 1979), and the kidney is the only
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Figure 1-4
Structures of anaesthetic imidazole derivatives






important route of excretion (Meuldermans & Heykants, 1976). All
metabolic products were found to be pharmacologically inert.
Doenicke et al (1982) administered etomidate intravenously by
bolus injection and infusion. Each injection caused a steep rise in
the plasma concentration and a moderate deepening of hypnosis,
whereas during infusion there was no such change in depth and only
a moderate increase in plasma concentration. Rapid exchange of
etomidate between the blood and cerebro-spinal fluid (CSF) was
correlated with the short hypnotic activity. Schiittler et al
(1980) using an infusion that maintained the plasma concentration at
about 0.5^g/ml found that the concentration on recovery was about
0.3 J*g/ml, whereas Doenicke et al reported that recovery occurred
at 0.13 jwg/ml.
The methyl ester also has hypnotic action (Godefroi & Platje,
1972) and was introduced into veterinary practice at about the same
time. Reports appeared concerning its use in pigs ( Callear & van
Gestel, 1973; Symoens & Gestel, 1973, 1974), horses (Hillidge, Lees
& Serrano, 1973) and cats (Erhardt et al, 1978); since when it
has been used clinically, mainly in pigs. Clinical reports on the
two drugs were uniformly favourable although a relatively high
incidence of non-purposive muscle movements and of myoclonia was
mentioned by some authors (e.g. Kay, 1976; Holdcroft et al,
1976). The latter, having compared the incidence of various side
effects of etomidate anaesthesia in man after four premedication
routines, reported that in many patients the excitatory phenomena
evoked were reflex and that opiate premedication made induction
acceptable in more than 90% of patients. Dundee et al (1961) have
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reported that pain can aggravate the excitatory muscle reactions
seen during methohexitone anaesthesia, and an equivalent effect may
underlie Holdcroft's findings. Studies of the use of metomidate in
domestic animals have usually incorporated a premedicant: the
butyrophenone azaperone in work on pigs, or the opiate fentanyl in
dogs and cats. Erhardt et al (1978) reported cramps and ataxia in
about 50% of cats during induction and recovery when fentanyl was
the premedicant; but since this ataxia was reduced by treatment with
the opiate antagonist Levallorphan, it probably arose from the
actions of fentanyl. A low incidence of tremors (4%) and myoclonia
(0.8%) was reported when azaperone was used as the premedicant in
pigs (Symoens & van Gestel, 1973).
Effects on the CNS Both etomidate and metomidate occur as two
optical isomers. Those of etomidate have been studied separately
and only the (+) isomer was found to be hypnotic when injected into
the cerebral ventricles (Hill & Taberner, 1975). The (-) isomer
failed to cause loss of the righting reflex in mice in doses of up
to 500 [Ag, whereas the ED)0o for a lQmin loss of the reflex was 67 ^g
for the (+) isomer.
Available reports suggest a GABA-mimetic action of (+)-
etomidate in several preparations: etomidate-induced depolarisation
was depressed by known GABA antagonists (Evans & Hill, 1978). The
previous report (Hill & Taberner, 1975) of an effect of (+)-
etomidate to depress the firing of single neurones in the medulla
was open to several interpretations and in any case occurred at
supra-anaesthetic concentrations (5 x 10"^ M, whereas concentrations
- 36 -
in the range 5 x 10~6M to 3 x 10-s"m have been measured during
etomidate hypnosis). In vitro tests using rat brain tissue showed
that neither isomer depressed the mitochondria when applied at
hypnotic concentrations, nor did they affect the active uptake of
radio-labelled GABA or glutamate. EEG changes occurring during
metomidate and etomidate-hypnosis have been likened to those
effected by the anaesthetic barbiturates (Doenicke et al, 1982).
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The Preparation
Although this dissertation is the report of a pharmacological
study of selected anaesthetic agents and is therefore principally
concerned with the drugs, brief comment on the biology of the
lamprey and on the reasons for the selection of the reticulo-spinal
cell preparation is appropriate.
General
Lampreys, of which several species exist, together with
hagfishes are the sole extant Ostracoderms, palaeozoic jawless
fishes. Grouped as the Cyclostomes, they are eel-like aquatic
chordates with a very primitive CNS. Because of their transitional
evolutionary position, lampreys have been studied extensively by
comparative neuro-anatomists so that a wealth of literature is
available. However, some (e.g. Nieuwenhuys, 1977) dispute that
they can properly be regarded as the phylogenetic ancestors of the
higher vertebrates, arguing that they have developed independently
from the hypothetical common ancestral craniate. Notwithstanding
this caution, it is recognised that the lamprey brainstem retains
many primitive features and contains the rudiments of structures,
such as the hippocampal cortex, which are developed to a far greater
extent and assume a functionally important role only in the higher
vertebrates.
Taking a linear view of the evolutionary process, Karamyan
(1972, 1975) placed the cyclostomes at Stage II in the development
of the CNS. In cyclostomes, integrative functions are performed by
the mesencephalic/bulbar apparatus; and although afferents
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transmitting information of different modalities have distinct
distributions within the brain, individual central neurones are
polymodal and the organization of the afferent system remains
diffuse. Diffuse organization is regarded as a primitive feature.
By contrast, the next stage (Stage III), which includes the fishes,
is marked by the development of the cerebellum, this together with
the mesencephalic nerve formations becoming the main apparatus for
the integration of afferent information.
Several recent reviews of the neuro-biology of lampreys are
available and the following account draws on those of Shapovalov
(1975), Nieuwenhuys (1977) , Hardisty (1979) and Rovainen (1979).
Reticulo-spinal cells
The bulbar reticulo-spinal cells that were used in this study
form part of the somato-motor system. The reticulo-spinal
projection is believed to be the most fundamental - phylogenetically
the oldest - direct line of supra-spinal motor control. It is
present in all classes of vertebrates from the cyclostomes to the
mammals, and is not subject to much interspecific variation,
occupying a constant position in the brain and spinal cord. Its
antiquity and persistence testify to its continuing importance,
although the precise role of this system has altered during the
evolution of the CNS. In mammals rapid motor signals are carried
by the pyramidal tracts and oL-motoneurones, but there is also
increased dependence of the spinal motor centres on higher centres
in the brain: the #-cells and Renshaw cells are influenced by
supraspinal structures.
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The bulbar cells are among the most prominent cells in the
lamprey brainstem and can readily be seen with the aid of a
dissecting microscope (x 40). Giant cells occurring bilaterally in
pairs were first described in the 19th Century (Muller, 1840) and
were found to be constant in position between specimens. These
Muller cells have been subjected to many subsequent studies (e.g.
Johnston, 1902; Tretjakoff, 1909; Saito, 1928; Stefanelli, 1933) as
have the giant axons present in the spinal cord. There was however
no consistent definition of a Muller cell in the classical
literature. For the purposes of this dissertation the
classification of Rovainen (1967) will be used: he defined Muller
cells as the cells of origin of the 8 pairs of uncrossed giant axons
in the medial longitudinal fasciculus of the spinal cord. These
cells are located in three brain regions:
the mesencephalon (cells Ml - 3);
the isthmus separating the 3rd and 4th ventricles (II);
the rhombencephalic basal plate (B1 - 4).
It is cells of the latter group that have been used for this study,
the bulbar cells lying near the midline in the centre of the medulla
immediately under the ependymal layer (Tretjakoff, 1909).
Nieuwenhuys (1972), in his slightly different classification, termed
this region the Nucleus reticularis rhombencephali medius. Smaller
reticulo-spinal cells also occur in this location but are less
readily seen and were not used in this investigation: the column of
reticulo-spinal cells is in fact continuous from the tegmentum to
the (lower order) primary somatomotor cells of the caudal hindbrain
(Addens, 1933).
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Afferent connections: Tretjakoff (1909), using a Golgi staining
method, was the first to demonstrate the dendrites of the Miiller
cells. More recently, Martin (1977, 1979b) used an intracellular
injection technique with the dye procion yellow to investigate the
ramifications of the dendritic trees of the Miiller and Mauthner
cells. Figure 1-5 shows six bulbar cells so stained. The bulbar
cells had ovoid somata with the long axis oriented transversely, and
their dendrites extended laterad, ventrad and caudad but did not
cross the mid-line. Comparing the dendritic trees with those of
mammalian reticulo-spinal neurones, Martin pointed out that both
were primarily distributed in a transverse plane, and both
intermingled freely with passing (descending and ascending) fibres.
As for the source and type of information carried by the
afferent fibres, Veselkin (1966) recorded the activation of large
axons in the medulla and spinal cord following optic nerve
stimulation; whereas Rovainen (1967) recorded, in nearly all
reticular neurones tested, some combination of EPSPs and IPSPs in
response to electrical stimulation of the optic, trigeminal,
vestibular and lateral line nerves. There was no consistent
pattern of response, nor was there any response to olfactory nerve
stimulation. Rovainen made no attempt to mimic the natural
stimuli, but deduced from the response latencies and the anatomical
relations of the Miiller cells that the sensory paths were
polysynaptic, possibly (Nieuwenhuys, 1977) being relayed in the
tectum. Nieuwenhuys considered that the existence of a spino¬
reticular projection was likely, but none had then been described.
Afferent synapses have also been described throughout the
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Figure 1-5
Bulbar reticulo-spinal cells (Mliller cells) stained with
procion yellow.
Orientation as in Figure II-3: long axis vertical with rostral
end at the top. Magnification xl80
(R.J. Martin, reproduced with permission)
 
length of the giant axons. These distributed synapses are by their
location, adjacent to the efferent synapses with segmental
motoneurones, admirably placed to modify the output to individual
motoneurones by local polarisation effects. Sub-threshold EPSPs
have been recorded (Rovainen, 1967), temporal or spatial summation
being necessary for impulse trains to be generated in the
motoneurones. Electrophysiological evidence for the existence of
the distributed synapses was presented by Rovainen (1967), and
involved simultaneous recordings from the cell body and axon whilst
the ipsilateral trigeminal nerve was stimulated.
Efferent connexions: The principal efferent channel for impulses
from the soma of a Muller cell is the giant axon. Miiller axons run
in the ipsilateral cord and are thought to act as pre-motoneurones
in that they synapse directly with the segmental motoneurones
(Rovainen, 1974). Morphologically these are mixed synapses, with
characteristics both of electrical and of chemical junctions.
Before the axon widens to continue as a giant axon, there is a
narrow section in the brainstem which, according to Martin (1979b)
could permit the integration of synaptic currents at the axon
hillock.
In contrast to the abundant axon collaterals of mammalian
reticulo-spinal cells, the giant axons of the lamprey Muller cells
are generally unbranched (Rovainen, 1967). However, a detailed
study of the brain and spinal cord of a single adult sea lamprey by
serial sections revealed not only some giant axons that migrated
from the ventral columns of the cord as far as the dorso-lateral
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column, but also that these deviant axons were mostly branched.
None however was observed to cross the mid-line (Rovainen et al,
1973) .
The size of the Miiller axons, and their action as the
functional terminals of the cells, making synapses directly with the
segmental motoneurones at all levels of the cord, suggest that this
is a channel for the rapid transfer of information that requires
little peripheral modification (see Rushton, 1951). The cell
bodies of the primary motoneurones are located immediately lateral
to the giant axons with dendritic trees that are confined to the
ipsilateral side. Both "fast" and "slow" primary motoneurones
occur.
Buchanan & Cohen (1982) recorded EPSPs from almost all slow
muscle fibres tested when swimming was induced by the application of
D-glutamate to the spinal cord. Action potentials were found in
twitch fibres only during high intensities of bursting activity in
ventral spinal roots. However, they also found that repetitive
stimulation of Miiller cells during such induced swimming evoked an
increase in "burst" activity in the ventral roots which was
associated with an increase or decrease in the frequency of
occurrence of bursts. Increased activity in Mliller cells should
therefore result in an increased activity of twitch fibres. These
considerations are consistent with Rovainen's finding (1967) that
movements elicited by intracellular stimulation of bulbar axons
included undulations or rapid waves of contraction spreading caudad,
and that with high frequency stimulation (100/sec), twitches of the
whole ipsilateral body occurred. Rovainen (1967) did not
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distinguish between the movements elicited by stimulation of the
various bulbar axons. However, he subsequently reported that B3 and
B4 make excitatory synapses with ipsilateral myotomal motoneurones
and lateral interneurones whereas B2 excites only the latter. The
information concerning the efferent connexions is still fragmentary
but implies that B3 or B4 could activate undulatory swimming
movements.
In relation to the movements elicited by stimulation of the
bulbar cells, it is interesting that Selzer (1978) found that
swimming movements were restored several weeks after complete spinal
cord transection in lampreys, but only at a time when some limited
regeneration of the reticulo-spinal axons could be demonstrated.
Histological and physiological evidence indicated that there was no
regeneration of long axon tracts: 12 out of 18 axons regenerated,
were branched and had migrated from their normal path. Selzer
suggested that new synapses were formed between the axon sprouts and
proprio-spinal interneurones, and that it was through these
contacts that descending volleys initiated rostral to the lesion
could activate giant interneurones. The implication of Selzer's
work was that some signal from higher centres is required to
initiate swiirming.
Transmitter systems: Both excitatory and inhibitory afferent inputs
to the bulbar Miiller cells have been described, but the natural
transmitter has not been positively identified at any synapse. A
wide range of putative neurotransmitters is now recognised and
several of these have been applied to the cells in an attempt to
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identify likely candidates for the role of natural transmitter.
The cells are known to respond to exogenous GABA and glycine
(Martin, 1978; Matthews & Wickelgren, 1979a), glutamate and
aspartate (Matthews & Wickelgren, 1979b). Of these Matthews &
Wickelgren favoured glycine as the inhibitory, and glutamate as the
excitatory transmitter. These responses are considered in greater
detail in Sections V & VI.
Transmitters tested and found to be without detectable effect
included acetylcholine, carbamylcholine, noradrenaline, dopamine,
histamine and 5-HT (Matthews & Wickelgren, 1979a). The observation
with acetylcholine was consistent with the earlier finding of
Wachtler (1974) that acetylcholinesterase activity, although present
elsewhere in the lamprey brainstem, was absent from the Miiller cells
and M'uller fibres.
The lamprey as a model for the study of the effects of
anaesthetics
...pour comprendre cette action ainsi interpretee,
rappelons que le chloroforme n'agit pas uniquement sur les
§lbments nerveux: loin de la, cet agent porte en rialite
son action sur tous les tissus; il atteint chaque Element h
son heure, suivant la susceptibility ... l'effet se
manifeste sur les autres tissus, apres qu"il s'est deja
manifeste sur le tissu nerveux, le plus dllicat de tous ...
1'anesthisique n'est done pas un poison special du systdme
nerveux; il anesth^sie tous les elements, tous les tissus
en engourdissant, en arr^tant momentarement leur
irritabilite nutritive...
Bernard (1875)
Bernard sought to justify the use of non-nervous tissues in
experimental studies of anaesthesia. In the light of this the
lamprey reticulo-spinal cells seem admirably suited for such a
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study: not only do they have counterparts in the mammalian brain,
but they respond to the same neuro-transmitters in an ostensibly
similar manner. However, Bernard claimed too much. It is true
that anaesthetics depress tissues other than the brain, but it is
not necessarily true that all effects contributing to an anaesthetic
state are produced in the same way or are manifestations of a single
non-specific action.
Lamprey ammocoetes were readily available in local waters and
could be maintained satisfactorily for long periods. The lamprey
brainstem has several features that make it a suitable preparation
in which to study the neuropharmacology of anaesthetic drugs. It
combines one of the virtues of invertebrate preparations -
accessibility - with the CNS organisation of a vertebrate.
Experiments could be carried out on identified cells which yet
retained many of their normal relationships. Intracellular
recording enabled changes in input resistance and membrane potential
to be measured. This was preferable to the use of indirect measures
of cell responses, such as changes in spike frequency. The bulbar
reticulo-spinal cells lie close to the surface of the 4th ventricle,
covered only by a single layer of ependymal cells; thus the
diffusion path for drugs applied in the perfusing Ringer is short
(Martin, 1979a,b). By applying drugs directly to the cells the
complicating influence of indirect circulatory effects was avoided.
In the lamprey brain, blood vessels are confined to the periphery
and so neither obscure nor impede access to the cells. Visualis¬
ation is also aided by the absence of myelin.
Most of the experiments described in this dissertation
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(Sections V & VI) were concerned solely with postsynaptic effects.
Furthermore, they have taken no account of processes subsequent
to the postsynaptic potential: no measurement of the impulse-
generating process has been made. These experiments
represent an advance inasmuch as anaesthetic effects on identified
brain cells in situ have been examined. These are cells some of
whose connexions are known, so prediction of the consequences
of observed effects in the living animal has a solid foundation. As
already described, the cells are thought to constitute a major motor
outflow to the somatic musculature of the lamprey. The equivalent
cells in mammals also have a motor function (Shapovalov, 1975). Any
stimulation of the neurones by anaesthetics, effected either
directly or via the removal of inhibitory influences, should
therefore elicit movements.
The results presented add to the growing body of data which
indicates distinct actions for different anaesthetics, but whether
any or all of them relate to mechanisms of anaesthesia must be a
matter for conjecture. The lamprey is a simple animal probably not
consciously aware of its surroundings; the mammalian reticulo-spinal
tract in any case is not concerned with mechanisms of consciousness,
and no role for the amino acid transmitters in such mechanisms has
been demonstrated. The techniques employed in this study involve
application of putative transmitters in the general vicinity of the
cell; these substances may not be identical to the natural
transmitters and may not necessarily act on the same receptors that
are involved in normal synaptic transmission. Although it cannot be
certain how far results obtained using the lamprey preparation are
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applicable to anaesthetic-induced unconsciousness in manmals, it
seems likely that they are relevant to the problem of voluntary
muscle movements which may occur during anaesthesia, and probably to
other brain functions which involve these same transmitters: the







Lamprey amrnocoetes were obtained locally from tributaries of
the Tweed. They were most readily caught in shallow areas of the
stream where the bed was mud or sand and the water was slow moving.
Initially electric fishing tackle belonging to the Tweed
Corrmissioners was used at the mouth of the Eden water near Kelso
(Grid reference: NT 766 376). Latterly, Departmental equipment
became availableand was used in the Eddleston water, between
Eddleston and Peebles (Grid reference: NT 238 454). This equipment
(Safari 100 Man Pack Electro Fisher: Marine Electrics Ltd. Donegal)
was designed with a landing net as the anode and, as the cathode, a
metal plate which could be trailed on the stream bed. It was
powered by two 12 volt batteries and gave out pulsed d.c. at
frequencies up to 400 Hz. Unidirectional pulsating current causes
fish to swim towards the cathode; if sufficiently strong, it
paralyses them (see Madden & Houston, 1976). The effect on lampreys
was to attract ammocoetes from their burrows in the stream bed and
then to paralyse them. Lampreys, unlike small fish in the vicinity,
were not always totally immobilised but their movements were so
sluggish that they could readily be netted or picked out by hand.
The anmocoetes caught were of two species: Lampetra
fluviatilis (river lamprey) and Lampetra planeri (brook
lamprey). The species differ slightly in appearance but no
distinction relevant to this investigation has been reported, either
in the organization of the brainstem or in the neuropharmacology of
the reticulo-spinal system. The responses of the bulbar Milller
cells are also similar to those of cells in the sea lamprey
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(Petromyzon marinus) on which many previous experimental studies
have been performed (e.g. Rovainen, 1967; Wickelgren, 1977; Matthews
& Wickelgren, 1979a,b).
In the laboratory the ammocoetes were stored in plastic tanks
measuring 44 x 33 x 18cm. The tanks were periodically replenished
with fresh stream water and were aerated using standard aquarium
pumps (Whisper 400: Interpet). Supplementary feeding proved
unnecessary when the tanks were provided with washed sand or grit
from the stream bed and the temperature was maintained at 4-6°C.
The sand enabled the ammocoetes to make burrows and also provided a
limited supply of nutrient material; additional feeding would have
increased the organic material present and so have added to the
oxygen demand. Tanks were always thoroughly cleaned before a new
batch of animals was introduced.
Ammocoetes 8-15cm long were anaesthetised with neutralised
tricaine methane sulphonate (lO'^g/l) and then transected caudal to
the gills. The rostal portion was divided in the ventral midline
and, after tissues covering the ventral notochord had been removed,
was pinned out on Sylgard (an elastomeric silicone resin) in the
experimental chamber, dorsal surface uppermost. A longitudinal mid¬
line incision exposed the brainstem. Removal of the choroid plexus
then exposed the bulbar reticulo-spinal cells, near the centre of
the 4th ventricle clustered on either side of the midline (Figures
II-1 to II-3). The preparation was continuously perfused with
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Dorsal view of brainstem
Orientation transverse with rostral end to the left.
Tissues covering brainstem divided in midline and pinned back.





Diagram of the preparation showing the location of micropipettes.
Bulbar reticulo-spinal cells (Miiller cells) lie in the floor of the
4th ventricle between the sulcus limitans of His (arrows) and the
median longitudinal sulcus (double arrow). Positions of recording
(V) and iontophoresis (T) electrodes are indicated.
 
Experimental Arrangement
The experimental chamber was constructed from perspex and
contained a central rectangular well with a drainage hole at one
end. After a layer of Sylgard 184 had been placed at the bottom the
liquid capacity of the well was 1ml. Beneath and around the sides
of the central well was an outer compartment through which could be
circulated cold fluid (see Figure II-4). The chamber was mounted on
a perspex base which was screwed to three rods and thence to the
cast iron base plate. This plate, to which were bolted also the
micro-manipulator mountings, rested on dense foam blocks. The
blocks, which acted as shock absorbers, rested on concrete paving
slabs placed across a rigid metal trestle. Micro-manipulators
(Zeiss) were used to hold the recording electrodes and those used
for the iontophoretic application of transmitters. The chamber was
illuminated from below and the preparation viewed through a
dissecting microscope (Olympus zoom microscope). Muller cells were
easily seen using the low power of the microscope. The microscope
was mounted separately so as to avoid unnecessary jolting of the
table.
Cooling was achieved by a flow heater (FH 15: Grant Instruments
(Cambridge) Ltd.) used in conjunction with a refrigerated flow
cooler (FC 15) and bypass system (BS 15). The system was filled
with proprietary anti-freeze, and a continuous record of temperature
in the well was made by a thermistor probe connected to the pen
recorder. This temperature was controlled to ± 0.5°C, and its
relation to the temperature set at the circulator is indicated in
Figure II-5. A high degree of control was necessary because the
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Figure II-4
Diagram to show experimental arrangement





A: Relation of temperature in experimental chamber to that set
at flow cooler: a continuous record with thermistor movements and
alterations in temperature settings at times indicated.
B: Variations of membrane potential (upper traces) with
temperature in chamber (lower traces).
Direction of changes: hyperpolarisation and decrease in temperature
downwards. Downward transient deflections of the membrane potential
are in response to injected current pulses.
A
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resting membrane potential of the bulbar Miiller cells showed marked
temperature sensitivity (see Figure II-5). The thermistor was
calibrated against a mercury thermometer, using as fixed points:
melting ice, and cold tap water (16°C).
Perfusion System
A continuous flow of Ringer through the chamber was provided in
early experiments by a peristaltic pump (Ismatec). The pump was
later abandoned in favour of a system of gravity feed, which allowed
solutions to be changed with minimal disruption of the flow and with
more precise timing. This change also removed one source of
electrical interference. Two aspirator jars were clamped to a 4ft
retort stand placed on the bench, and the outflow tubes so arranged
that there was an optional communication between the lines. The pre¬
terminal section of each line lay within the tube that led the
coolant away from the experimental chamber. This arrangement ensured
that the Ringer entering the chamber was cool: the counter flow
maximized the efficiency of heat exchange.
In order to assess the adequacy of the flow rate, the empty
chamber was filled with a dilute solution of potassium
permanganate, and the time measured for all traces of colour to be
flushed out. A flow of 6ml/min achieved this within 20-30s.
Ringer Solutions
The solutions used to perfuse the preparation were modified
from that used by Martin, Wickelgren & Ber^nek (1970) (Table II-l).
The original solution used (solution A) included a Tris maleate
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experiment, the Ringer was modified by the inclusion of 15mM
magnesium to minimize trans-synaptic effects (del Castillo &
Engbaek, 1954; del Castillo & Katz, 1954) .
During the course of the experiments, particularly in the
sunmer months, it became apparent that preparations could rarely be
used for more than 6-7 hours after they were decapitated. After
this time it was found repeatedly that cells deteriorated before an
experiment could be completed, even if the membrane potential was
high when a cell was first penetrated. The whole preparation also
took on an opaque appearance. In order to reduce this problem
temperature control was instituted and the Ringer was modified. No
attempt was made to assess the influence of the individual changes,
but the overall result was a marked improvement in the useful life
of the preparation.
Martin (1978, 1979a) used solution A but he, too, noted opacity
of the preparation in the later stages of an experiment, and in any
case did not attempt to prolong experiments beyond about seven hours
(Martin, personal communication). In view of reports that several
artificial buffers, including Tris, have adverse effects on other
preparations (Gillespie & Mcknight, 1976; Altura et al, 1980), it
was decided to revert to a bicarbonate buffer as used by Martin,
Wickelgren & Beranek (1970) for experiments with lampreys. A small
amount of sodium dihydrogen phosphate was also included, and this
solution (solution B) was used for some experiments. However, the
solution was hypertonic to lamprey haemolymph, especially when the
magnesium concentration [Mg1-'*'] was raised (solution B). Recorded









A0.456°C in Lampetra fluviatilis (Hardisty, 1956) and
A0.40°C in Lampetra planeri (Morris, 1958); and the ionic
composition given by Robertson (1954) for Lampetra haemolymph sums
to 238.7mMolAg (Table II-2). The freezing point depression of
solution B was not measured, but its ionic content exceeded 238.7mM.
It was decided to reduce the tonicity of the Ringer by
adjusting the concentration of NaCl. Thereafter, solutions C or D
(Table II-l) were used in all experiments. A COA0*. mixture (5:95)
was bubbled through the solution continuously. These changes were
beneficial: there was no evidence of a reduction in either the
resting membrane potentials or the ability of the Miiller cells to
generate action potentials, despite the reduced sodium
concentration. However some change in membrane potential may have
been masked by the effects of the newly instituted temperature
control.
Because it was impossible to reproduce exactly the environment
in which the Miiller cells exist in the living animal, the criteria
used to indicate acceptable conditions were the measured behaviour
of the cells and the appearance of the preparation. Solutions C and
D were satisfactory in this respect. The problems of Ringer
composition have been discussed in greater depth by Beament (1960)
and by Lockwood (1961). Lockwood reported that inclusion of a
respiratory substrate, glucose in this study, reduced the tendency
of isolated tissues to lose potassium ions and to gain sodium,
chloride and water; and improved the metabolic activity particularly
of brain cells, these having a high turnover of ions but only a
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limited store of energy. Reduction of the experimental temperature
(from room temperature, 18-22°C, to 10°C) should also have helped to
preserve the energy stores because it resulted in a reduced level of
spontaneous synaptic activity (not illustrated).
The level of spontaneous activity was also used as the
criterion when deciding by how much to raise [Mg1+]. The solution
used, containing 15mM magnesium, abolished all spontaneous
potentials; but it cannot be certain that evoked activity would be
similarly suppressed because this was not tested. Nor can an
interaction between magnesium and the anaesthetics be ruled out.
However, the results of Section IV - showing only a small
stimulation of synaptic activity, and this from only two anaesthetic
solutions - suggest that the contribution of any such interaction to
the observed effects (Sections V & VI) would be minimal. Any
changes in membrane potential measured when a drug was applied were
therefore provisionally attributed to direct effects of the drug on
that cell.
Fresh Ringer solutions were always prepared for an experiment,
using stock solutions of the individual salts.
Recording System
Standard intracellular recording techniques were employed to
measure the trans-membrane potential and the input resistance of the
bulbar Miiller cells.
Micropipettes were pulled from glass capillary tubing (GC 120F
-15, Clark Electromedical Instruments) using a vertical electrode
puller (Cat. No. 2001, Scientific & Research Instruments Ltd.).
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They were back-filled with 2M potassium methyl sulphate using a
syringe and 28g 2.5in needle. Filling of the tip was aided by a
fine fibre present in the tube lumen.
The criteria used to assess the acceptability of an electrode
were its appearance, on inspection and under a microscope, and the
voltage response to injection of a constant current pulse. An
electrode was rejected if the tip was broken or distorted, if air
bubbles were present in the shank of the pipette, if the resistance
fell outwith the range 15 to 30MJI, if the time constant of the
response exceeded 0.5ms, or if there was appreciable (>10%)
rectification as evidenced by asymmetrical responses to current
pulses equal in magnitude but opposite in polarity.
The properties of an electrode often altered during an
experiment. An increase in electrode resistance could sometimes be
reversed by briefly increasing the capacitance feedback of the
circuit so as to induce oscillations. This manoeuvre, also used to
effect cell penetration, is thought to cause vibration of the
electrode tip, and it may have dislodged particulate material
blocking the tip.
Measurement of input resistance
The input resistance was measured as the change in membrane
potential produced by injection of a constant hyperpolarising
current pulse through the recording electrode. A bridge circuit
(Martin, 1977) was used to balance the potential change due to the
electrode resistance, which was of the same order or up to lOx
greater than the cell's input resistance. The bridge circuit was
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switched off while the electrode resistance was being measured.
Bridge circuits of different design have been described, for example
by Coombs, Curtis & Eccles (1959). Both these authors and Frank &
Fuortes (1955) commented on the change of electrode properties with
time: the latter reported quite extensive changes in resistance when
the electrode was moved short distances within the tissue of the
spinal cord. Coombs et al (1959) found that the electrodes did
not behave as simple resistances, especially when the injected
current exceeded 30nA, or the resistance 20MJI: this was also the
case in the present investigation. However, the hyperpolarising
pulses used in this study did not exceed l.OnA. When the electrode
resistance increased unduly it became impossible to "balance the
bridge": this was the reason why some penetrations were abandoned
while the cell showed no sign of deterioration.
Despite its limitations, the bridge method of measuring input
resistance has been used in the present study because the interest
was in changes in resistance rather than in its absolute value, and
there was a higher probability of a successful experiment if
penetration with a second electrode was not required. Even with a
two electrode system, in a cell 30-50^ in diameter the tips would
be sufficiently close for artefacts to be introduced into the
measurements.
The high input impedance pre-amplifier incorporating the bridge
circuit was built in the Department to a design previously used by
Martin (1977). It was connected to the recording electrode via a
Ag/AgCl wire placed in the stem of the micropipette. An Ag/AgCl
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electrode (E 208, Clark Electromedical Instruments) was placed in
the bath to act as an indifferent electrode. Membrane potentials
were displayed on a cathode ray oscilloscope (Tektronix, 5113 Dual
Beam Storage Oscilloscope) and a permanent record made using a high
speed pen recorder (Lectromed, MX 212).
Criteria for satisfactory penetrations
Muller cells were penetrated under direct visual control. Most
cells had resting membrane potentials in the range -60 to -65mV and
input resistances greater than 3Mil. On several occasions the
penetration was not clean and was irmediately followed by a rapid
discharge of action potentials, considered to be an "injury
discharge". Sometimes this discharge was protracted and accompanied
by a continued decline of the membrane potential, which commonly had
been in the range -45 to -50mV when first measured. Such cells were
badly damaged and were not used. In other cases the discharge of
action potentials ceased within l-2min, and there was then a
recovery of the resting potential and a gradual increase in input
resistance. When their membrane properties had stabilised it was
considered admissable to use these cells for experiments, as it was
likely that the observed phenomena could be explained by a gradually
improving seal of the surface membrane around the micropipette.
Further evidence of the satisfactory condition of cells was the
observation at high gain of spontaneous synaptic potentials (see
Section IV).
Application of Neurotransmitters
Apart from the preliminary tests, in which amino acids were
applied to the preparation dissolved in the perfusate, the technique
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of microiontophoresis (del Castillo & Katz, 1957; Curtis, 1964) was
used. This decision meant that the better control of transmitter
concentrations afforded by the former method was sacrificed in the
interests of allowing an experiment to be completed within a
reasonably short time span. However, even with bath application of
transmitter, the concentration achieved at the receptors cannot be
known accurately because of the uncertain influence of uptake
mechanisms. Prolonged bath application would not allow measurement
of the peak responses if there were any desensitisation process.
3-barrelled glass micropipettes were routinely used for
iontophoresis. These were pulled using another vertical electrode
puller (S.R.I.) from fused capillary tubing (Clark Electromedical
Instruments, 3GC 120F-15). Use of this technique resulted in an
assembly in which the barrels were parallel but the tips, although
separate, were closely adjacent. The pipettes were back-filled in
the same manner as were the recording pipettes. It was feared that
such close apposition of the tips would lead to the spread of
solution between barrels, but when only one barrel was filled liquid
was rarely drawn into the other two tips. Furthermore, no
difference in the response to a transmitter was detected which could
be related to whether the three barrels were filled with the same or
different solutions, or two barrels were left empty. Electrodes in
which contamination was known to have occurred were rejected, as
were any that were improperly filled or whose tips were broken.
Iontophoretic currents employed in the experiments rarely exceeded
200nA, but each barrel used was capable of passing 800nA for 5s. If
no current was passed when the electrode was first tested, the tips
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were either broken back under a dissecting microscope using a soft
tissue, or, if only one channel was affected, that channel was not
used. An electrode was discarded if repeatable pulses could not be
obtained. If one channel ceased to pass the current set during an
experiment, the data for the transmitter affected were discarded.
Before being used, an iontophoretic electrode was held vertical
with its tips in Ringer for at least 3Qmin to allow a degree of
equilibration at the electrolyte-Ringer interface. This was done so
that regular pulses applied to the barrels would result in the
ejection of standard pulses of transmitter. Electrodes that were
still performing well at the end of an experiment were saved for re¬
use. In the interim they were stored held vertical with their tips
in distilled water, and covered to reduce evaporative losses. This
procedure did not result in detectable mixing of the solutions, and
on occasion an electrode was used on 5 successive days.
The solutions used were: GABA 0.5M pH 2.5
Glycine 0.5M pH 5.0
L-glutamate 2M pH 8.5
NaCl 0.5M pH 7.0
GABA and glycine were ejected as cations and glutamate as an anion.
Retaining currents were not routinely employed. Any leakage of
drug was insufficient to cause detectable changes in the membrane
potential or resistance of the cells, and the detection of such
changes would in any case have been the criterion by which a
retaining current was judged adequate. In view of Bradshaw &
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Szabadi's conclusion (1974) that the diffusional release of a drug
from the pipette tip was best countered by the use of dilute drug
solutions, low concentrations (0.5M) were used when possible.
However, glutamate responses of reasonable amplitude were recorded
only when the electrode was filled with a 2M solution.
It was necessary to estimate the direct effect of the ionto-
phoretic current on the Mliller cells. Pulses of reverse polarity
were therefore applied to the drug-containing barrels - invariably
with no detectable result other than that artefacts were recorded at
the onset and offset of each pulse. Since this was done with all
three transmitters, the lack of response was demonstrated both to
cationic and anionic currents. In addition, NaCl was incorporated
as a control in some experiments. In all experiments an Ag/AgCl
indifferent electrode was placed in the bath for the return of
iontophoretic current.
The ejection cycle was controlled by a micro-iontophoresis
programmer (Model 160, W-P Instruments Inc.) driven by a Digitimer
(D100). The three transmitters were applied in rotation by currents
that either were of the same strength or differed by a factor of
10. GABA and glycine were usually ejected by currents in the range
50 to 90nA whereas higher currents (100-400nA) were frequently
needed to elicit glutamate responses: a xlO switch present on the
programmer accommodated this difference. Pulses lasting between 0.3
and 7.0s were applied at intervals of 1 or 3min. The pulse length
was determined for each transmitter individually and then kept
constant for the duration of an experiment.
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In experiments testing the influence of transmitter
concentration on the anaesthetic effect only one transmitter was
used. To vary the transmitter dose a cycle of pulses of
differing durations but the same amplitude was employed. The
quantity of drug ejected by an iontophoretic pulse is affected by
the immediately preceding pulse, but the use of a fixed pulse
sequence ensured that this factor was unchanged during an
experiment. Differences between the amounts of the transmitter
delivered by the test pulses were therefore constant although
unknown, so measurements of the responses are comparable but only
within an experiment.
Both drug emission and retention are time-dependent processes
(Bradshaw & Szabadi, 1974), so there cannot be a retaining current
that is always just adequate. Furthermore, the relation between the
pulse length and the quantity of drug emitted must be non-linear,
particularly with short pulses. Therefore any dose-response curve
constructed in Sections V and VI must have a non-linear scale for
the abscissa (dose). However, use of the alternative method of
varying the dose, that of varying the pulse amplitude, would have
resulted in less reproducible doses and no gain in linearity -
unless pulses long enough to establish a plateau rate of release
were employed. The latter would however raise again the possibility
of receptor desensitisation.
Iontophoresis techniques are limited in that the concentration
of drug achieved at the receptor can only be estimated. Had
perfusion not been continuous, it would have been possible to make
some estimate by comparing the responses to identical pulses before
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and after a known movement of the electrode. However, the micro¬
manipulators were calibrated only for vertical movements and these
were not always in a plane normal to the cell surface. Furthermore
the complex cell architecture invalidates the implicit assumption of
a "point" receptor. Additional complications were introduced by the
existence of eddy currents caused by the obstruction which the
preparation presented to the flow of Ringer.
The effects of anaesthetics on transmitter responses
Anaesthetics were applied to the preparation dissolved in the
perfusing Ringer solution. No application was continued after
25min; this limit was imposed to allow the responses to recover
before cell deterioration supervened. The sequence of iontophoretic
pulses continued during the perfusion with anaesthetic. Changes in
input resistance associated with the transmitter actions were
measured by injecting constant hyperpolarizing current pulses
(strength 0.5-1.0nA; frequency 1Hz) whose duration was long (30ms)
in relation to the time constant of the cell (<10ms).
Penetrations were held for periods up to three hours, so
application of several concentrations of an anaesthetic to a single
cell was sometimes possible. When this was done, the solutions were
applied in order of increasing concentration, with or without an
intervening wash. Because of the possibility that anaesthetic drugs
may interact (Richards & White, 1981), only one was tested on any




The drugs used were GABA (Sigma), L-glutamic acid (BDH),
glycine (BDH), substance P (Sigma), tricaine methane sulphonate (MS-
222, Sandoz), pentobarbitone (May & Baker), ketamine (Vetalar, Parke,
Davis & Co. Ltd.), alphaxalone/alphadolone (Saffan, Glaxovet) and
metomidate (Hypnodil, Janssen). The vehicle present in Saffan was
kindly donated by Glaxovet. AnalaR grade reagents were used in the
preparation of Ringer solutions.
The veterinary medicinal product Vetalar contains:
Ketamine hydrochloride lOOmg/ml
Benzethonium chloride 1:10,000.
The ketamine base (di-2-(o-chlorophenyl)-2-(methylamino)
cyclohexanone) is 86.7% of the salt. Benzethonium chloride is
included as a preservative and the product is supplied as an acid
solution (pH 3.5-5.5).
Analysis of results
The responses to GABA and glycine were essentially similar.
Numerical values were obtained for the peak resistance changes as
indicated in Figure II-6A. A videoplan (Reichert-Jung) was used to
measure the time integral of the membrane potential response (area
"X"). Figure II-6B shows how the ratio of this area to the peak
hyperpolarisation distinguishes between an increase in area due
solely to an altered peak amplitude and one effected by prolongation
of the response. The ratio was calculated in experiments in which
pentobarbitone or ketamine were tested, because these drugs altered
the GABA response profile.
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Figure II-6
A. Tracing of a typical response to an iontophoretic pulse of GABA.
Vertical deflections (downward) from the resting membrane potential
are in response to repeated injections of hyperpolarising current
pulses (InA, 30ms). GABA was applied during the period indicated by
the horizontal bar.
Features measured: 1) peak change in membrane potential (Vz - V[ ),
2) membrane potential change in response to
hyperpolarising current pulses before (V^ - V, ) and during
(V^ - Vj_) action of GABA. The height of each vertical
deflection is directly proportional to the input resistance.
Because constant current pulses were used, the fractional
change in input resistance at peak GABA effect is
(Vj - V, ) - (V^ - \) .
(V^ - V, )
3) area (X) enclosed by the envelope of the
membrane potential response.
B. Diagram to illustrate use of measurement of ratio area : peak.
Control (- - -) and test ( ) responses are superimposed.
(i) Simple potentiation of membrane potential response.
(ii) Alteration of response profile showing both delayed peak
response and slowed recovery.
In both (i) and (ii) the area of the response is increased from
9mV.s (control) to 19mV.s (test); but whereas in (i) the ratio




In contrast to the hyperpolarising GABA and glycine responses,
those to glutamate were invariably depolarising. Fewer measurements
were made on the glutamate responses. The change in input
resistance was often barely detectable and could not be measured
with any accuracy. Furthermore there was no visible change in the
response profile following perfusion with anaesthetic so the
area:peak ratios were not calculated.
There was considerable variation between cells in the absolute
magnitudes of the responses, particularly in the membrane potential
measurements. Therefore, before different experiments were
compared, their results were normalised by expressing the change
in a GABA or glycine response measured during exposure to the
anaesthetic as a percentage of the mean control value in that cell.
Student's t-test was applied to these standardised data to assess
the statistical significance of the anaesthetic effects. The null
hypothesis used was that the proportional difference between the
mean response amplitudes in the control period and in the presence
of anaesthetic did not differ from zero. The numerical measurements
and significance values are shown in Appendices I & II. The results
are only semi-quantitative and the pictorial display of the
collected results given in Sections V and VI is probably more
helpful.
Two-way analysis of variance (AOV) used in conjunction with the
F test is a more powerful method of analysing data of this sort and
has been used in experiments on preparations, such as the neuro¬
muscular junction, where there is greater uniformity of the control
values. However, it is not applicable in the present case because
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normalisation of the results removes all variance from the
population of control readings, thereby invalidating the test.
Application of AOV to the raw (unstandardised) data caused some
dramatic results to appear insignificant: this occurred when the
differences between the control responses of different cells were
greater than the absolute values of the anaesthetic effects (see
Appendix III) . Those effects shown as significant in Appendix III
were genuine effects of the anaesthetic: when the "main"
(anaesthetic) effect was tested all sources of variation were taken
into account in calculating the variance ratio. The further
objection, that the change in response had not always reached
equilibrium, applies also to the t-test; but in the latter this








...a small flounder was introduced into a vessel filled
with solution of nitrous oxide in water over mercury. He
remained at rest for ten minutes and then began to move
about the jar in different directions. In half an hour he
was apparently dying, lying on his side in the water. He
was now taken out and introduced into a vessel filled with
water saturated with common air, he very soon recovered...
Davy (1800)
The term "anaesthesia" has received many definitions since it
was first coined by Dioscorides in the 1st Century A.D., but in
essence it is the reversible loss of conscious awareness of, and of
motor responses to, external stimuli including strong and noxious
stimuli. The extent to which a lamprey is consciously aware of its
surroundings is debatable; so therefore also must be the contention
that a lamprey can be anaesthetised. However lampreys, like fishes,
respond to light and vibratory stimuli, and several studies have
been made of anaesthesia in fishes (e.g. McFarland, 1959; Oswald,
1978; Stuart, 1981).
Each of the drugs used in this study has been reported to
anaesthetise fishes (see Stuart, 1981). The experiments described
in this section were carried out to test whether this was true also
in lamprey ammocoetes. Previous neurophysiological and neuro-
pharmacological studies have suggested that the lamprey brainstem
behaves in a similar manner and is organised along similar lines to
those of higher vertebrates (Section I). If extrapolations from the
actions of anaesthetics on transmitter responses in the lamprey are
to have any relevance to events occurring during anaesthesia in
higher animals, it is essential that it be known that the drugs
anaesthetise lampreys, and at what concentrations this occurs.
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Otherwise the argument that neurones of the lamprey brainstem may
differ pharmacologically from those of other species is hard to
refute.
Methods
Ammocoetes within the size range 40 to 120mm were used in the
experiments. A treatment group (three ammocoetes) was rarely
exposed to more than one drug concentration during an experiment,
and never to more than one drug. In the preliminary tests the
anaesthetics were dissolved in Ringer solution C (1.8mM Mgr+):
subsequently fresh stream water was used. Ammocoetes were exposed
to the same concentrations of the drugs as those used in the
experiments of Sections IV, V and VI.
Before exposure to an anaesthetic, all groups were left at room
temperature for an hour to permit the water temperature to stabilise
- both the stream water and the lampreys were stored at 4-6°C. At
the beginning of the test period each group was transferred to a
fresh vessel containing a 250ml volume either of an anaesthetic
solution or of stream water. A watch was kept on the unstimulated
activity of each ammocoete. Anaesthesia was classified according to
the scheme proposed by McFarland (1959) and since widely accepted
(see Table III-l). Comparable stimuli were used to test the
reactivity of the ammocoetes: a flashing light; tapping the rim of
the vessel in order to set up vibrations in the solution, and
sometimes direct agitation of the solution to create a similar but
stronger stimulus; and mechanically stimulating the ammocoetes by
pinching their tails with forceps.
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At the end of the test period the lampreys were transferred to
fresh stream water, and observations continued. In most cases the
exposure was limited to 30min; but the effect of the highest
concentration of alphaxalone (2.7 x 1CTVM) was so profound that the
ammocoetes were removed after 5min (and after lQnin from the next
lower concentration) in order to prevent unnecessary deaths.
Exposures to (10~3M) pentobarbitone and (3.7 x lCf^M) ketamine were
prolonged to 60min in case the anaesthetic effects of these
solutions were slow in developing.
Each drug was tested on a minimum of 6 ammocoetes. This number
was increased when the response was in doubt, as was the case with
pentobarbitone and the lower concentrations of ketamine. The
variable replicate numbers which resulted were accepted because no
statistical analysis of the results was envisaged. Most experiments
were conducted at room temperature (water temperature 15-18°C), but
alphaxalone was also tested at 4°C, with similar results. An
accurate record of temperature was not kept. The preliminary
experiments, in which anaesthetics were dissolved in Ringer, were
performed during June and July when the ambient temperature was
high; the solution temperature then may have exceeded 18°C. It is
recognised that both the rate of induction and the depth of
anaesthesia in fishes are affected by temperature, the induction
time commonly being shorter at higher temperatures (discussed by
McFarland, 1959; Houston & Woods, 1976). Notwithstanding this,
a strict acclimatisation routine was not employed because of the
essentially qualitative nature of the study. In any case, the issue
of possible temperature effects is peripheral to the main object of
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these experiments.
Pentobarbitone was tested also by direct systemic injection to
three ammocoetes. The ammocoetes were blotted and then weighed on
an Oertling balance. The dose for each individual was calculated on
a body weight basis and administered through a 28g needle as an
intra-peritoneal injection. A proprietary solution diluted 1:1000
with 0.9% saline was used (Sagatal, May & Baker; containing
pentobarbitone 60mg/ml). A fourth lamprey was injected with a
similar volume of 0.9% saline as a control. The three ammocoetes
received different doses of pentobarbitone:
1) 15mgAg;
2) 35mg/kg;
3) 15mg/kg followed after 15min by 30mg/kg;
and the volume of injection was of the order of 0.1ml. This was a
relatively large volume for an ammocoete weighing only about 1.2g.
Ammocoetes tolerated the procedures of weighing and injection
without undue resistance so prior sedation by bath application of
an anaesthetic such as tricaine methane sulphonate was considered
unnecessary. Use of a sedative might have masked some of the
effects of the injected pentobarbitone, although Oswald (1978)
claimed otherwise in his studies on trout. Restraint for injection
was achieved by covering the anterior portion of the ammocoete with
a swab wet with stream water, the animal lying on a smooth surface.
Following the injections, the ammocoetes were transferred to fresh
water and maintained in isolation for observation.
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Results
The results of the experiments in which anaesthetics were bath-
applied are presented in tabular form in Table III-2. McFarland's
scheme, used to classify the stage of anaesthesia reached at fixed
time intervals after exposure to a drug, is shown in Table III-l.
The behaviour of the ammocoetes fitted his description of
anaesthesia in fishes in general terms. The effects of the
anaesthetics are described separately below. No deaths ocurred
during this series of experiments.
Unstimulated ammocoetes exhibited a variety of behaviour
patterns that were characteristic yet are not readily described.
Once accustomed to the vessel the ammocoetes did not break the
surface of the water. Periods of quiet swimming alternated with
others when the ammocoetes lay on the bottom of the vessel dorsal
surface uppermost or, around the perimeter, with the dorsum against
the side of the vessel. Rapid movements were rare in unstimulated
ammocoetes. In control animals, both light and vibratory stimuli
caused an increase in the general level of activity. This
observation contrasts with McFarland's finding that visual stimuli
caused fish to sink to the bottom of the tank in a "fright"
reaction. Pinching the tail elicited a violent lashing escape
movement which usually freed the tail from the forceps; when escape
was impossible, the ammocoetes coiled back against the forceps. A
period of rapid swimming ensued which lasted for up to one minute.
It was notable that although forward progress was fast, the waves of
contraction passing down the body were relatively slow.
Breathing movements could be counted reliably only when the
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Table III-2
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Drugs dissolved in river water (unbuffered), times measured from
moment of transfer of ammocoetes to anaesthetic solution.
Classification of anaesthesia after McFarland (1959), tabulated
stages are the averages for the group (3-8 ammocoetes).
lampreys were still, but they appeared to be more frequent during
swimming. This indicated that the level of activity should be taken
into account before attributing a change in breathing rate to a
direct effect of the drug under test.
Pentobarbitone
Pentobarbitone was unique in not inducing anaesthesia deeper
than Stage I when bath applied in any concentration. Even 10"^ M
pentobarbitone produced only mild sedation in 8 ammocoetes.
Intraperitoneal injection proved more effective: these results
are presented in Table II1-3. Because the ammocoetes were
separated, measurement of the breathing movements was easier than in
the other experiments, and more readings were obtained. These
observations were not in accord with those of McFarland, pento¬
barbitone acting as a greater respiratory depressant in lampreys
than would be predicted from the level of anaesthesia induced. For
example, comparison of Table III-l with Table III-3 reveals that
Stage I anaesthesia was accompanied by a marked fall in breathing
rate in all three lampreys, but not in fish. Deep sedation was
produced by the higher dose levels - 30mg/kg (following 15mg/kg) and
35mg/kg - but surgical anaesthesia was probably never achieved.
No evidence of excitement was seen during either induction or
recovery; but there was a period (e.g. 20-40 minutes after receipt
of 15mg/kg pentobarbitone) when stimulation evoked exaggerated
responses, the lampreys seemed restless and non-propulsive movements
occurred. These movements characteristically were composed of
contraction waves which were more frequent and of shorter wavelength
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Table II1-3
The anaesthetic effect of pentobarbitone administered by
systemic injection
Pentobarbitone: 15mg/kg 30mg/kg* 35mg/kg
Exposure Stage Breathing Stage Breathing Stage Breathing




10 I 58 I 42
15 II-l





60 I 34 55 II-l 67
70 I 48
80 0 42 0
100 0 46 0
* following 15min after a dose (15mg/kg) which had no apparent effect
Classification of anaesthesia after McFarland (1959); tabulated
rates are breathing movements per minute.
than those occurring in the resting state or in the control animal.
The contraction waves passed both rostrad and caudad. Sedated
ammocoetes spent more time than did the control animal lying on the
bottom of the vessel. Nevertheless, even after their response to a
tail pinch was markedly reduced by 30mg/kg pentobarbitone, two
lampreys swam for short spells in a slow and uncoordinated manner.
Recovery was evidenced by restoral of the escape reaction to its
previous brisk nature.
Ketamine
The lowest concentration (3.7 x lCf^M) was tested on 15
lampreys. There was no excitement evident and only mild sedation
was induced. By about twenty minutes there was some loss of
equilibrium and incoordination apparent in all ammocoetes, but
movement was still stimulated by persistent vibratory or light
stimuli.
When first tested, dissolved in Ringer, this concentration of
ketamine had induced Stage II-2 anaesthesia within ten minutes in
all three ammocoetes, the lampreys making only feeble attempts at
escape when the tail was pinched quite hard. The failures of
attempts to repeat this observation may have related to temperature
differences - the preliminary experiments were carried out when the
ambient temperature was high (in July) whereas the majority were
performed during the winter months. Two batches of ketamine were
used on the second occasion so the difference cannot be attributed
to loss of potency of the solution. The tabulated results (Table
III-2) are those obtained using the new batch. A further
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preliminary observation had been that immediately on exposure to
ketamine all ammocoetes showed signs of irritation: rapid twitching
and lashing movements, rubbing against the side of the vessel and
attempts to leap out. This may have been the response to irritation
by acid (ketamine is supplied as the hydrochloride, in acid
solution). However, the point was not proved: when the drug was
tested more fully neither were the solutions very acid (see Table
III-4) nor did they have an irritant effect. It is interesting that
Ohr (1976) found neutralised tricaine methane sulphonate to be
more potent as an anaesthetic of goldfish and frogs, and to cause
less stress, than when it was tested in acid solution.
After five minutes exposure to 3.7 x 1CTVM ketamine the
responses to both light and vibratory stimuli were much reduced.
However, the brisk escape reaction was retained, and 2 out of 8
ammocoetes still swam spontaneously.
In contrast, 3.7 x lCf^M ketamine abolished spontaneous
movements within five minutes, and by fifteen minutes all ammocoetes
responded to a squeeze of the tail with only a brief and feeble
twitch. At thirty minutes this response also was lost. Recovery
from anaesthesia was uneventful and within forty minutes the
ammocoetes could be roused, some of them also swimming
spontaneously.
Alphaxalone
The immobilising effect of the most concentrated solution used
(2.7 x lCf^M) was instant and dramatic. All ammocoetes immediately
sank to the bottom, and although initially they twitched in
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Table III-4
The reaction of ketamine solutions and their effects on
breathing rates
Ketamine 3.7 x 10 3.7 x 10 3.7 x 10 3M
pH 7.2 6.9 5.2
Breathing 96, 84 62
(96, 120, 120) (112)
Breathing rate (per minute) measured during action of
anaesthetics; individual measurements quoted, with recovery values
in parentheses.
response to a tail pinch, there was no real attempt at escape. Two
minutes later this response had failed and the opercular rate was
reduced to between 14 and 28 per minute.
The onset of action of the more dilute solutions was gradual.
Within five minutes of first immersion in 2.7 x lCf^M alphaxalone
there was no response to vibratory or light stimuli. A brisk
reaction occurred when the tail was pinched but this was not
followed, as in the control group, by a period of swinming. The
twitch response was more sluggish after a further five minutes, and
the opercular rates recorded in two individuals were now 12 and 18
per minute. Exposures to both the higher concentrations of
alphaxalone were restricted to ten minutes.
The lowest concentration, 2.7 x 10"6M, was tested in the
expectation that anaesthesia would not be induced, since the
estimated concentration of alphaxalone in the brain during surgical
anaesthesia is 8 x 10~?M (Table III-5). Nevertheless, it was
evident after ten minutes that the general level of activity was
reduced as were the responses to stimulation, and by twenty minutes
the anaesthesia was classified as Stage II-2: pinching the tail
elicited only a twitch.
No hyperactivity was observed during induction with any
concentration of alphaxalone, but during recovery there was a period
when uncoordinated movements occurred: both rolling and other non¬
propulsive movements. Exaggerated reactions to stimulation, such
as have frequently been reported to follow alphaxalone anaesthesia
in mammals (see Section I) were not detected; nor were convulsions
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Table II1-5
Estimated brain concentrations of anaesthetics during clinical
use in fish
Anaesthetic Dose Brain Cone. (M) Effect on Fish Ref.
(Estimate)
Pentobarbitone 30mg/kg 1.1 x lCT^
i.p.






18mg/kg 8.1 x 1CT?
i.p.




13Qng/kg 9.5 x 10 ^ * surgical anaesthesia 1
surgical anaesthesia 1
surgical anaesthesia 2
* upper limit 1 = Oswald (1978) 2 = Stuart (1981)
Assumptions (Minchin, 1981): rapidly acting compounds (alphaxalone,
metomidate) distributed in E.C.F. (= 30% body weight); slowly acting
compounds (pentobarbitone, ketamine) distributed in total body water
(= 66% body weight); protein binding 40% for alphaxalone and
pentobarbitone.
elicited. Muscle tremors were not observed during the period of
anaesthesia. Recovery was slow, in contrast to the rapid induction,
and after ammocoetes were removed from the more concentrated
solutions it was an hour before there was even a slight response to
a tail squeeze.
Metomidate
All concentrations of metomidate tested had some sedative
effect on the ammocoetes, although in the case of 1.8 x lCf^M this
was limited to a slowing of the responses to stimulation: inter¬
mittent swimming still occurred. The two higher concentrations both
had an apparently irritant effect: immediately on being placed in
the solution the ammocoetes exhibited rapid thrashing movements,
rubbing against the side of the vessel and making as if to jump
out. This phenomenon was not investigated further, and the
experiments were not repeated with neutralised solutions because the
objective, to establish that metomidate could anaesthetise lampreys,
had been achieved. The behaviour of the ammocoetes was, however,
very similar to that just described for ketamine, and to that
regularly observed if an unbuffered (acid) solution of tricaine
methane sulphonate was used to anaesthetise lampreys prior to their
decapitation. Ammocoetes picked out of the 1.8 x 10_1M solution were
noticeably more rigid than the limp ammocoetes in the 1.8 x lCf^M
solution.
Recovery from metomidate anaesthesia was notable for its
rapidity. The three ammocoetes removed from a 1.8 x 10_3M solution,
where they were anaesthetised so deeply that a hard squeeze elicited
only a slight movement, were swimming within thirty minutes of their
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return to fresh water. Recovery from the effects of a 1.8 x lCf^M
solution took only between ten and twenty minutes.
Discussion
Anaesthesia in lampreys: their behaviour compared with that of
higher vertebrates
McFarland (1959) stressed the remarkable parallelism that
exists between anaesthesia in fishes and that in man, and concluded
that in both cases anaesthesia was produced by the sequential
depression of functionally equivalent nerve centres in the brain.
Anaesthesic stages were defined according to the brain functions
that were suppressed.
In this study, a comparable progression of stages has been
found in lamprey ammocoetes, such that McFarland's classification
scheme can be applied. The chief deviations of lamprey behaviour
from the scheme were in the nature of the "fright" response of
fishes to visual stimulation, and in the effects of anaesthetics on
breathing movements. These are points where McFarland, too, noted
some inter-species variations. The lampreys exhibited nothing
comparable to the fright response: stimulation, whether by light or
vibration, served merely to increase the level of activity. Such
responses are appropriate in the field, where agitation of the water
causes lampreys either to retreat into their burrows or, if they are
freely swimning, to increase their activity so that they can
maintain their position or reach quieter waters. Similarly, an
increase in activity in response to light stimuli can be seen to
favour lampreys' movement into shady areas, and so constitute a
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further adaptation to the burrowing lifestyle (Hardisty, 1979). A
fright response may require a higher level of integrative activity
than is present in the lamprey brain.
It is clear from Tables III-2 & III-3 that all four drugs
tested have anaesthetic activity in lampreys. Reference to Table
III-5 shows that, with the exception of pentobarbitone,
concentrations likely to obtain in the brains of fishes during
clinical anaesthesia were capable of inducing anaesthesia. The
equivalent figures for mammals (not shown) are of the same order.
Effective brain concentrations of the anaesthetics
The precise relation of anaesthetic concentrations in the CNS
to those in the water is uncertain. A dynamic equilibrium must
ultimately be reached between the various phases: external bulk
solution, solution at the absorptive surface, the blood, extra¬
cellular fluid and the various tissues and membranes of the body.
The length of time required for equilibrium to be achieved is
illustrated by the experiments using alphaxalone: a low
concentration (10-6M) initially had no apparent effect, but by
twenty minutes the ammocoetes were in Stage II-2 anaesthesia. This
result was surprising since the calculated CSF concentration of
alphaxalone during surgical anaesthesia in mammals is of the order
of 8 x 10"fM (Table III-5). However, in clinical practice
alphaxalone is usually given by i.v. bolus injection. Peak levels
are not sustained sufficiently for there to be equilibration within
the brain because elimination mechanisms are operative from very
shortly after the moment of injection. Much lower concentrations
are used in continuous infusion techniques. In this connexion it is
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interesting that Richards & Hesketh (1975) were rarely able to
expose olfactory cortex slices to 5 x lCf^M alphaxalone for more
than twelve minutes without causing irreversible loss of the
responses to the excitatory transmitters glutamate and acetyl
choline.
Factors affecting the anaesthetic potencies of drugs in
poikilotherms
The experiments in this section exemplify several points of
practical import to the anaesthetist working with aquatic poikilo¬
therms. Factors such as the oxygen content, temperature and
hardness of the water are important determinants of the narcosis
produced by a given dose. This observation, in addition to that of
species differences in sensitivity to noxious stimuli, led
Ollenschloeger (1975) to point out that general guide-lines, only,
can be given for dose-rates appropriate in fish. Such factors
operate by varying the availability of a drug to the absorptive
surface or, by metabolic means, by affecting the rate of elimination
of the drug. The routes by which drugs can be absorbed include the
skin and the gill system. Little is known about the former, but
Hunn & Allen (1974) have reviewed the literature concerning
absorption by the gills of fishes. Among the drugs they considered
was the lampricide "TFM" and, although they did not discuss its
basis, the existence of a selective toxic effect against lampreys
raises the possibility that the barrier to drug absorption is less
in lampreys than in fishes.
Factors affecting the rates of absorption of drugs do so by
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altering the trans-membrane concentration gradient or the
permeability of the absorptive membrane. They include the
temperature, pH and ionic composition of the external solution, as
well as the presence of any potential drug chelators or compound
that may alter the fixed electrical charges on the membrane
surface. Thus Houston & Woods (1976), working with rainbow trout
(Salmo gairdneri), found that the blood level of tricaine methane
sulphonate at the onset of anaesthesia was independent both of
temperature and of the body weight, despite the fact that the
concentration measured in the brain varied with temperature (that at
5<>C was lower than that at 15°C) . Factors pertaining to the test
animal are also important; in particular, the permeability of the
gill membranes and the blood flow to the gills. For example,
tricaine methane sulphonate reduces gill blood flow by up to 24%
(Houston & Woods, 1976), a self-limiting action, and other
anaesthetic drugs may have comparable effects, as they do on the
mammalian circulation (e.g. Vickers, Wood-Smith & Stewart, 1981).
The gill system of the lamprey presents but little barrier to
diffusion - two layers of cells, a basement membrane, and the
flanges of the pillar cells which enclose the blood spaces. The
total thickness of this barrier has been estimated at 4.57^.m in the
ammocoete (Lewis, 1976).
Temperature
The effects of temperature on the induction of anaesthesia in
poikilotherms are complex, and involve several stages in the
process. Temperature affects the activities of a wide range of
enzyme systems: a typical Q10 for an enzymic reaction is 2. Of
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direct importance to anaesthesia are those enzymes acting as ion
pumps to maintain the trans-membrane ion gradients and thus the
membrane potential. In addition, recent measurements of the
properties of single ion channels have shown that the open channel
lifetime is increased at low temperatures, at least in the case of
chloride channels operated by GABA and glycine. The depolarising
effect of a fall in temperature is illustrated in Figure II-5, and
must have repercussions on the excitability of excitable membranes.
Other transport systems, and therefore membrane permeabilities, may
also be affected, as may those enzyme systems that determine the
rate of elimination of a drug.
However, poikilotherms have been shown partially to compensate
for variations in temperature by making metabolic changes (Bullock,
1955). This observation was put forward by McFarland (1959) to
explain the discrepancies he observed between anaesthetic potencies
measured at different temperatures. The potency difference at two
temperatures was less if the fish were acclimatised to each
temperature tested, rather than being subjected to sudden changes in
temperature during the course of an experiment. Induction times
were generally less at high temperature. The effect of temperature
depended on the drug concerned and reflected the means by which it
was eliminated. Variations in temperature are likely also to affect
the physical properties of an anaesthetic solution, such as the
mobility of the drug, and thence also the availability of
anaesthetic to the absorptive surface.
In the present study lampreys were routinely stored at 4-6°C,
and before being used for an experiment, were left for an hour at
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room temperature so that the water temperature stabilised. Since
the results were essentially qualitative no detailed temperature
record was kept; but with the exception of ketamine, the recorded
anaesthetic levels were consistent to within a substage,
irrespective of the ambient temperature. As a further check,
alphaxalone was also tested at 4°C and was found to induce a similar
quality of anaesthesia then to that previously induced at room
temperature.
Pentobarbitone-calcium interaction
The anomalous behaviour of pentobarbitone was consistent with
previous observations on fishes, notably those of McFarland (1959)
and Oswald (1978), and with their conclusion that bath application
of the barbiturates is not a clinically useful procedure. McFarland
attributed the failure of barbiturates to anaesthetise marine
teleosts to an antagonistic action of the calcium in sea water;
observing that the anaesthetic effect of sodium amytal on Fundulus
was greater in fishes adapted to fresh water. Addition of a calcium
chelating agent, citrate, increased both the rate of induction and
the depth of anaesthesia in fresh water (Caz+ 0.28-0.30mM), although
not in sea water {Ca1-* 8.8-8.9mM) or fortified distilled water (Cax+
0.04mM). The mechanism of this calcium antagonism is unclear but
could involve complex formation with the barbiturate base, or a
direct effect of calcium on barbiturate uptake by the gills.
The hardness of the water used to dissolve a barbiturate is
thus of prime importance. Water used in the present investigation
was soft, obtained from local streams which had granite as the bed-
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rock. A sample of the fresh water had a total calcium content of
0.106mM, whereas one taken from a tank in which lampreys had been
stored for some weeks had 3.8mM total calcium. These
concentrations, like that in the Ringer solution used (2.6mM) were
in the range where addition of a chelator might have an observable
effect. This theory, however, was not tested.
Oswald (1978), administering pentobarbitone to trout by intra¬
peritoneal injection, found that whereas 30mg/kg produced sedation,
48mg/kg caused apnoea and 72mg/kg induced protracted anaesthesia.
Only 4 fish received pentobarbitone in that study, and only 3
lampreys received injections in the present experiments, but the
results were consistent. The apnoea mentioned by Oswald has a
counterpart in this study in the recorded slowing of the opercular
movements (Table III-3). Protracted recovery was not noted with
lamprey ammocoetes, nor was persistent ataxia; but the dose rates




The effects of anaesthetics on spontaneous synaptic activity
recorded in bulbar Muller cells
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Introduction
The experiments reported in Section III demonstrated that the
drugs used in this investigation are able to induce a state of
reversible loss of responsiveness (anaesthesia) in lamprey
ammocoetes. Because the experiments that form the bulk of this
dissertation were concerned not with the whole animal but with the
responses of the bulbar Muller cells to exogenous putative
transmitters, it was of interest to test also whether the
anaesthetic drugs influenced the spontaneous synaptic activity
recorded from these cells.
Abnormal patterns of activity were to be expected because
severance of cranial nerves and of the spinal cord produced partial
deafferentation of the Muller cells. Spinal section must also have
transected the giant axons, and there may have been other dissection
damage. However, other afferent connexions to the cells were
essentially undisturbed so it was likely that, while a preparation
remained viable, some normal synaptic activity would continue.
Small spontaneous potentials, both hyperpolarising and
depolarising, have been recorded from Muller cells (Rovainen, 1967;
Martin, 1977). Because all were eliminated when the magnesium
content of the bathing solution was raised to 10-15mM it was
inferred that their origin was trans-synaptic: a decrease in the
calcium-magnesium ratio in the external solution is known to inhibit
the release of transmitter from pre-synaptic nerve terminals (del
Castillo & Engbaek, 1954; del Castillo & Katz, 1954). I have not
considered it appropriate to make the detailed analysis of these
potentials a major feature of this investigation. In some
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preparations it is now possible to analyse synaptic events at the
level of single ion channels, using biophysical techniques such as
voltage and current fluctuation analysis and patch clamping (for
review see Mathers & Barker, 1982). Gold & Martin (1982b) have
recently applied noise analysis to the lamprey preparation and have
interpreted spontaneous inhibitory post-synaptic currents (IPSCs)
recorded under voltage clamp as the synchronous activation of around
1500 glycine "channels". They were unable to record IPSCs when
tetrodotoxin was included in the bathing solution: since this drug
blocks nervous conduction, the result suggests that the spontaneous
potentials seen in the present experiments were related to activity
in presynaptic terminals rather than to spontaneous quantal release
of transmitter.
Gage & Hamill (1976, 1981) have examined the effects of several
anaesthetics on motor end plate currents and miniature end plate
potentials in the mouse diaphragm preparation, and pointed out
certain differences between drugs. Barbiturates speeded the decay
of end plate currents and so limited the amplitude of the end plate
potential (EPP). This action was shared by several volatile
anaesthetics to an extent which was correlated with their lipid
solubilities. Despite reducing the end plate channel lifetime, high
concentrations of ether increased the duration of the EPP; a result
attributed to an anticholinesterase action of ether. The short
chain alcohols such as ethanol potentiated neuromuscular
transmission by increasing the lifetime of acetylcholine channels.
The authors concluded that there was insufficient evidence to
support any particular molecular model of the anaesthetic effects.
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Anaesthetics have long been known to disrupt brain function
both by inhibiting conduction of the nervous impulse and, at lower
concentrations, by interfering with inter-neuronal communication
(Larrabee & Posternak, 1952). The result must be to distort coded
information by altering the pattern of impulse traffic. If the
activities of the bulbar cells or of their inputs are appreciably
affected by anaesthetic drugs, this should be reflected in the
recorded spontaneous activity. It is of particular interest to
investigate the activity of reticular cells because the reticular
activating system has been implicated in the control of wakefulness
and has therefore been considered to be a prime target for
anaesthetic actions (Moruzzi & Magoun, 1949). The bulbar Miiller
cells, however, are not directly concerned with mechanisms of
consciousness, rather do they contribute to somatic motor control.
Anaesthetics are known to have dissimilar effects on the EEG
recorded from the reticular formation (Winters et al, 1972; Figure
IV-6 and see Section I). Such differences may be reflected in
differential effects on the synaptic potentials recorded from single
neurones, and may be caused by a combination of pre- and post¬
synaptic actions. Full discussion of the results of this section
has been deferred until Section VII so that the results of the
experiments in which postsynaptic effects were examined in isolation
can be taken into account.
Methods
The procedures for dissection and making electrophysiological
recordings from bulbar Muller cells have been described in Section
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II. After a cell had been penetrated, a continuous record of its
membrane potential was made using the pen recorder at high gain and
with a slow paper speed. The shapes of individual potential events
could more readily be seen on the oscilloscope screen. Detailed
analysis of individual potentials was not envisaged so a
photographic record was not routinely made.
The preparation was perfused with a Ringer solution containing
a physiological concentration of magnesium (1.8mM: Solution C).
Most experiments were conducted at 10°C, but the spontaneous
activity was originally noted during perfusion with Ringer at room
temperature (water temperature 15-18°C). The effect on the activity
of lowering the temperature to 2°C was also noted. Sometimes the
same cells were later used for iontophoresis experiments. In these
cases the [Mg7-+ ] was increased (perfusate changed to Solution D)
while recording continued to check that the spontaneous potentials
were indeed blocked as a result.
The results are presented as chart records in which a potential
"event" appears as a transient vertical displacement of the trace.
The lateral separation of the transients is indicative of the
frequency of events; transient length is a measure of the amplitude
of the potential displacements, within the limits imposed by the
frequency response of the chart recorder. The duration of a typical
small EPSP was 40ms: if this be regarded as the wavelength of the
fundamental signal, the implied frequency is 25Hz. Faithful
reproduction of the signal would therefore require a flat response
up to frequencies of the order of 250Hz. The manufacturer's
specification states that the frequency response of the chart
- 90 -
recorder is flat ±0.5dB at 20mm p-p deflection to 100Hz, and flat
±0.5dB at 50mm p-p deflection to better than 50Hz. It is therefore
likely that the shapes particularly of the larger potentials were
distorted - at the gain used routinely, small EPSPs caused pen
excursions of 8-12mm. Had a quantitative analysis been envisaged, a
different recording technique would have been appropriate, but for
the purposes of this study neither this source of distortion nor the
tangent distortion introduced by the design of the pen recorder was
important.
Anaesthetics were applied dissolved in the perfusing Ringer.
No osmotic compensation was made because the anaesthetic
concentration never exceeded 1CT3 M. When repeated applications were
made to a preparation, at least twenty minutes was allowed as a
recovery period between tests. More usually this period was between
thirty and forty minutes; but when successive solutions were
applied in order of increasing anaesthetic concentration there was
sometimes no intervening wash.
Results
Spontaneous synaptic potentials
When intracellular potential recordings were made at high gain,
small brief perturbations of the membrane potential could be
distinguished. Such spontaneous potential changes occurred in both
hyperpolarising and depolarising directions, with amplitudes usually
in the range 0.5 to 3.0mV. They have been interpreted as IPSPs and
EPSPs respectively. The rise and decay times varied with the
amplitudes of the potentials, but small events commonly lasted 40ms
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and had time constants close to 10ms (rise) and 15ms (decay). When
displayed on an expanded time scale so that their shapes could be
seen it was evident that some of the larger potentials were composed
of superimposed smaller events. There were discrete steps in the
amplitudes of the potentials but, because electrical interference
was appreciable when recordings were made at high gain, it was not
possible to measure the smallest displacements sufficiently
accurately to justify a quantitative analysis. The situation is
more complex than at the neuromuscular junction where all the
recorded MEPPs occur at a single synapse: there is no reason to
suppose that all EPSPs recorded from a Muller cell reflected events
at a single excitatory synapse. It is likely that, if the
potentials were quantal in nature, the unit response at each synapse
was different. This would complicate any analysis of potentials
using the Poisson or binomial distributions and necessitate the
accurate measurement of amplitudes. To facilitate description of
the sample traces displayed in Figures IV-1 to IV-5, for each
experimental condition the width of the envelope of the membrane
potential trace was measured at ten equally spaced points; and the
mean and standard error of each set of ten measurements was
calculated.
These potential transients were likely to result from the
action of small quantities of transmitter at synapses in the
vicinity of the recording electrode. Their amplitude should reflect
the change in conductance of the cell membrane, and the driving
force (due to the electro-chemical gradient) on the ion species to
which the membrane permeability was temporarily altered. However,
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no change in amplitudes or polarities of the transients were
detected when the resting membrane potential fluctuated (as in
Figure IV-1A) - since the reversal potential for IPSPs has been
shown to be only about 6mV negative to the resting potential in
these cells (Wickelgren, 1977) their amplitudes would be expected to
be very sensitive to membrane potential. The frequency of
occurrence of spontaneous potentials showed strong temperature
dependence; individual events could not be resolved at 15°C, whereas
at 4°C the transients were widely spaced in time (not illustrated).
Elevation of the magnesium content of the Ringer (changing from
solution C to solution D) abolished all these potentials.
When the spontaneous activity was greatly increased, as during
the application of glutamate or substance P, action potentials were
elicited (see Section VI). A few cells showed "bursting" activity
in which periodically there was a depolarisation of 6-7mV
accompanied by a burst of action potentials (e.g. Figure IV-3). It
is interesting that similar behaviour was also elicited by bath
application of substance P (Section VI). Other cells showed
intermittent hyperactivity, and it was for this reason that a
continuous record of membrane potential was made although only small
sections can be displayed. The records were made at slow speeds
because alterations in the frequency, or in the balance between
IPSPs and EPSPs, were then clearer.
The effects of anaesthetics
Each anaesthetic was tested on several preparations, initially
at room temperature. Under these conditions it proved impossible to
detect any influence of the anaesthetics, but a small change in
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activity would not have been apparent. A further problem was the
rapid deterioration of many cells. The results illustrated in
Figures IV-1 to IV-5 and tabulated in Tables IV-1 to IV-4 were all
taken from experiments in which the temperature in the chamber was
controlled at 10°C. No permanent record of the potentials was kept
in the other experiments.
Since the results have not been treated quantitatively, the
Tables show only the direction of changes in the frequency of
potentials: an increase in the proportion of large transients has
been recorded as an increase in frequency because superimposition
of small potentials had been observed. No amplitude measurements
have been recorded. In a few cases there was a biphasic anaesthetic
effect: for example, alphaxalone (2.7 x lCf^M) increased the
frequency before suppressing it (Figure IV-4). Such responses
figure twice in the table: as "+" and as "(-)".
The IPSPs were the more susceptible to anaesthetic blockade:
whereas the frequency of EPSPs was sometimes maintained or increased
while that of IPSPs was reduced, the converse never occurred. If
EPSPs were abolished the cell became quiescent. Similarly, during
the recovery period following exposure to an anaesthetic, it was
always the EPSPs which were restored first and sometimes they,
alone, returned. When activity was enhanced it was always
predominantly excitatory; although when the increase was pronounced,
as in the presence of 3.7 x 1CF*M ketamine (Figure IV-6), it was
impossible to resolve individual events and to ascribe a polarity to
them.
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Most cells had resting membrane potentials in the range -60 to
-70mV. No anaesthetic consistently altered the membrane potential.
Measurements of input resistance were not made in all cells. Those
that were made, and those made during the iontophoresis experiments,
showed that the highest concentrations of pentobarbitone and
metomidate (10~aM), only, affected the input resistance, causing a
small reduction.
Pentobarbitone
Pentobarbitone was tested at different concentrations on a
total of 8 cells from 5 preparations. Of these, results from three
cells in a single preparation are tabulated (Table IV-1), and
typical records are displayed in Figure IV-1.
There was a clear reversible depressant effect on all the cells
tested. It was a consistent finding that IPSPs were the first
lost; and that they reappeared, if at all, later than the EPSPs when
the preparation was washed. Increasing the concentration of
pentobarbitone from 10~^M to 10"^ M served only to emphasise the
depression. In one experiment from which sample records are shown,
the width of the envelope was measured in each experimental
condition; the figures (mean ±s.e.m., mV; n=10) were:
Cell A: Control 1.36 ±0.149
Pentobarbitone 2.5 x 10"*"M 0.90 ±0.080
Wash 0.78 ±0.039
(later) 1.15 ±0.106
In this cell pentobarbitone reversibly depressed the mean width
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Figure IV-1
The effects of pentobarbitone on spontaneous synaptic activity
(A) and (B) are sample records from different preparations. Note
that in both cases hyperpolarising potentials (downward transients)
are more completely lost and return later (B) or not at all (A).
Note also, particularly in (A), the apparent absence of effect of
fluctuations in membrane potential on the amplitudes and polarities
of the transients.
Exposure times: (A) 2.5 x lCT^M 5min; 10_i M 2min
(B) 2.5 x 10"^ M 4min






















The effect of pentobarbitone on spontaneous synaptic activity
IPSPs EPSPs
Pentobarb. + - n.c. + - n.c.
(M)
10-v 1 1
3-5 x 102 2
10~l 1 1
Figures tabulated are the numbers of tests in which an increased
(+), decreased (-) or unchanged (n.c.) level of activity (frequency
of potential transients) was observed.
of the envelope by 34%. The method is not entirely satisfactory
because it fails to distinguish between EPSPs and IPSPs. The mean
value gives some indication of the amplitudes of potential
transients, whereas the standard error is related more directly to
their frequency of occurrence: small values for the latter would be
expected when transients were either very frequent or very rare.
Ketamine
Ketamine at various concentrations was tested on a total of 15
cells from 11 preparations. Experiments conducted at room
temperature were hard to interpret, but Figures IV-2 and IV-3 show
sample records from a preparation tested at 10°C: the three cells
tested in this preparation all responded similarly. The collected
results from cells tested at 10°C are tabulated (Table IV-2).
In the cell illustrated, changes effected by ketamine at
concentrations below lO"^ M were not dramatic, with the exception of
the intermittent bursting activity recorded in the presence of
3.7 x 10-7 M ketamine. This was an isolated observation although a
dramatic result, and it cannot be certain that it was a genuine
effect of the drug. However, increased activity was also noted in
the presence of 3.7 x 10~fcM ketamine, and was a transient
observation during the onset of action of more concentrated
solutions.
The depressant effects of 3.7 x lCT^M ketamine were confined to
those on the frequency of transients, the amplitudes were not
detectably reduced, and were common to both IPSPs and EPSPs. They
were reversible on washing. In this cell the effects of the low
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Figure IV-2
The effects of ketamine on spontaneous synaptic activity
(part 1)
Sample records taken from 1 experiment. Depolarising potentials
(upward transients) increased by 3.7 x 10~?M ketamine. This change
was only partially reversed, and hyperpolarising activity appeared
during the wash period. Loss of hyperpolarising transients when
3.7 x 10_a"M solution applied may be coincidental, but depolarising
transients clearly reversibly reduced in amplitude and frequency.










The effects of ketamine on spontaneous synaptic activity
(part 2)
Records from later in the same experiment as that featured in Figure
IV-2. Ketamine at 3.7 x lCf^M had little effect, but vigorous
synaptic activity developed during the wash period. This settled to
intermittent depolarising excursions before ketamine (3.7 x 10->M)
re-applied. Thereafter depolarising excursions were followed by
similar vigorous synaptic activity for l-2min. The 2 samples shown
were typical of the alternating states. When the ketamine
concentration was increased to 3.7 x 10~VM smaller depolarising
excursions still occurred but were not succeeded by a general
increase in activity.












concentrations (Figure IV-3) were tested after washing off a more
concentrated solution (Figure IV-2), a fact which may have distorted
the results if traces of ketamine remained. When a 3.7 x 10"^M
solution was reapplied following the dilute solutions, the
suppression of the bursts of synaptic activity was dramatic, but the
depolarising excursions of the base-line on which this activity had
been superimposed remained.
The envelope measurements (mean ±s.e.m., mV; n=10) for this
cell were:
Control 1.16 ±0.092
Ketamine 3.7 X 10~5M 1.11 ±0.088 (= 4% decrease in mean)
Wash 1.30 ±0.104
Ketamine 3.7 X 10"*-M 0.73 ±0.042 (= 44% decrease)
Wash 1.10 ±0.086
Ketamine 3.7 X 10"bM 1.02 ±0.096 (= 7% decrease)
Wash 1.77 ±0.212
(later) 2.48 ±0.318
Ketamine 3.7 X lO"1 M * 3.70 ±0.434 (= 49% increase)
* 2.00 ±0.186 (= 19% decrease)
3.7 X 10-4M 1.08 ±0.044 (= 46% or 71% decrease
from previous test)
Wash 1.30 ±0.096
* these measurements were taken from samples representative of
the alternating states (see Figure IV-3).
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Table IV-2
The effect of ketamine on spontaneous synaptic activity.
IPSPs EPSPs
Ketamine + - n.c. + - n.c.
(ML
3.7 x 10"* 1 - 1
3.7 x 10~fc 1 1
3.7 x 10~s 2 3 3-2
3.7 x 10_i* 4 4
Figures tabulated are the numbers of tests in which an increased
(+), decreased (-) or unchanged (n.c.) level of activity (frequency
of potential transients) was observed.
Alphaxalone
Alphaxalone was tested on 4 cells from 4 preparations with the
results tabulated in Table IV-3. The 2.7 x 10-t>M solution was
tested after it had been found that the higher concentration
(2.7 x 10""?M) induced a transitory increase in activity. A clear
increase in the depolarising activity was produced by the lower dose
in 1 of 2 cells tested; in this cell the increase coincided with a
decrease in IPSP frequency. In some cells few IPSPs could be
distinguished from the baseline noise: but even in these a transient
alphaxalone-induced increase in EPSP frequency could be detected
(e.g. Figure IV-4B).
The late depressant effect of alphaxalone (2.7 x lCfrM) was
seen on more than one occasion (e.g. Figures IV-4A & B); and was not
just the result of cell deterioration, because in one case (Figure
IV-4A) a measure of reversal was obtained on washing: EPSPs but not
IPSPs returned.
The envelope measurements for the cells illustrated
(mean ±s.e.m., mV; n=10) were:
Cell A: Control 1.22 ±0.062
Alphaxalone (2.7 x 10~^M) 1.40 ±0.128 (17% increase)
Wash 1.14 ±0.042
Cell B: Control 0.78 ±0.063
Alphaxalone (2.7 x 10 fcM) 0.96 ±0.106 (23% increase)
Wash 0.86 ±0.100
Alphaxalone (2.7 x 10~^M) 0.80 ±0.109 (7% decrease)
(later) 0.53 ±0.021 (38% decrease)
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Figure IV-4
The effects of alphaxalone on spontaneous synaptic activity
(A) and (B) are samples from 2 different experiments. In both,
alphaxalone (2.7 x 10~?M) transitorily increased the frequency of
depolarising (upward) transients. Hyperpolarising transients were
also more frequent in (A). Prolonged application of alphaxalone
caused loss of activity (A): this was not always reversible
(contrast A and B). Despite the early increase in activity
following 2.7 x lCFfM alphaxalone, there was (A) no clear increase
when 2.7 x 10~6M alphaxalone was applied.
Exposure times: (A) 2.7 x lCT^M 2.5min
(B) 2.7 x 10-s"m 1.5min



















The effect of alphaxalone on spontaneous synaptic activity
IPSPs EPSPs
Alphaxalone + - n.c. (-) + - n.c. (-)
(M)
2.7 x 10"fe -11- 1-1-
2.7 x 10"5" 1141 4-22
Figures tabulated are the numbers of tests in which an increased
(+), decreased (-) or unchanged (n.c.) level of activity (frequency
of potential transients) was observed. Tests recorded in the
columns headed "(-)" are those in which the activity was reduced
only after first having been increased (see p.94).
Metomidate
Records were obtained of tests on 5 cells from 2 preparations
exposed to different concentrations of metomidate. The results are
tabulated (Table IV-4).
That concentration nearest to the clinically relevant figure
(1.8 x lCT^M) had no consistent effect on the spontaneous activity,
and even with 1.8 x lCf^M the effects were not dramatic. Depression
by the high concentration (1.8 x 10~3 M) was much more striking, and
once again the IPSPs were those first affected. The depression
illustrated (Figure IV-5) was reversed on washing the preparation,
albeit not to the previous condition.
Envelope measurements were made on the records from the cell
illustrated, and were as follows: (mean ±s.e.m., mV; n=10)
Control 1.42 ±0.154
Metomidate (1.8 x 10"5"M) 0.90 ±0.115 (37% decrease)
(1.8 x 10~VM) 0.76 ±0.062 (46% decrease)*
(1.8 x 10"^ M) 0.52 ±0.032 (63% decrease)*
Wash 0.65 ±0.065
* these figures are the calculated percentage decrease from the
control values.
Discussion
Concentration of drugs in the brain
There is a problem in deciding what concentration of an
anaesthetic applied to an isolated CNS preparation best mimics
conditions obtaining in the brain during surgical anaesthesia. The
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Figure IV-5
The effects of metomidate on spontaneous synaptic activity
Sample records from a single experiment. Metomidate had little
effect at 1.8 x lCfrM, but in the presence of 1.8 x lCf^M there was
a shift in balance so that depolarising transients were relatively
more frequent. When 1.8 x 10~* M metomidate was applied the
hyperpolarising transients were abolished completely before the
depolarising activity was reduced. A measure of restoration of both
types of activity was achieved by washing the preparation for 26min.
Exposure times: 1.8 x lCT^M 5min (total 8min)
1.8 x 10"*" M 7min (total 8min)









The effect of metomidate on spontaneous synaptic activity
IPSPs EPSPs
Metomidate + - n.c. (-) + - n.c. (-)
(M)
1.8 x 10"y - 25 - 1-32
1.8 x 10T* 121- 121-
1.8 x 10~J 12-1 13-1
Tabulated figures are the numbers of tests in which an increased
(+), decreased (-) or unchanged (n.c.) level of activity (frequency
of potential transients) was observed. Tests recorded in the
columns headed "(-)" are those in which the activity was reduced
only after first having been increased (see p.94).
most readily available figures are the induction doses of
anaesthetics in a variety of mammalian species. In the case of a
gaseous or volatile anaesthetic the problem is reduced because the
partial pressure of anaesthetic in the end-tidal air can be
measured: this air is in equilibrium with venous blood and thence
with the brain. With injectable drugs the influence of factors such
as absorption from the injection site, binding to plasma proteins,
the relative uptake by the brain and other tissues, and the rate of
elimination cannot be ignored, but can be only estimated. It may be
most appropriate to use the drug concentration found clinically in
the CSF, because the preparation is likely to concentrate drugs from
the Ringer in the same manner as does the brain from the blood.
Translation of this principle into the experimental situation
is complicated by the absence of reliable information as to the CSF
concentrations of the various anaesthetics during surgical
anaesthesia. Blood concentrations are available in some cases
(pentobarbitone, ketamine, etomidate), but for the rest they must be
estimated with due allowance for the effect of protein binding and
for the extent of distribution within the body (See Table III-5).
The brain concentration of a drug will be under- or over-estimated
according as the drug is preferentially distributed to the brain or
is eliminated faster than it is absorbed from the site of injection.
The problem was skirted by Schueler & Gross (1950) who took blood
from an anaesthetised animal in order to study the effect of the
anaesthetic on respiration in isolated brain slices.
Even could it be established that experiments were conducted
with appropriate concentrations of drugs, the picture would not be
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clear. Anaesthesia has no clearly defined end-point: the neuronal
derangement is graded as are the effects of the drugs on isolated
tissues. What is a barely detectable effect in an electrophysio¬
logical experiment may have either little or considerable impact on
the normal functioning of the cell. It is well known to clinicians
that the depth of anaesthesia is affected by the intensity of the
surgical stimulus: much higher doses of anaesthetic are required to
prevent motor responses to certain very painful operations, such as
those on the hip or the ear. Yet the drug does not disappear from
the brain when the stimulus intensity is increased.
Anaesthesia and electrical activity in the brain
In assessing the results of the experiments in this Section it
must be made clear what has been measured. The spontaneous activity
recorded from a bulbar M'tiller cell must be the response of the cell
to the activity impinging on it, because abolition of synaptic
transmission results in a quiescent preparation. A change in the
former activity may result from changes in the receptor or other
membrane properties of the penetrated cell, or from presynaptic
changes originating elsewhere in the CNS - if it can validly be
assumed that the spontaneous potentials are not merely the central
equivalent of MEPPs at the motor end plate. No distinction can be
made between these possibilities on the basis of the present
experiments alone. However, the resultant change in activity of the
Muller cells will have repercussions for those cells with which they
make efferent synapses.
The input to the Muller cells is of many modalities (Rovainen,
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1967; Wickelgren, 1977) and represents the resultant of central
integrative processes, insofar as these determine the appropriate
motor response in any set of circumstances. A reduction in afferent
activity reflects either a reduced sensory input or a suspension of
the integrative processes from whatever cause. In the present case
it is not possible to state that a recorded decrease in activity was
the result of anaesthetic effects on the Muller cell's receptors
rather than on presynaptic processes. The techniques employed could
not measure detailed changes in responses at individual synapses;
nor was a statistical analysis of synaptic potentials after the
manner of del Castillo & Katz (1954) feasible, although some larger
potentials were seen to be composed of super-imposed smaller
events. There would in any case be little benefit in analysing the
potentials in detail because, as already discussed, the use of
techniques enabling measurement of single channel conductance is to
be preferred, and is likely to be possible in this preparation.
Werman (1969) has discussed in detail the relative merits of
potential and conductance measurements in pharmacological
experiments: conductance changes are closer to the fundamental drug
action than are potential changes, and are therefore a truer
reflection of it.
The output of the Muller cells is to the ipsilateral segmental
motoneurones and thence to the somatic musculature. Thus
stimulation of the bulbar cells elicits a variety of movements
(Rovainen, 1967; and see Section I). However, a recent study of
spinal interneurones (Buchanan, 1982; Buchanan & Cohen, 1982) has
shown that bulbar cell stimulation excites also those interneurones
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which inhibit the contralateral motoneurones, an action which must
be important in motor coordination. Reduced activity in the Muller
cells is likely to disinhibit these contralateral motoneurones
thereby causing uncoordinated movements when muscles on both sides
of the body contract simultaneously. An effect of this type could
explain at least partially the observation (Section III) that
during the induction period uncoordinated movements occurred: both
rolling movements and frequent waves of contraction which passed
down the body yet were non-propulsive and of small amplitude.
It came as no surprise to find that high concentrations of all
four anaesthetics suppressed the spontaneous activity. Reference to
Table II1-5 shows that these were concentrations far in excess of
those encountered clinically, and previous studies have indicated
that the selectivity factor, by which concentrations blocking
synaptic transmission and axonal conduction differ, is about 10
(e.g. Larrabee & Posternak, 1952).
Consideration of the effects of low concentrations of
anaesthetics is of more interest. Until recently, anaesthesia was
equated with a reduction in the electrical activity of the brain
(e.g. Bernard, 1875) that proceded ultimately to the electrical
silence of death. Many of the early EB3 studies were performed
using the anaesthetics ether and pentobarbitone, a choice which was
both fortuitous and misleading since both drugs, in concentrations
producing a surgically acceptable state, do indeed depress the
activity. Winters and his co-workers (Winters et al, 1967;
Winters et al, 1972) have since shown that, far from being
depressed, the EEG is excited by some of the other barbiturates and
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Figure IV-6
Diagram to show the multiple states of anaesthesia
(Adapted from Winters et al, 1972)
All anaesthetics induce the initial excitement (Stage I).
Thereafter some (e.g. barbiturates) induce surgical anaesthesia
directly; whereas others (e.g. ether) produce an intermediate stage
(Stage II) of increased CNS excitement, manifested as hallucinations
(A,B) and catalepsy (C). Drugs such as ketamine, phencyclidine and
tf-hydroxybuyrate do not depress the CNS. The righting reflex is
lost during Stage IIC. Stages IIC and III are surgically acceptable
because motor responses are absent and the patient is amnesic. The
further stages, myoclonic jerking/convulsions and Stage IV
(medullary paralysis) are unacceptable although usually reversible.
REM: "rapid eye movement" or "dream" sleep.
 
by drugs such as X-hydroxybutyrate, phencyclidine and ketamine;
these latter producing EEG changes akin to those of REM sleep, when
the brain is highly alert. Winters proceded to classify anew the
progressive CNS changes produced by anaesthetics and convulsants:
Figure IV-6 indicates that some compounds commonly regarded as
anaesthetics never produce CNS depression, the excitatory changes
progressing instead through convulsions to death. Of the drugs used
in this study, pentobarbitone is a conventional depressant whereas
ketamine does not elicit the depressed stages (III and IV) but has
epileptoid activity. The changes induced by alphaxalone and
etomidate have been likened to those of #-hydroxybutyrate and
anaesthetic barbiturates respectively.
In view of this it was interesting to see whether "convulsant"
anaesthetics produced an increase in the afferent input to the
bulbar Miiller cells at concentrations below those likely to block
axonal conduction. Depolarising activity was sometimes increased
by "clinical" concentrations of ketamine, alphaxalone and
metomidate, but invariably reduced by pentobarbitone. However, the
changes were time-dependent and increased activity was usually seen
only in the first few minutes after application of the drug was
commenced, presumably as the concentration built up at the sites of
action. The absence of a steady state effect, other than one of
total depression by high concentrations, raises the problem of how
to "freeze" what is essentially a continuous process, and is one
reason why these results should be regarded as qualitative rather
than quantitative.
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Observations on the hyperpolarising potentials were less
certain since these were generally more labile (e.g. their abrupt
appearance and disappearance in Figure IV-2, which may or may not
have related to the effects of ketamine). IPSPs were not detected
in all cells, but when present they were consistently more readily
depressed by anaesthetics than were EPSPs. It is interesting that
IPSPs are produced by stimulation of the ipsilateral vestibular
nerve (Wickelgren, 1977). Whatever the neuronal mechanism of
responses to vestibular stimulation in the lamprey, it is likely
that the early loss of inhibitory potentials in the Miiller cells is
related to the fact that loss of balance is an early sequel to
anaesthetic administration. Such loss may have contributed to the
rolling reported in Section III; and in higher animals is an effect
caused by all anaesthetics, hence the widespread use of the loss of
the righting reflex as a test for anaesthesia. This test does no
more than assess the integrity of one reflex pathway, and is not
relevant to the level of consciousness.
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SECTION V
Anaesthetics and Inhibitory Transmitters
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Introduction
Amino acid transmitters in the CNS
For many years after their presence in brain tissue was first
recognised, and after inhibitory effects were demonstrated, neither
GABA nor glycine was considered to be a good candidate for the role
of inhibitory central neurotransmitter. GABA was identified in
brain homogenates in 1950 (Awapara et al, 1950; Roberts & Frankel,
1950; Udenfriend, 1950) and was subsequently found to be depressant
when applied to the cerebral cortex (Hayashi, 1952; Iwama & Jasper,
1957; Purpura, Girado & Grundfest, 1957), spinal cord (Curtis,
Phillis & Watkins, 1959) and cerebellum (Purpura et al, 1957).
Indeed, Krnjevid & Phillis (1963) found that GABA depressed the
firing of all cells to which it was applied in the cerebellum and
cerebral cortex.
Glycine was identified in the CNS simultaneously (Roberts &
Frankel, 1950) and was assumed to have the same properties, since
the structures of the two compounds were so similar (Curtis &
Watkins, 1960). Investigation of the effects of exogenous GABA
showed that it inhibited both the EPSPs and IPSPs of spinal moto-
neurones and increased their membrane conductance. It did not
however produce the hyperpolarisation characteristic of the natural
inhibitory transmitter released in response to stimulation of a
peripheral nerve (Curtis, Phillis & Watkins, 1959), and was not
inhibited by strychnine, as was the natural inhibitory system. GABA
was therefore rejected as a CNS inhibitory transmitter, and with it
glycine, although the latter had received only perfunctory
attention.
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Recognition that although the two substances acted similarly
(Krnjevifc & Schwartz, 1966,1967; Werman, Davidoff & Aprison, 1968)
they did so at specific sites which did not show cross-sensitivity,
and were to a large extent differently distributed (glycine mostly
in the spinal cord and GABA in the brain) led to a reexamination of
the transmitter status of both compounds. Transmitter functions
were formally proposed for GABA by Krnjevic & Schwartz (1966), and
for glycine by Davidoff et al (1967). Glycine was thought to be
the inhibitory transmitter in the spinal cord because its
distribution there corresponded to that of known inhibitory
synapses, and because parallel functional losses and depletions both
of neurones and of glycine occurred following experimental anaemic
anoxia of the cord, whereas there was no equivalent change in GABA
levels. GABA exerts presynaptic inhibitory effects on the
central terminals of primary afferents, which accounts in part for
the early confusion over its relationship with the natural post¬
synaptic inhibitory pathways.
Experimental studies of inhibitory amino acids have since
mushroomed and it is now generally accepted that glycine is a major
transmitter in the spinal cord and lower parts of the brainstem,
whereas GABA fulfils this role in the cerebral cortex. It is not
immediately clear what are the functional roles of GABA receptors in
those other parts of the nervous system where the receptors are
apparently extrasynaptic. For instance, in the dorsal root ganglion
(DRG) GABA exerts a potent depolarising effect (Nishi, Minota &
Karczmar, 1974; Desarmenien, Feltz & Headley, 1980) but there are no
afferent synapses, and in autonomic ganglia a similar position
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obtains (de Groat, 1970; Bowery & Brown, 1974). In both sites
exogenous glycine had no comparable effect, and the GABA effects,
although depolarising, were chloride sensitive. This implied that
tissues differ in their chloride content - Coombs, Eccles & Fatt,
(1955) had shown previously that the hyperpolarising IPSP in spinal
motoneurones was determined mainly by the transmembrane
concentration gradients and membrane conductances to chloride and
potassium ions.
The work was greatly aided by the discovery that the known
convulsants strychnine and picrotoxin (and later, bicuculline) acted
as specific antagonists for glycine and GABA respectively: a
realisation which implied that the evidence suggestive of a
transmitter role for the amino acids was a good deal older. Owen &
Sherrington (1911) had described strychnine reversal of the reflex
inhibitory effects of peripheral nerve stimulation, but had been
unable to deduce a mechanism which had adequate experimental
support.
Presence of the suspected transmitter in the appropriate
neurones, and identity of action with the effects of natural
stimulation are but two of the criteria which must be satisfied if a
transmitter function is to be accepted. Description of specific,
high affinity sodium-dependent uptake mechanisms for GABA and
glycine fulfilled another. For example, Iversen & Bloom (1972)
found that one or other amino acid was taken up by 51% of identified
synaptosomes prepared from spinal cord homogenates. Separate,
similar sized populations of neurones were involved. This work
suggested that GABA and glycine are quantitatively much more
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important inhibitory transmitters than are those monoamine
transmitters for which an inhibitory effect has been described, such
as nor-adrenaline and 5-HT in the spinal cord (Engberg & Ryall,
1966; see discussion by Snyder, 1975). However, the picture is
complicated because amino acids also have a role in normal cellular
metabolism.
Aspects of the more recent work on GABA and glycine have been
reviewed at frequent intervals (e.g. Hebb, 1970; Curtis & Johnston,
1974; Krnjevib, 1974; Snyder, 1975; Roberts, Chase & Tower, 1976;
Nistri & Constanti, 1979). In relation to the extrasynaptic GABA
receptors, it is interesting that uptake of GABA by astrocytes,
neuroglia and other equivalent satellite cells in the autonomic
nervous system has been demonstrated; and that the release of GABA
from glial cells is stimulated by depolarisation. Such release
could be evoked were there to be a local extracellular accumulation
of potassium.
Effects of GABA and Glycine
GABA and glycine exert similar effects when they are applied to
a cell possessing receptors for both of them. The response consists
of an increase in membrane conductance to chloride ions (e.g Barker
& Ransom, 1978a). The associated change in the membrane potential
varies with the tissue under test and the experimental conditions,
and has repeatedly been shown to be very sensitive to the trans¬
membrane concentration gradient for chloride. It must therefore be
assumed either that the internal chloride concentration in cells
from different tissues are not identical or that the ion
specificities of the "channels" operated by the transmitters differ
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between tissues. A few preparations have been developed which
permit closer examination of the mechanisms involved using
techniques, such as noise analysis, which have previously been
applied only at cholinergic synapses. Barker, McBurney & MacDonald
(1982), applying current fluctuation analysis to cultured cells,
have made some distinction between the chloride channels opened as a
result of GABA and glycine's binding to their respective receptors.
In particular, the estimated lifetime and unit conductance of
channels activated by the two amino acids on an individual cell
differed, as did the relative charge transfer associated with the
channels (GABA:glycine 1.00:0.74). However, Barker et al were
unable to conclude that the two transmitters must be operating
distinct channels, because it remained possible that the different
configurational changes in the channel protein necessarily produced
on binding the transmitters would result in different permeabilities
to chloride ions.
The recent reports of Gold & Martin (1982a,b) concerning
glycine responses indicate that techniques of noise analysis can be
applied to the bulbar Milller cells of the lamprey. Patch clamping
has yet to be tried and neither technique has yet been used in
experiments with anaesthetics in this preparation. In the latter
technique a small patch of the surface membrane is isolated, where
the recording electrode seals to it, and rectangular current pulses
caused by the opening of single ion channels are measured with a
high gain current-voltage converter.
Recent studies have identified multiple types of GABA and
glycine receptors, particularly in invertebrates (see Andrews &
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Johnston, 1979; Nistri & Constanti, 1979), and complex potential
changes have sometimes been recorded especially when large doses of
transmitter have been applied. Barker & Ransom (1978a) attributed
the the biphasic hyperpolarising/depolarising responses they
recorded in cultured spinal cells to a redistribution of chloride
which altered the "driving force" on chloride ions during a long
pulse. It was not explicable as desensitisation, although the
latter has been demonstrated in the DRG (Desarmenien, Feltz &
Headley, 1980). Regional differences in the effect of GABA
according to whether it was applied to the soma or the dendrites
were recorded in hippocampal pyramidal cells by two groups (Alger &
Nicoll, 1979,1982; Andersen et al, 1980). Whilst it was argued
that the dendritic depolarisation could be indirect, resulting from
an effect on adjacent cells, Diamond (1968) had previously reported
that both the somata and dendrites of goldfish Mauthner cells were
sensitive to GABA, and Barker & Ransom (1978a) in their well-
controlled study also recorded dendritic responses, this time
hyperpolarising. There is no necessity that different GABA and
glycine receptors should operate identical membrane ion channels.
Pharmacological distinctions, also, have been made between GABA
receptors from different cells. GABA is able to exist in several
stable configurations but some of its active analogues are more
rigid and are not equally effective in all preparations. Similarly,
not all GABA receptors are sensitive to the antagonists bicuculline
and picrotoxin. Andrews & Johnston (1979) have suggested that GABA
in its extended form interacts with receptors that are sensitive to
bicuculline; whereas receptors for the folded form are insensitive.
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Nistri & Constanti (1979) proposed the following grouping of GABA
receptors found in the mammalian CNS:
i) sympathetic ganglia; spinal interneurones; spinal motoneurones;
ii) DRG; primary afferent terminals; cortical neurones.
Of these, the first group was relatively sensitive to bicuculline
and relatively insensitive to certain key agonists such as )(-amino-^-
hydroxybutyric acid. Picrotoxin was a more effective antagonist
than bicuculline at GABA receptors in the second group.
A third type of receptor has now been proposed to mediate the
presynaptic actions of GABA at peripheral autonomic synapses (Bowery
& Hudson, 1979; Brown & Higgins, 1979; Bowery et al, 1979). This
receptor is resistant to bicuculline and is stimulated by the GABA
analogue baclofen to reduce transmitter release. In studies on
cultured embryonic sensory neurones Dunlap (1981) showed that
baclofen acted like GABA in attenuating the calcium action
potential, but that it did not reduce the membrane resistance.
Should a similar reduction of calcium movements occur at nerve
terminals transmitter release would be inhibited. Baclofen was
already known to have presynaptic effects, increasing the release of
GABA and reducing that of glutamate and aspartate (see Andrews &
Johnston, 1979), but these had not previously been identified with a
GABA-mimetic effect.
Anaesthetics and inhibitory transmission
Anaesthesia is thought to result from a reversible drug-induced
disruption of brain function. Since Sherrington (1906) drew
attention to the susceptibility of reflex arcs, attention has
focussed on the synapse as the site of action of anaesthetic drugs
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(see Section I). It has become apparent that anaesthetics differ in
their effects at individual synapses (Larrabee & Posternak, 1952)
and that different central pathways have unequal sensitivities (Mark
& Steiner, 1958). Indeed, as already indicated in Section I, some
such differential activity is required to explain the characteristic
clinical states which follow administration of the various drugs
(Vickers, Wood-Smith & Stewart, 1981).
Anaesthetic enhancement of presynaptic and postsynaptic
inhibition is well documented, the principal anaesthetics concerned
being barbiturates, ©t-chloralose and ether (e.g. Eccles, Schmidt &
Willis, 1963). However, it has become apparent that this is not
true of all inhibitory pathways: for example, Frank & Ohta (1971)
found that a variety of anaesthetics including pentobarbitone
blocked the reticulo-spinal inhibitory pathway in decerebrate cats,
whereas reticular facilitation showed greater resistance to
inhibition. Interestingly this was particularly obvious with
compounds known to cause excitement in intact mice.
In this Section, the abilities of the anaesthetics to interfere
with the actions of GABA and glycine are compared. Although
anaesthetics could equally affect synaptic transmission by a pre¬
synaptic action, in this study postsynaptic mechanisms alone have
been considered: the transmitters were applied directly to the




The procedures for dissection, intracellular recording and for
the iontophoretic application of transmitters have been described in
Section II.
After a few pilot experiments in which both anaesthetics and
transmitters were applied in the perfusing Ringer, iontophoretic
techniques were introduced, thereby allowing more precise timing of
the transmitter pulses and shortening the required duration of an
experiment. When transmitters were bath applied there were the twin
uncertainties as to whether the same concentration of transmitter
was achieved at the cell surface during successive tests, and
whether applications were sufficiently long to cause desensitis-
ation. The time (20-30s) required for completion of a change in
bath solution was considerably greater than that for development of
a response so any effect of an anaesthetic on the kinetics of the
response must have been masked. With bath application it was rarely
possible to obtain a full set of control and test exposures before
cell deterioration supervened.
The experimental protocol and the method of analysis of the
results have also already been described (Section II,p.64). When a
suitable sequence of GABA and glycine pulses had been established,
it was continued during and after perfusion of the preparation with
a solution of the anaesthetic under test (dissolved in Ringer
solution D). These experiments were carried out concurrently with
those of Section VI, so the iontophoretic pulse sequence often
consisted of a standard pulse of each of the three transmitters.
The pulses were normally of the same amplitude (usually in the range
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40 to 90nA for GABA and glycine), although that for glutamate was
sometimes larger by a factor of 10, but the optimal duration was
determined for each transmitter individually. The pulse lengths
fell within the range 0.3 to 7.0s, and pulses were applied at
intervals of 1 or 3 minutes. Changes in input resistance associated
with the transmitter actions were assessed by injecting constant
hyperpolarising current pulses (strength 0.5-1.0nA, frequency 1Hz)
through the recording electrode during, and immediately before and
after, each transmitter pulse. The timing of these injections was
under manual control, and the necessary movement in the vicinity of
the preparation was the cause of artefacts visible on some sample
records.
When experiments were carried out to test the influence of
transmitter concentration on the anaesthetic effect only one
transmitter was used. Different concentrations were produced by
employing a sequence of pulses of increasing durations. Because it
was now impossible for spread of the iontophoretic current between
barrels to cause more than one transmitter to be ejected, these
experiments also acted as a check that the previous findings had not
resulted from cross-contamination between barrels.
The results are presented as sample traces taken from typical
experiments; and as bar charts in which the mean anaesthetic-induced
changes in the GABA and glycine response amplitudes are represented
by bars of appropriate length. Each bar represents a separate test
but not necessarily a different cell. The numerical data from which
the bar charts were constructed are available in Appendix I,
together with the results of the tests of statistical significance.
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The manner in which the measurements were made has been detailed in
Section II.
Results
Responses to GABA and Glycine
Most cells had resting potentials in the range -60 to -65mV and
input resistances >3Mil. The usual response to iontophoretic
application of either GABA or glycine was a transient hyperpolaris-
ation accompanied by reduction in the input resistance of the cell.
A small minority of cells (4 out of 92) showed depolarising
responses to both amino acids. In some cells the potential change
was minimal or varied between a small depolarisation and a small
hyperpolarisation: the resting potential in these cases was
presumably very close to the reversal potential for the ion channels
opened by the transmitter.
High concentrations (increased pulse strength or duration) of
either agonist elicited complex responses. Figure V-1A shows
responses to three doses of glycine, the highest dose producing a
triphasic hyperpolarising/depolarising/hyperpolarising response, and
illustrates the common finding that complex responses did not retain
their shape over a period of time. Typically, the depolarising
component was the more labile. A more dramatic illustration of this
is Figure V-1C where the initial brief hyperpolarisation was
succeeded by a long-lasting depolarisation. The depolarising
component was drastically reduced after twelve minutes (glycine
pulses applied at 3min intervals) and was never restored. The
appearance of the complex responses was sometimes yet more bizarre
(Figure V-1B): only occasionally was this attributable to variations
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Figure V-l
Variation of response to glycine with dose applied
A: responses of a cell to 80nA pulses of glycine.
Pulse durations (left to right): 5s, 2s, 3s.
Hyperpolarising pulses: InA
B: bizarre responses of 2 cells to glycine.
Iontophoretic pulses: (left) 200nA, 4s; (right) 300nA, 10s.
Hyperpolarising pulses: InA
C: desensitisation of depolarising component of complex glycine
response. Glycine pulses were applied at 2 minute intervals; record

















in iontophoretic current. The occurrence of such responses and
their changing form set an upper limit to the agonist concentrations
that could be used in experiments with anaesthetics.
The effects of anaesthetics on the responses to GABA and glycine
63 ammocoetes were exposed to the anaesthetics: pentobarbitone
(19 ammocoetes), ketamine (15), alphaxalone (19), metomidate (10).
10 arnmocoetes were tested with the Saffan vehicle alone. No
anaesthetic consistently altered the membrane potential and only the
highest concentrations of pentobarbitone and metomidate (10~3M)
affected the input resistance, causing a small reduction. The
alterations in the GABA and glycine responses measured during
exposure to the four anaesthetics are displayed in Figures V-2 to
V-7.
Most experiments were carried out at 8-10°C but the results
were qualitatively similar at room temperature and at 2°C (not
illustrated).
Pentobarbitone
The effects of pentobarbitone were complex and dose-dependent.
Records from typical experiments are displayed in Figure V-2. Low
concentrations (1-5 x lCT^M) potentiated the GABA responses in some
cells, but only in 8 out of 19 tests did the potentiation exceed
10% (Figure V-3A). The remaining 11 tests showed little change.
Potentiated responses were increased both in amplitude and
duration. In two preparations the concentration was raised to
10~3M: this caused a reduction in amplitude of the GABA response.
No concentration of pentobarbitone significantly affected the
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Figure V-2
Effects of pentobarbitone on GABA and glycine responses.
Records from 2 cells showing:
(upper traces), GABA potentiation by 10~VM pentobarbitone and
antagonism by 10-SM pentobarbitone (no intervening wash);
(lower traces), lack of effect of 2.5 x 1CPVM pentobarbitone on
glycine responses.
Durations of exposures to pentobarbitone:
(upper traces) 13min (ltX^M), 6min (1CT3M);
(lower traces) 14min.
Preparations washed for 8min (upper traces), 14min (lower traces).
Iontophoretic pulses: GABA 0.5s, 60nA; glycine 3s 200nA.








Effects of pentobarbitone on responses of individual cells
A: peak change in input resistance, B: ratio of area to peak.
Each bar represents the % potentiation of the control measurement
for a single cell. Changes of less than 10% (bars lying wholly
between the lines drawn at +10% and -10%) were not considered
important. Note that GABA potentiation by 1-5 x 10~^M
pentobarbitone was not always detected, and that there was no
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glycine responses (Figure V-3A & B).
Ketamine
Ketamine selectively potentiated the GABA responses (Figure
V~4), an effect consistently detectable at 3.7 x lCf^M and reaching
statistical significance at 3.7 x lCf^M ketamine (Figure V-5B).
Unlike the potentiation by pentobarbitone, that due to ketamine was
almost entirely attributable to prolongation of the response, as is
shown by the arearpeak ratios. Slowing of the onset and offset of
the GABA response was most striking at high concentrations of
ketamine (3.7 x 10~^ M).
In contrast, Figure V-5B shows a dose-dependent antagonistic
action of ketamine on glycine responses. This effect was
statistically significant at 3.7 x lCT^M when the response was
measured as the peak change in resistance. Only two cells were
tested with ketamine at 3.7 x 10~Vm but in both cases depression of
the response was dramatic. No effect of ketamine on the response
profile was detected for glycine (e.g Figure V-4).
Alphaxalone
The action of alphaxalone (>10_SM) was consistently to depress
responses to both GABA and glycine (Figures V-6 & V-7). The
commercial vehicle, which contains poly-oxyethylated castor oil, had
an antagonistic action in some experiments (7 out of 10 tests using
GABA and 3 out of 6 with glycine showed a reduction in response
amplitude which exceeded 10%). This latter effect was small, and
was statistically significant only in the case of resistance
measurements on GABA responses.
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Figure V-4
Effects of ketamine on GABA and glycine responses.
Records from 1 cell showing GABA potentiation by 3.7 x lCf^M
ketamine and complex effect of 3.7 x 10-iM (no intervening wash).
In this cell glycine responses were unaffected by 3.7 x lCT^M
ketamine but reversibly depressed by 3.7 x 10-i M.
Duration of exposures to ketamine: 8min (3.7 x 10~VM),
IGnin (3.7 x lCf-5 M) .
Preparation washed for lOmin (upper trace), llmin (lower trace).
Iontophoretic pulses: GABA & glycine 3s, 60nA.
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Figure V-5
Effects of ketamine on responses of individual cells
A: peak change in input resistance, B: ratio of area to peak.
Each bar represents the % potentiation of the control measurement
for a single cell. Changes of less than 10% were not considered
important. Note that prolongation of the GABA reponse (B) was a
consistent finding during exposure to ketamine >10~SM whereas
depression of glycine responses (A) is first consistently observed
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Figure V-6
Effect of alphaxalone on GABA and glycine responses.
Records from 2 cells showing reversible depression of GABA
(9min exposure to 2.7 x 10~5M alphaxalone) and of glycine (8min
exposure to 1.4 x lCf^M) responses. Preparations washed for 22min
(upper traces), 8min (lower traces).
Iontophoretic pulses: GABA 2s, 30nA; glycine 5s, 500nA.




1-4 x 10"5 M
Alphaxalone Wash
Figure V-7
Effects of alphaxalone on responses of individual cells
Peak change in input resistance measured. Each bar represents the %
potentiation of the control measurement for a single cell. Changes
of less than 10% were not considered important. Depression of both
GABA and glycine responses was a consistent finding during exposure
to alphaxalone >10_5"m. Depression by the commercial vehicle was









Metomidate, too, had a dramatic depressant action on both GABA
and glycine responses (Figure V-8), but only at high concentration
(1.8 x lCf^M). There was no evidence either of potentiation at any
concentration (Figure V-9) or of alteration in the response profile.
The effect of agonist dose on the modulating influence of
anaesthetics
It was recognised that the agonist concentration at the
receptors might affect the recorded influence of the anaesthetic
drugs. Experiments were therefore performed in which different
doses of a single transmitter were applied to a cell.
The same anaesthetic-transmitter combinations as previously
described were tested in these experiments, each combination
receiving 2-8 tests in between 2 and 4 preparations. Only the
potentiation effects were consistently affected by transmitter dose,
and pentobarbitone was more affected than was ketamine. Thus
pentobarbitone consistently potentiated GABA responses only
when short iontophoretic pulses were used. Measurements of peak
change in input resistance obtained in one such experiment are shown
in Figure V-10. In this particular experiment 10"^ M pentobarbitone
approximately doubled the response to a 0.5s GABA pulse, whereas the
response to a 2s pulse was increased by only about a quarter.




Effect of metomidate on GABA and glycine responses.
Records from 1 cell showing lack of effect of 1.8 x 1CTS M metomidate
on GABA and glycine responses. Antagonism by 1.8 x 1CT3 M
metomidate was total in both cases. Durations of exposures to
metomidate (no intervening wash): lOmin (1.8 x 10~y M),
5min (1.8 x lCf3 M) .
Preparation washed for 18min (upper traces), 17min (lower traces).
Iontophoretic pulses: (GABA & glycine) 2s, 300nA








1-8 x 10^ M
Metomidate
1-8 x 10"3 M
Wash
Figure V-9
Effects of metomidate on responses of individual cells
Peak changes in input resistance measured. Each bar (of unit
width) represents the % potentiation of the control measurement for
a single cell. Changes of less than 10% were not considered
important. Depression of GABA and glycine responses was consistent
only in the presence of 1.8 x 10"^ M metomidate, although GABA
responses were sometimes markedly depressed by 1.8 x 10-<k M. Note
the absence of any potentiation.
GABA




GABA-induced resistance changes measured in a single cell
before, during and after application of increasing concentrations of
pentoba rbitone.
Ordinate: GABA-induced resistance change (%);
Abscissa: time after pulse sequence started (min).
GABA pulses (amplitude 60nA) applied for 0.5s (■), 1.0s (O) and
2.0s (•) in repeated sequence.
Pentobarbitone at 10"VM approximately doubled the response to a 0.5s
GABA pulse whereas the response to a 2.0s pulse increased by only




The effect of agonist dose on the recorded responses
Whereas the response to a small dose of GABA or glycine was
unambiguous, the complex responses observed when large doses of
either compound were applied resembled responses recorded by Barker
& Ransom from cultured spinal cells (Barker & Ransom, 1978a: Figure
4). These authors suggested that the complexities could be
explained by changes in the driving force on the permeant ion
species (probably chloride) brought about by changes in the
transmembrane electro-chemical gradient.
More recently, Alger & Nicoll (1982) have examined a similar
phenomenon, in the pyramidal cells of the rat hippocampus, and have
presented several lines of evidence suggesting that there are at
least two types of GABA receptor, mediating respectively hyperpolar-
ising and depolarising responses. They equated the hyperpolarising
responses with those of extrasynaptic receptors found principally on
the soma, whereas the depolarising responses were thought to be the
result of GABA's binding to synaptic receptors on the dendrites.
The question as to whether hyperpolarising-type receptors were also
present on the dendrites was not resolved. The two receptor types
could be distinguished pharmacologically although both were blocked
by the GABA antagonist bicuculline. Thus the GABA analogue THIP
(4,5,6,7-tetrahydroisoxazolo [5,4-c]pyridine-3-ol) was more potent
in eliciting hyperpolarising responses; and pentobarbitone and




Conversion of glycine responses from depolarising to hyper-
polarising after movement of iontophoresis electrode.
Pulse lengths: (depolarising; left to right) 2s, 3s, 7s;
(hyperpolarising; left to right) 2s, 3s, 5s.
Pulse amplitudes: 200nA
Hyperpolarising pulses: InA





Alger & Nicoll (1982) reported only on GABA receptors. The
results presented here suggest that glycine, also, may act
on more than one receptor type. Indeed in one cell a slight
adjustment of the electrode position converted a pure depolarising
response into a hyperpolarising one (Figure V-ll). Since there was
no equivalent change in membrane potential this was evidence for
there being glycine responses with two reversal potentials.
However, the tip of the iontophoresis electrode could not be clearly
seen, so its position in relation to the cell's dendritic tree could
not be estimated.
Alger & Nicoll reported that the depolarising component of the
IPSP was more prominent at low temperature and that it showed strong
temperature dependence. In this connection it is interesting that
the present lamprey experiments were conducted at temperatures which
were low, although not unphysiological for the species. However,
there was no consistent difference between the shapes of responses
recorded at 2°, 10°C and at room temperature.
Anaesthetics differ in their post-synaptic effects
These experiments were designed to compare the abilities of the
four anaesthetic drugs to interfere with the responses of bulbar
Miiller cells to GABA and glycine. Other comparative studies have
not utilised all of these particular drugs and the lamprey prepar¬
ation has not previously been used for this type of investigation.
Many workers have stressed the GABA potentiating properties of
the barbiturates in a range of preparations (e.g. Barker & Ransom,
1978b). In this study, as in that of Bowery & Dray (1978), the GABA-
- 122 -
potentiating action of pentobarbitone was evident only in a
proportion of cells, and showed marked dependence on the agonist
dose, being detectable only if low amplitude or short iontophoretic
currents were employed. The foregoing discussion may cast some
light on the capricious nature of this effect, but large doses of
GABA were required to elicit responses with an appreciable
depolarising component whereas pentobarbitone's potentiating effect
was much more marked when the GABA doses were small (Figure V-10).
Ketamine, also, selectively potentiated the responses of Mliller
cells to GABA, but the effect differed from that of pentobarbitone
in that it was principally on the time course of the response; both
the onset and offset of the response were slowed by ketamine
(>10~?M). Other studies (e.g. Jessel & Richards, 1977; Minchin,
1981) suggest that this potentiation is not the result of altered
GABA uptake mechanisms. Potentiation of GABA responses in the
superior cervical ganglion has recently been demonstrated to follow
administration of ketamine in concentrations similar to those use in
this study (Little, 1982). Only peak amplitude measurements were
quoted, but the potentiation, occurring over the range 1.8 x lCT^M
to 3.7 x 10"^ M was maximal at 1.8 x lCfvM, a result consistent with
the present findings. These results are also consistent with the
reported inefficacy of ketamine against strychnine convulsions.
In contrast, neither alphaxalone nor metomidate caused
significant potentiation of GABA responses at any concentration
tested; instead, both drugs produced parallel depressions of the
responses to GABA and glycine. There are no previous reports of the
effects of either anaesthetic on responses to the inhibitory
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transmitters; but etomidate, an imidazole derivative closely related
to metomidate, has been studied: it is reported to be similar in
action to pentobarbitone, selectively potentiating GABA responses at
low doses (10-s\m) but having a depressant effect at high doses
(lCf^M). As with the barbiturates, the potentiating action shows
stereo-specificity (Hill & Taberner, 1975; Huang & Barker, 1980).
The optical isomers of metomidate have not been tested separately,
but those of etomidate have been shown to differ in their
pharmacological actions (Hill & Taberner, 1975).
There is little published information about the actions of
alphaxalone/alphadolone on inhibitory mechanisms but Scholfield
(1980) has described a potentiation of recurrent inhibition in the
olfactory cortex caused by a range of anaesthetics including
alphaxalone, pentobarbitone and ketamine. This study will be
discussed in some detail in Section VII. Smaje (1976) and Richards
& Smaje (1976) reported depressed responses to acetyl choline and
glutamate in the olfactory cortex; and Pennefather & Quastel (1980)
described alterations in endplate currents recorded at the neuro¬
muscular junction.
Relevance to clinical anaesthesia
Although the reticulo-spinal cells are not concerned with
consciousness, the effects just described are likely to operate
during anaesthesia and may be related to side effects produced by
the drugs. The results are hard to reconcile with a unitary
biophysical hypothesis of anaesthetic action. Such an hypothesis
predicts similarity of action of different anaesthetic compounds
(Metcalfe, Hoult & Colley, 1974), however exerted, and this was not
- 124 -
a present finding. The concentrations at which the anaesthetics
have been tested in this study include those likely to obtain in the
brain during clinical anaesthesia (Table III-5Q , and were themselves
capable of inducing anaesthesia in lamprey ammocoetes (Table III-2).
The finding that neither GABA nor glycine responses were
potentiated by alphaxalone and metomidate lends no support to the
unitarian contention that general anaesthesia is the result of the
enhancement of central inhibitory mechanisms (e.g. Cheng & Brunner,
1975; Scholfield, 1980). Scholfield recorded post-synaptic
potentials in cortical neurones and found marked potentiation of
those features generally held to be due to activation of an
inhibitory interneurone during exposure to anaesthetics including
pentobarbitone, alphaxalone and ketamine. However, the effect was
also observed when the concentrations used were sub-anaesthetic.
Scholfield's study will be discussed in detail in Section VII. The
available evidence suggests that GABA and glycine receptors on the
bulbar Miiller cells of the lamprey are pharmacologically similar to
those in higher vertebrates (Martin, 1979a; Nistri & Constanti,
1979).
Only with alphaxalone was depression of GABA and glycine
responses in the lamprey seen at concentrations likely to be
encountered during clinical anaesthesia in fish (Table III-2) and
higher vertebrates. Should a comparable depression of inhibitory
mechanisms underlie the excitatory phenomena commonly observed
during anaesthesia with alphaxalone/alphadolone in mammals, a
logical preventive treatment would be premedication with a GABA-
potentiating agent such as a benzodiazepine (Curtis et al, 1976).
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It thus is interesting that there are clinical reports of a reduced
incidence of tremors and non-purposive movements when diazepam is
used as a pre-medicant before anaesthesia with etomidate (Holdcroft




Anaesthetics and Excitatory Transmitters
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Introduction
Since Hayashi (1952) first discovered the clonic convulsions
produced by application of L-Glutamate to the cortex, the amino
acids L-glutamate and L-aspartate, ubiquitous within the vertebrate
brain, have been found to excite virtually all neurones to which
they have been applied. A neurotransmitter role for glutamate has
been proposed (see Curtis & Crawford, 1969), and the extensive
literature concerning the different types of membrane receptor for
glutamate has been reviewed recently by Nistri & Constanti (1979),
Di Chiara & Gessa (1981) and Watkins & Evans (1981).
Pharmacological studies have distinguished only three types of
glutamate receptor in the vertebrate CNS as compared with more than
six in invertebrates. The receptors are thought to coexist on cells
and, whilst their selectivities are not absolute, the receptors are




These are agonists of relatively rigid 3-dimensional configuration
and have been used as pharmacological tools although they are not
suspected of having a transmitter function. The putative natural
ligands L-glutamate and L-aspartate are more flexible and are able
to bind to more than one receptor type. There is however some
selectivity: quisqualate and kainate receptors preferentially bind
glutamate whereas NMDA receptors prefer aspartate. Apart from
showing different selectivities for agonists (NMDA receptors also
bind D,L-homocysteate (DLH), and kainate receptors bind ibotenate)
- 128 -
the receptors also discriminate among antagonists. As with the
agonists this discrimination is not absolute and, for example,
D-<X.-amino adipate (DocAA) selectively antagonises NMDA responses
whereas glutamate diethylester (GDEE) blocks the effects of
quisqualate. The responses are also differentially affected by
divalent cations and anaesthetics. Thus Anis, Burton & Lodge (1982)
have recently reported a selective antagonistic action of ketamine
on NMDA responses.
The excitatory transmitter roles of glutamate and aspartate in
specific nervous pathways have not yet been clearly established
because the amino acids also have metabolic functions and are very
widely distributed, as are mechanisms for their uptake and
synthesis. Probably the best current marker for glutamate pathways
is the demonstrable presence of calcium-stimulated glutamate release
(Cotman, Foster & Lanthorn, 1981). Glutamate responses are not
invariably depolarising in the vertebrate CNS: hyperpolarisation has
been recorded in the cerebellum, and a long-lasting inhibitory
effect of glutamate has also been found in some cells, mediated by
dendritic receptors and selectively activated by ibotenate (Nistri &
Constanti, 1979).
Both glutamate and aspartate have been shown to excite the
bulbar Muller cells of the lamprey (Wickelgren, 1977), causing a
small decrease in input resistance associated with a membrane
depolarisation. Bursts of synaptic potentials were superimposed on
the depolarisation, except when the Ringer contained 20mM Mg'1-'1". A
more detailed analysis of these responses (Matthews & Wickelgren,
1979b) showed that glutamate was a good candidate for the role of
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the natural excitatory transmitter: both glutamate responses and the
natural EPSPs had reversal potentials that were of the same order
(about -35mV) and that were varied in a similar manner by cell
damage. The latter, by permitting leakage of cell constituents,
reduced the trans-membrane ion gradients. EPSPs were insensitive to
variations in the chloride gradient, and it was thought that they
were mediated by an increase in membrane permeability to both sodium
and potassium ions, although this was not proved. By comparison
with the GABA responses (Section V) the Miiller cell response to
glutamate was characterised by its faster onset and smaller
associated decrease in membrane resistance.
Responses could be recorded whether glutamate was applied to
the soma or the dendrites, but iontophoretic application to the
giant axon, an area devoid of excitatory inputs, was without
effect. However, Barker & Ransom (1978a) observed a non-uniform
distribution of responses when glutamate was applied over the
surface of cultured mouse neurones; and Zieglgansberger & Champagnat
(1979), applying glutamate to the somata or dendrites of spinal
neurones in cats, also observed differences in effect. Whereas both
sites gave depolarising responses, only after application of a high
concentration to the soma was there a measurable and progressive
rise in membrane conductance. The question has yet to be resolved
whether a conductance decrease occurring in the dendrites is
undetectable purely because of electrotonic decrement; decrement has
previously been invoked to explain differences observed between the
reversal potentials of the EPSPs and the glutamate responses (e.g.
Curtis et al, 1968). Wickelgren (1977) suggested that the
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dendritic response in lampreys was the result of electrotonic spread
from neighbouring cells that were also affected by glutamate.
However, the spread of iontophoretically applied glutamate is
limited.
The possibility of an interaction between anaesthetic drugs and
neuronal responses to transmitters was recognised early in the study
of CNS transmitters, as was its importance: many studies that
involved measurement of neuronal firing rates during the ionto-
phoretic application of transmitters were conducted on anaesthetised
animals. Of the anaesthetics used in this study, the effects of
pentobarbitone are particularly well documented, this being an
anaesthetic commonly used in such experiments. Although some of the
evidence was conflicting, the consensus was that pentobarbitone
caused a greater depression of ACh than of glutamate or DLH
responses; indeed glutamate and DLH were sometimes employed to
"activate" neurones that were otherwise silent, so that the effects
of inhibitory transmitters could be investigated. Several unrelated
anaesthetics have been shown to depress responses to glutamate, for
example pentobarbitone and alphaxalone do so in the prepyriform
cortex, but this is not a property shared by all anaesthetics.
Halothane at concentrations associated with light anaesthesia (up to
approx. 1%) was one exception (Richards & Smaje, 1976).
ACh, also, is an excitatory transmitter in parts of the
vertebrate CNS, and there have been many reports of anaesthetic
reduction of its effect within the brain (e.g. Exley, 1954; Krnjevic
& Phillis, 1963; Curtis & Ryall, 1966; McCance et al, 1968) . Yet
Smaje (1976) found that whereas alphaxalone reduced the
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sensitivities of cells in the prepyriform cortex to ACh, pento¬
barbitone at anaesthetic concentrations (5 x 10"yM to 4 x lCf^M) had
no similar consistent effect. Curtis & Crawford (1969), reviewing
the available evidence, had earlier drawn attention to the variable
extents of anaesthetic depression occurring in different regions of
the brain: for example the brainstem (Salmoiraghi & Steiner, 1963)
and spinal cord (Curtis & Ryall, 1966) were minimally affected.
The Muller cells of the lamprey have been found not to respond
to ACh (Matthews & Wickelgren, 1979b) but there is evidence
suggesting that ACh does have a functional role elsewhere in the
lamprey CNS. Wachtler (1974) detected acetylcholinesterase in many
parts of the brainstem but not in the region of the Muller cells.
This, then, is the context in which the present experiments
were performed, in which glutamate was applied to the bulbar Muller
cells in the absence and presence of the anaesthetics. ACh has not
been tested. Because it is likely that other excitatory trans¬
mitters also affect these cells, a few experiments have been
conducted using substance P, an undecapeptide whose existence was
first recognised in 1931 (von Euler & Gaddum, 1931) and which has
been shown more recently to be neuro-active (e.g. Konishi & Otsuka,
1974; Nicoll, Alger & Jahr, 1980). Full examination of the actions
of substance P in the lamprey preparation has been deferred.
The experiments using iontophoresis were carried out
concurrently with those of Section V, with solution D (15mM Mg*-+ )
used as the perfusate. Other studies, using isolated spinal cord
preparations, have shown that the NMDA-preferring receptor is
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selectively blocked by even a low concentration (2mM) of magnesium,
and also by other divalent cations including calcium (Evans &
Watkins, 1978; Ault et al, 1980). This suggests that the
responses measured were probably those of receptors preferring
kainate or quisqualate.
Methods
The procedures for dissection, recording intracellular
potentials, iontophoresis of glutamate and application of
anaesthetics have been described in Section II. Frequently GABA,
glycine and glutamate were tested on the same cell, standard pulses
of each transmitter being applied in repeated sequence. In case
there was undetected contamination of the responses, caused either
by mixing of solutions within the 3-barrelled electrode or by
leakage of transmitters from the electrode tips, some experiments
were carried out in which the iontophoresis electrode contained
glutamate alone. As in Section V, two types of experiment were
performed:
i) fixed test pulses repeated at intervals of 1 or 3 minutes,
ii) a repeated sequence of test pulses in order of increasing
length - in case the anaesthetic effect was related to the dose of
transmitter.
Current controls were provided by incorporation of 0.5M NaCl in
one barrel (and in the pulse sequence) or by application of pulses
of reversed polarity to the glutamate-containing barrel. Neither
with glutamate nor with GABA or glycine, did the latter procedure
cause detectable ejection of transmitter from other barrels in the
electrode assembly. Most experiments were performed with the
- 133 -
preparation perfused with Solution D (15rnM MgL+), although the
effect of glutamate at normal [Mg1+] was also tested.
Analysis of the results was less detailed than with the
inhibitory transmitters. In most cells the change in input
resistance could not be measured with any degree of accuracy, so
measurements were confined to the changes in membrane potential and
in the area enclosed by the envelope of the response. The latter
has been described in Section II. As in Section V, the results of
different experiments have been combined after the proportional
change in glutamate response amplitude at the peak of the drug
effect has been calculated.
Pilot studies with substance P were carried out with the
peptide bath-applied. A solution of the peptide was prepared at
10"^ M and 0.1ml volumes injected into the inlet tube close to the
chamber. The concentration of peptide at the cell surface
therefore was unknown, and no attempt was made to quantify it.
Similar injections were made when the preparation was perfused with
high [Mg1+ ] Ringer, and with normal Ringer (solution C).
Results
Responses of bulbar Muller cells to glutamate
Contrary to previous reports in which bath application of
glutamate in solutions of "normal" magnesium concentration was said
to reliably excite bulbar cells (Wickelgren, 1977), iontophoresis of
glutamate in high magnesium Ringer elicited a response in only about
70% of cells. The form of the response varied greatly between cells
but the direction was always depolarising. Figure VI-1 illustrates
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two typical shapes: the one a rapid large depolarisation with
equally rapid decay, and the other a much smaller sustained change
in potential with sharp onset and offset and showing no sign of
desensitisation. Responses were frequently intermediate in shape.
The only consistent relation between the change in input resistance
and the magnitude or speed of the depolarisation was that the
"squat" responses (e.g. Figure VI-lA(i)), seen in 4 cells out of 45,
were associated with a minimal change in input resistance. Records
of resting potential were not kept but there was no obvious relation
between the resting potential and the shape of the glutamate
response: small amplitude responses were seen in cells with high
resting potentials as well as in those that were relatively
depolarised.
Because an unexpectedly high proportion of cells did not
respond to glutamate, the different types of response were not
distinguished when the effects of the anaesthetics were assessed.
No differential effect was readily discernible and it has already
been mentioned that, in motoneurones, the use of high [Mg2-* ] Ringer
operates to select the kainate or quisqualate-preferring receptors.
The different shapes could be the result of glutamate's acting at
receptors at different distances from the recording electrode, but
the onset of the smaller responses was still rapid. These small
responses could not be increased appreciably by prolonging or
increasing the amplitude of the iontophoretic pulses, although the
positioning of the iontophoresis electrode was much more critical
for glutamate than for GABA or glycine responses.
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Figure VI-1
Responses of different cells to pulses of glutamate
A: (i) low amplitude sustained response to 70nA applied for 6s. The
amplitude was not increased by increasing the pulse strength or
duration. Change in input resistance undetectable.
(ii) larger amplitude depolarisation associated with 39% decrease
in input resistance in response to glutamate pulse (300nA, 10s).
B: stability of glutamate responses over a period of 80min. 350nA
pulses applied for 3s (t=0,24min) and 2s (t=40,80min). Note the
rapid onset of the responses. Changes in input resistance minimal.
5 mV [
10s
24 min 40 min 80 min
The amplitude of the depolarisation was markedly affected by
fluctuations in the resting membrane potential in some experiments;
but in the absence of such fluctuations, and of anaesthetic effects,
remained stable over periods of an hour or more (Figure VI-1B).
Elevation of the [MgL+] reduced the tendency for the glutamate-
induced depolarisation to be interrupted by synaptic potentials and
intermittent firing of action potentials (Figure VI-2). However, in
some experiments such potentials occurred even though the [Mg'J-+] was
appeared to be adequate to block the spontaneous activity between
applications of glutamate. Response amplitudes were not measured in
these experiments because the full extent of the depolarisation was
masked. There was no evidence that magnesium acted as a glutamate
antagonist at the receptors responsible for the responses obtained,
but it is possible that such antagonism accounted for the unexpect¬
edly low proportion of cells in which responses were detected.
The effects of anaesthetics on the responses to glutamate
Responses were measured in cells from a total of 33 ammocoetes.
Numbers exposed to the anaesthetics were: pentobarbitone (10
ammocoetes); ketamine (7); alphaxalone (10); metomidate (4). In
addition two ammocoetes were exposed to the Saffan vehicle.
The most striking feature of these experiments was the lesser
effect of anaesthetics on glutamate than on GABA and glycine
responses, despite the fact that small changes in membrane conduct¬
ance would exert a more readily detectable effect on the glutamate
response, whose reversal potential is far from the resting
potential. No drug caused potentiation of the glutamate responses.
- 136 -
Figure VI-2
Effect of magnesium on responses to glutamate
A: Application of glutamate was followed after a 20s delay by an
increase in synaptic activity and a sustained depolarisation. The
latter, initially slowly developing, was sufficient to generate
action potentials. These have been truncated by the pen recorder.
B: Responses of a different cell to 3 pulses of glutamate lOmin
after [Mgr+] raised to 15mM. Synaptic potentials recorded during
first two responses, only, and no action potentials were generated.
Note the hyperpolarising after potential following the second
response; this was not a consistent feature of the response.




Sample records are displayed in Figures VI-4 & 6, and the collected
results for each drug in Figures VI-5 & 7. The numerical data from
which the latter were prepared are presented in Appendix II.
Pentobarbitone
A clear dose-related depression of the glutamate response was
observed, and only in 3 out of 16 tests in which measurements were
made did depression not exceed 10% (Figure VI-5). In one of the
three tests, one where lCT^M pentobarbitone was used, there was an
increase in the glutamate response. Serial measurements made during
a single experiment are displayed in Figure VI-3, and illustrate
the reversible depression of glutamate responses during exposure to
a relatively high concentration of pentobarbitone (5 x lCT^M) . This
depression was the more striking since this cell was hyperpolarised
by pentobarbitone, a change that might be expected to accentuate the
glutamate response. A small reduction in input resistance caused by
pentobarbitone would have accounted for the result, but was not
detected. Such a clear change in resting potential was rarely
observed. Sample records from another cell exposed to 2.5 x lCT^M
pentobarbitone are shown in Figure VI-4A.
Ketamine
Sample records from a single experiment are displayed in Figure
VI-4B, and the accumulated measurements are surtmarised in Figure VI-
5. The latter suggests a dose-related depressant effect detectable
at 3.7 x lCf^M (the clinically relevant dose); but the one anomalous
cell and the variable extent of the effect in different cells
combined to render the effect statistically non-significant
(Student's t-test, see Appendix II). The depressant effects of
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Figure VI-3
The effect of pentobarbitone on glutamate responses
Serial measurements made during a single experiment. 2 applications
of 2.5 x 1CTVM pentobarbitone were made, 25min apart. In this cell
pentobarbitone caused hyperpolarisation (3.5mV and 4mV) as well as a
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Figure VI-4
Effects of pentobarbitone and ketamine on glutamate responses
A: Pentobarbitone (3 x lCf^M) reduced both the depolarisation and
the change in input resistance produced by standard pulses of
glutamate. Exposure time: 3min Wash time: 8min
Iontophoretic pulse: 600nA, 2s
Hyperpolarising pulses: InA
B: Ketamine (3.7 x lCf^M) had only a small depressant effect.
Exposure time: 8min Wash time: lOmin
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Figure VI-5
Effects of pentobarbitone and ketamine on responses of
individual cells
Area enclosed by the envelope of the response measured. Each bar
represents the % potentiation of the control measurement for a
single cell. Changes of less than 10% were not considered
important.
Pentobarbitone (upper bar chart): all concentrations depressed the
responses and the depression appears to be dose-related.
Ketamine (lower bar chart): no concentration produced a consistent
change, but the response was depressed in the majority of cells when
the concentration exceeded 10-5"m.
Pentobarbitone (M)
-100 -50 -10 10 50 %
Potentiation of response to Glutarnate
Ketamine ( M )
Potentiation of response to Glutamate
higher concentrations of ketamine were no greater, nor were they
more consistently seen.
Alphaxalone
As with ketamine, the variation between experiments resulted in
all effects being statistically non-significant (Appendix II).
However, Figure VI-7 shows that depressant effects predominated and
were on balance greater in the presence of alphaxalone than when the
commercial vehicle was presented alone. There was no clearly dose-
related effect and the biggest depressions were seen during exposure
to the lowest concentration of alphaxalone.
Records from a single experiment are shown in Figure VI-6A, but these
cannot be considered typical in view of the variable results.
Metomidate
The number of experiments carried out with metomidate was
small, but the sumnary figure (Figure VI-7) shows that, as with
ketamine and alphaxalone, there was considerable variation between
the results. Increasing the experimental numbers was likely merely
to emphasize this, as in the case of the clinically relevant
concentration of alphaxalone (1-3 x 10~? M, Figure VI-7). The only
cell in which a potentiated response was seen was one exposed to the
lowest concentration of metomidate, and depressed responses were
seen only at supra-anaesthetic concentrations. It is notable that
in two out of three tests the depression by 1.8 x 10_iM metomidate
did not exceed 15% (contrast the total elimination of GABA and
glycine responses; Figures V-8 & 9). Records taken from an
experiment in which the effects of metomidate were only slight are
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Figure VI-6
Effects of alphaxalone and metomidate on glutamate responses
Alphaxalone (A) depressed the glutamate responses slightly but
metomidate (B) had little effect.
A: sample responses after llmin exposure to alphaxalone; 27min wash.
Iontophoretic pulses: 500nA, 5s
Hyperpolarising pulses: 0.9nA
B: sample responses after 7min exposure to metomidate; 16min wash.
Iontophoretic pulses: 400nA, 4s
Hyperpolarising pulses: InA
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Figure VI-7
Effects of alphaxalone and metomidate on responses of
individual cells
Area enclosed by the envelope of the response measured. Each bar
represents the % potentiation of the control measurement for a
single cell. Changes of less than 10% were not considered
important.
Alphaxalone (upper bar chart): note the variability of the effects;
only the highest concentration (1-3 x lOT^M) depressed the responses
of a majority of cells (3 out of 4).
Metomidate (lower bar chart): no concentration produced a
consistent effect, and only 1 test in 10 showed an increased
response.
Potenhiation of response to Glufamafe
Metomidate (M)
Potentiation of response to Glufamate
displayed in Figure VI-6B. When the results from all cells were
combined, no concentration of metomidate had a statistically
significant effect (Appendix II).
The effect of agonist dose on the anaesthetic effects
(not illustrated)
In no case did variation in the pulse length have any
detectable effect on the influence of the anaesthetics. This was
not surprising in view of the inconsistent effects of three of the
drugs.
The effect of substance P on bulbar Miiller cells
Injection of substance P into the perfusate (solution C) had a
dramatic excitatory effect on the bulbar cells that was manifested
as periodic depolarisations of 5-lQmV accompanied by excessive
synaptic activity and bursts of action potentials (Figure VI-8A).
This response represented an accentuation of the normal behaviour
seen in some cells; it was also very similar to behaviour seen in
the presence of a low dose of ketamine (Figure IV-3). Elevation of
the extracellular [Mgi+] to 15mM eliminated all synaptic activity,
leaving a response to substance P which consisted of a small




Whereas all cells tested responded to GABA and glycine (Section
V), an unexpectedly high proportion gave no detectable response to
glutamate. This finding is striking because glutamate is widely
distributed in the vertebrate CNS (Hebb, 1970) and, in an earlier
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Figure VI-8
The excitatory effect of substance P on bulbar Miiller cells
A: injection of substance P (0.1ml of 10"^M solution) into the
perfusion line caused a short latency excitatory effect which
consisted of synaptic potentials superimposed on a depolarisation
lasting Imin, followed by phasic depolarisations at progressively
increasing intervals. Note that the depolarising potentials have
been truncated by the pen-recorder; in fact action potentials were
fired at the height of the activity.
B: the direct efect of substance P on Miiller cells: in the presence
of 15mM Mg1"1" the synaptic potentials have been abolished but there
remains a small (1.5mV) depolarising response to a bolus injection
of substance P. The temperature trace is displayed to demonstrate
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study using the lamprey preparation, there was no mention of
unresponsive cells (Matthews & Wickelgren, 1979b). Whilst rapid
receptor desensitisation could account for some cells' not
responding to glutamate, it should have affected the latter study
also. Curtis, Phi11is & Watkins (1960) found no evidence that
spinal neurones became desensitised to glutamate. Possibly the
position of the iontophoresis electrode in relation to a Mliller cell
was more critical in the case of glutamate. This would be expected
if, for example, the glutamate receptors were not distributed
throughout the cell membrane but were localised to synaptic regions
or even to synapses on particular processes. To resolve the
question, experiments using an improved optical system are required,
so that the position of the electrode tip is known more precisely.
When an electrode was positioned, it was moved until the response
was optimal or, in experiments where the inhibitory transmitters
were used as well, at least adequate. In this context it was
notable that few cells showed a response when the micropipette was
filled with 0.5M glutamate instead of 2M (see Section II), this
contrasting with the satisfactory responses obtained using 0.5M
solutions of GABA and glycine. However, no conclusions can be drawn
without a knowledge of the transport numbers of the three amino
acids in the solutions used.
The shapes of the responses observed lay between two extremes;
the one with much greater depolarisation, and the other a smaller
response which could not greatly be increased by lengthening the
iontophoretic pulse (i.e. applying a larger dose of glutamate). It
is possible that these were distinct responses with different
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reversal potentials, but reversal potentials were not measured in
these experiments. The associated decrease in input resistance
ranged from 65% to undetectable and was not correlated with the
change in membrane potential. The change did not exceed 15% in 28
out of 45 cells, and lay between 20% and 30% in 11 cells. The
suggestion that more than one receptor type was concerned receives
some support from previous observations in other preparations. For
example, Lambert & Flatman (1981) reported that prolonged
application of glutamate to lumbar motoneurones in cats caused
depolarisation and a slowly developing increase in membrane
conductance, and that whereas this conductance increase was always
reduced by barbiturates, the depolarisation was not reduced in all
experiments. It is interesting that, by grouping the excitatory
amino acids according to the nature of the response elicited from
motoneurones, Lambert, Flatman & Engberg (1981) produced a
classification which differed in some respects from the
pharmacological classification discussed previously. For example,
L-glutamate and L-aspartate were alike in causing an increase in
conductance and a depolarisation fast in onset and offset, whereas
NMDA caused a marked fall in conductance coupled with a much slower
depolarisation. Responses to kainate were unlike those to any
other amino acid tested. Matthews & Wickelgren (1979b) measured a
conductance increase only when glutamate was applied to the somata
of lamprey bulbar cells: although depolarisation was also recorded
following application to the axons. These authors suspected that
axon depolarisation was the result of passive spread of current from
cells that were coupled electrically; both electrical and chemical
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afferent synapses have been described on Mailer axons (Rovainen,
1967).
The almost universal excitatory effects of glutamate and
aspartate have been used as arguments for the presence of extra-
synaptic receptors for these amino acids on most cells (Nistri &
Constanti, 1979). If this be so, then an added uncertainty is the
extent to which the pharmacological properties of synaptic and
extrasynaptic glutamate receptors differ. By virtue of their
position, extrasynaptic receptors must be more accessible to
exogenous amino acids, and it is possible that the big responses,
seen only rarely, represent the responses of synaptic receptors.
However, the iontophoretic currents that elicited large amplitude
depolarisations were often much smaller than those required to
produce a small "squat" response in other cells. This might argue
for the former's being extrasynaptic. Such differences were
observed between cells in a preparation as well as between
preparations so they cannot have been due merely to differences
between electrodes. There was no information as to the quantity of
glutamate delivered when a given iontophoretic current was passed by
a particular pipette (see Section II).
Allusion has been made already to the existence of multiple
glutamate receptor types, and to the fact that they differ in their
sensitivities to magnesium. Evidently the effects of the magnesium
concentration used in the present study varied between preparations,
since synaptic potentials in response to glutamate were not always
eliminated.
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The effects of anaesthetics on glutamate responses
The most striking aspect of these experiments was the contrast
with the results of experiments with GABA and glycine. Only two
drugs showed any consistent effect, and only with pentobarbitone
was the depression statistically significant and apparently dose-
related. The results with metomidate were particularly dramatic as
indicated already, and suggest that the depressant effects of high
concentrations of all anaesthetics on the inhibitory responses
cannot be the result of an entirely non-specific neuronal
depression.
The depressant effect of pentobarbitone is consistent with
earlier reports of barbiturate depression of responses to excitatory
amino acids (e.g. Krnjevic & Phillis, 1963; Crawford & Curtis,
1966; Johnson, Roberts & Straughan, 1969; Richards & Smaje, 1976;
Nicoll & Wojtowicz, 1980). A similar depressant effect of
alphaxalone, described by Richards & Smaje (1976) in the prepyriform
cortex, was not found in the lamprey preparation. Barker & Ransom
(1978a) in studies on cultured mouse neurones found the
sensitivities of the GABA and glutamate responses to pentobarbitone
to be about equal. Pentobarbitone depressed the glutamate responses
in the absence of an increase in membrane conductance, and the
interaction appeared to be one of non-competitive antagonism.
The suggestion that ketamine also has some glutamate inhibitory
effect is consistent with the report (Anis, Burton & Lodge, 1982)
that ketamine selectively inhibits NMDA responses and has a lesser
depressant effect on responses to glutamate, quisqualate and
kainate. The capricious nature of the effect in the lamprey may be
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connected with the variable effect of 15mM Mg2-* , since magnesium has
been shown selectively to depress NMDA-preferring receptors (Ault
et_al, 1980). It should be noted also that Anis et al were
using sub-anaesthetic doses of ketamine (2.5-10mg/kg) or, when
ketamine was applied by iontophoresis, currents smaller than those
which affected GABA and glycine responses (see Section V).
As to the mechanism of these effects there is little relevant
published evidence. However, Minchin (1981) in biochemical uptake
studies found that whereas pentobarbitone (but neither alphaxalone
nor ketamine) inhibited potassium-stimulated GABA and aspartate
release from the cortex, no drug tested appreciably affected either
the spontaneous release or the uptake of aspartate. Moroni et al
(1981) reported that pentobarbitone did not reduce glutamate
release from the cortex.
Implications for the anaesthetised animal
Consideration of the implications of these results for an
anaesthetised animal requires a synthesis of the results of
Sections IV, V & VI, and is deferred to Section VII. However, a
few comments are appropriate here. Firstly, the depressant effects
of pentobarbitone on the bulbar Miiller cells, part of an inhibitory
pathway, is consistent with the finding of Frank & Ohta (1971) that
several anaesthetics, including pentobarbitone, blocked the reticulo¬
spinal inhibitory pathway which inhibits segmental reflex potentials
in decerebrate cats, and this at concentrations no greater than
those attained during surgical anaesthesia. Secondly, the absence
of depression of glutamate responses by alphaxalone and metomidate
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may relate to extraneous non-purposive movements and muscle
twitching reported by clinicians to occur during anaesthesia with
these drugs: such movements are likely to be central in origin
(Granit, Holmgren & Merton, 1955) and, in any case, the effects of
alphaxalone at the neuro-muscular junction are inhibitory
(Pennefather, Puil & Quastel, 1980).
Effects of substance P
At this preliminary stage of the investigation, little can be
said beyond the observation that substance P excited the bulbar
cells. The phasic nature of the excitement produced was
characteristic and it is tempting to relate it to the phasic
activity recorded by Buchanan & Cohen (1982) from interneurones,
motoneurones and slow muscles of the lamprey. Whilst the synaptic
potentials evidently arose elsewhere in the CNS, there was also an
observable direct effect on the bulbar cells in the presence of
15mM Mgr+ to block synaptic transmission: synaptic potentials were
not then observed but there remained a sustained depolarisation that
was small (about lmV) yet reliably produced. This peptide has been






...whenever we attempt to combine our scattered
physiological facts, we are stopped by the want of
numerous intermediate analogues: and so loosely connected
or so independent of each other, are the different series
of phaenomena, that we are rarely able to make probable
conjectures, much less certain predictions concerning the
results of new experiments...
Davy (1800)
Davy's remark, made in a different connection, sums up the
problem of extrapolating from the results presented here to the
complex and progressive changes which occur in the brain of a mammal
during anaesthesia. Observations on the interference by sundry
anaesthetics with synaptic functioning and with the responses of
cells to transmitters abound and the investigation of anaesthetic
actions in the brain has not so far been tackled in a coordinated
manner. When the question of the general applicability of results
obtained in the lamprey is addressed, several supplementary
questions demand answers, among them:
i) are the receptor/ionophore complexes in the membranes of
lamprey cells identical to those in equivalent cells in mammals?
ii) Are the receptor/ionophore complexes in synaptic and
extrasynaptic sites within the membrane of a single cell identical
in their responses? Inevitably in experiments in which ionto¬
phoresis or bath application of transmitter has been employed, there
is no control over the exposures of individual receptors.
iii) Are the receptor/ionophore complexes the same in different
regions of the brain, or are there fundamental differences which
render any comparison of their responses to anaesthetics
meaningless?
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iv) Is the effect of an anaesthetic when the natural trans¬
mitter is acting on its sub-synaptic receptor similar to its effect
when an exogenous transmitter is applied generally to the membrane?
v) Some of the more recent elegant studies have used cells in
culture (e.g. Barker & Ransom, 1978a,b; Barker, McBurney &
MacDonald, 1982): are there any fundamental differences between the
functioning of these cells and that of cells in situ?
To such questions there are as yet few answers; the
investigation of anaesthetic-transmitter interactions is still at
the descriptive stage. The lamprey preparation enables anaesthetic
modulation of the responses of single identified cells to be
assessed, and thus serves as a model for one link in the complex
chain of events occurring in the brain. It is useful in the sense
described by Beament (1960) in his discussion of the application of
physical models in biology - the model is simpler than the original
but is in similar circumstances to those of the original.
My findings are restated in summary form in Table VII-1. Some
comment on the likely implications of the effects described is now
possible in the light of the three series of experiments.
Pentobarbitone
Sub-anaesthetic concentrations potentiate responses of Muller
cells to GABA whilst having little effect on those to glycine and
glutamate. Anaesthetic concentrations in addition have a depressant
effect on glutamate responses and on the level of spontaneous
synaptic activity. Since glycine rather than GABA is thought to be
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conditions, no conclusions about the relative importance of pre- and
postsynaptic effects can be drawn. The role of the GABA receptors
on these cells is not known, any more than is that of extra-synaptic
GABA receptors elsewhere in the nervous system, nor is the origin of
the GABA to which they normally respond. However if the GABA is of
synaptic origin, it would be predicted that potentiation of the
cells' responses to GABA would in part offset the implied depressant
effect on presynaptic function. Pentobarbitone had no effect likely
to increase activity in the Mliller axons; all effects described
would be expected to reduce motor responses to stimulation and so
promote muscle relaxation.
Ketamine
The increase in the spontaneous activity of Muller cells seen
during exposure to low concentrations of ketamine (Section IV) was
not matched by an equivalent change in their responses to exogenous
amino acid transmitters (Sections V & VI). As with pentobarbitone,
the most dramatic effects were those on GABA responses; and their
significance must depend on the extent to which the extra-synaptic
receptors are important in themselves and respond to anaesthetics in
a manner similar to that of synaptic receptors elsewhere in the
CNS. I observed no potentiation of glutamate responses resulting
from exposure to low concentrations of ketamine but have tested no
other putative excitatory transmitter. In view of the similarity of
the activity recorded in 3.7 x 10"7 M ketamine to that caused by bath
application of substance P, it may be that peptide transmitters are
involved in such excitatory reactions. Anaesthetic concentrations
of ketamine depressed glycine responses more than those to glutamate
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and IPSPs were more susceptible to block than were EPSPs. Both
results suggest that there will be resultant disinhibition of these
motor cells and so, potentially, exaggerated motor responses to
stimulation. This presupposes that the other central actions of
ketamine do not interfere with the afferent input to the cells, and
such a supposition may not be valid since ketamine is regarded as a
dissociative anaesthetic. However, the results are consistent with
the high level of muscle tone found clinically during ketamine
anaesthesia.
Alphaxalone and Metomidate
Such complete block of responses to inhibitory amino acids as
was seen with alphaxalone (>10~rM) and metomidate (lCf 3M) should be
reflected in reduced transmission at synapses involving these
receptors. The relative lack of effect on the glutamate responses
was marked with these drugs, also, and would reinforce the dis-
inhibiting effect. The results are consistent with the recorded
occurrence of non-purposive movements during anaesthesia with these
drugs, particularly during the recovery period. When the
anaesthetic concentration is higher, perhaps at levels present
during surgery, the presynaptic depressant effect implied by the
abolition of EPSPs and IPSPs probably offsets the disinhibition.
The effects of the two drugs were similar, but the significance of
the observation that those of metomidate were only apparent at
rather high concentrations is not clear. However, it would seem
prudent to avoid unnecesssary stimulation when either drug is used
clinically.
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It was a general finding that the IPSPs were more susceptible
to anaesthetic blockade. If IPSPs are in part concerned with
discriminative inhibition, as has been suggested by Andersen et al
(1980), this may contribute to the reduction in the fine control
of motor responses commonly found during induction and recovery from
anaesthesia.
This investigation has little to add to the current theories of
anaesthesia. Any proposed general mechanism of anaesthesia must be
shown to involve effects that are both necessary and sufficient for
anaesthesia. The only general conclusion that can be drawn from the
present experiments is that none of the effects described is
necessary, much less sufficient, for anaesthesia. Provided that
amino acid receptors on the bulbar Mliller cells in the lamprey brain
are acceptable as a model for synaptic amino acid receptors in the
mammalian brain, this means that it is not necessary for anaesthesia
that the effects of any of the transmitters glutamate, GABA and
glycine on receptors of the types present on Miiller cells be either
potentiated or inhibited. The argument will be strengthened if
similar results are obtained with other preparations, and if
experiments measuring anaesthetic effects on responses to endogenous
transmitters are carried out in parallel. The latter will demand
control of, or compensation for, possible effects of the anaesth¬
etics on presynaptic mechanisms. Even were this possible, the
objection would remain that anaesthesia is a clinical state (or
states) which cannot fairly be represented by easily measurable
effects on a single cell.
The response feature which I have measured in Section V, the
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input resistance, is closer to the fundamental response than are
such features as changes in membrane potential or firing frequency.
Changes in membrane potential depend on the resting membrane
conductance, the induced change in conductance and the driving force
on the permeant ions, and have been classed as second order effects
(Werman, 1969). Justification of the use of changes in firing
frequency depends on the dubious assumption that the membrane
potential is linearly related to the firing frequency. Ideally,
the quantity measured should be directly proportional to the
fundamental response. With cells of complex geometry, such as the
bulbar Miiller cells, calculation of the membrane conductance from
the input conductance is not simple and has not been attempted.
This does not affect my results adversely: it would have been more
important had I attempted a quantitative treatment of the kinetics
of the responses (see discussion by Werman, 1969). Moreover,
because the experiments were not conducted under voltage clamp,
membrane potentials were measured, not membrane currents, so the
quantity measured was an inverse function of conductance. To
calculate the conductance from the potential measurements would thus
be to emphasise unduly the measurement errors when the resting
conductance was high. I have therefore chosen to display the
measurements of input resistance rather than their reciprocal, the
membrane conductance. It is unfortunate that the errors were
necessarily greater at the peaks of the GABA and glycine responses.
Notwithstanding this, in most previous studies of anaesthetic
effects on single neurones in the CNS it is firing frequency that
has been measured.
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Mention has been made already of the different CNS states
induced by anaesthetic agents (Sections I & IV, pp.24 & 104).
Anaesthetic drugs have a range of pharmacological effects and
some actions, only, are common to all drugs. Anaesthetics
frequently depress respiratory and cardiovascular function as well
as consciousness, and induce varying degrees of analgesia and muscle
relaxation. The relative potency in respect of these different
actions is not the same for all drugs. One way of achieving
specificity of action would be for drug-specific effects on the
various neurotransmitter systems to exist; and in support of this
suggestion is the growing body of evidence that anaesthetics
interact stereo-specifically with certain proteins in such a way as
to affect their functional properties. For example Baker & Shapira
(1980) have shown that some anaesthetics increase the emission of
light by the calcium-sensitive protein aequorin in the presence of
constant ionised calcium levels. If their suggestion that other
calcium-binding proteins may behave in a similar manner proves true,
alterations in presynaptic function are likely. It is equally
possible that transmitter receptor proteins may bind anaesthetics
stereo-specifically and that their properties may change
accordingly. Stereo-isomers of three of the anaesthetics I have
used (pentobarbitone, ketamine and alphaxalone) are known to differ
in their anaesthetic properties. So far as I am aware isomers of
metomidate have not been tested, but those of etomidate have been
shown to have different anaesthetic potencies (see Section I).
As an illustration of the difficulty of making extrapolations
from single cell studies, I shall discuss in some detail an apparent
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conflict between some of my results and those of a study already
cited (Scholfield, 1980; see Section V) and show that a degree of
reconciliation of the two studies is possible. Scholfield's study
concerned the effects of anaesthetics on recurrent inhibition in the
guinea-pig olfactory cortex. Recurrent inhibition was shown to be
prolonged and intensified by a variety of anaesthetics including
pentobarbitone and alphaxalone (prolongation of IPSCs at least xlO)
and ketamine (prolongation up to x2). The effect of alphaxalone and
the relative lack of effect of ketamine are particularly surprising
in view of my results.
Scholfield stimulated the lateral olfactory tract electrically
and recorded intracellularly from cortical cells. The response
feature measured - a prolonged after-depolarisation associated with
an increase in membrane conductance (IPSC) - is thought to result
from activation of an inhibitory interneurone (Pickles & Simmonds,
1978; Scholfield, 1978) . The IPSC therefore represents the result
of transmission at a minimum of two synapses, and the anaesthetic
effects recorded may have arisen at one or more of several sites.
In the present study I have applied transmitters directly to the
Muller cells, so any effect of the anaesthetics on presynaptic GABA
or glycine receptors should not be apparent. The time course of the
IPSCs in the olfactory cortex (200-500ms) was considerably longer
than the average duration of an IPSP recorded from a lamprey Muller
cell (40ms).
The identities of the transmitters at each site in the
olfactory cortex have yet to be firmly established but there is
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evidence that both GABA and aspartate are involved (Pickles &
Simmonds, 1976; Collins, 1979) . There are also indications that
GABA acts here on two or more pharmacologically distinct receptor
types. Thus both bicuculline, a GABA antagonist at postsynaptic
sites, and baclofen, an agonist at presynaptic GABA receptors (Hill
& Bowery, 1981) block the IPSC and its field potential correlate,
the "I" wave (Pickles & Simmonds, 1978; Cain & Simmonds, 1982;
Scholfield, 1982,1983). Baclofen is likely to have reduced
transmitter release at both synapses in the chain leading to the
IPSC whereas bicuculline probably blocked the inhibitory effect of
GABA released from the inhibitory interneurone. Pickles (1979)
invoked different postsynaptic GABA receptor types on the somata and
dendrites of cortical cells to explain an anomalous action of
bicuculline in potentiating the effects of high doses of GABA.
Insofar as their pharmacology is understood, the GABA receptors on
lamprey Muller cells seem to be of the conventional bicuculline-
sensitive type (Martin, 1978, 1979a; Matthews & Wickelgren, 1979a).
Where the anaesthetics were acting in Scholfield's study cannot
be certain, but extrapolations from my results (Table VII-1) lead to
some suggestions:
Pentobarbitone has been shown to increase the "I" wave (Pickles
& Simmonds, 1978) and is known to potentiate the effects of GABA in
many preparations (see below). It is likely that the effect of GABA
released from the inhibitory interneurone was increased. The result
is the opposite of that predicted were pentobarbitone to potentiate
GABA's actions at presynaptic receptors. Scholfield's peak effect
was recorded at sub-anaesthetic concentrations (2 x 10-ffM). It may
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be that at higher doses depressant effects, such as were responsible
for the loss of spontaneous synaptic activity in Section IV,
outweigh the GABA potentiation.
Ketamine may have exerted only a moderate potentiation of the
IPSC in Scholfield's study because it not only potentiates GABA
actions, it also antagonises the effects of aspartate (Anis, Burton
& Lodge, 1982; see Section VI). The transmitter exciting the
interneurone has yet to be identified but release of aspartate has
been demonstrated following stimulation of the lateral olfactory
tract (Collins, 1979). As with pentobarbitone, my observation of
reduced spontaneous activity at higher concentrations (>10~^M)
suggests that any potentiation effect seen at lower doses in a poly¬
synaptic pathway would be attenuated by higher doses.
Alphaxalone markedly increased the IPSC at concentrations below
those required to antagonise GABA in the lamprey. It is possible
that an antagonistic effect was outweighed by facilitation of
transmission at the excitatory synapse on the inhibitory
interneurone - Scholfield reported no reduction of the EPSP at
concentrations below 10_5"m. I have shown in Section IV that
low concentrations of alphaxalone increased the frequency of
EPSPs recorded from Miiller cells and, although I have found no
potentiation of glutamate effects (Section VI), I did not test
aspartate. An added consideration is that the concentrations of
alphaxalone in Scholfield's solutions may have been lower than the
figures quoted - the steroid has low solubility and was dissolved
(or "dispersed") directly in Krebs solution by vigorous shaking.
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Scholfield did not test metomidate or etomidate. By analogy
with alphaxalone, my results predict that metomidate would
potentiate the IPSC. The potentiation might be less pronounced
than with alphaxalone, there being less increase in EPSPs recorded
in Section IV. Since metomidate had little effect on transmitter
responses at concentrations below 10"J M, reduced potentiation would
be expected only at high concentrations. However, I did not test
aspartate, which is thought to be one excitatory transmitter in the
olfactory cortex. Predictions of this nature can only be
speculative - Scholfield's observations concerned the responses of
synaptic receptors to their natural transmitter in a polysynaptic
pathway. Quite apart from these differences, the region of the
brain and the species of animal were also different.
Another point of difference between the studies is the much
greater effect Scholfield observed on passive membrane properties.
I have found nothing comparable to the 40% reduction in input
resistance which he obtained with alphaxalone concentrations over
10~rM, or to the 90% reduction due to pentobarbitone (2 x lCf^M to
10"* M); nor have I detected an effect of the higher concentrations of
ketamine to increase the input resistance.
There is no necessity that anaesthetics should exert identical
effects on different membranes or GABA receptors in the brain so the
disparities in the results do not immediately rule out the lamprey
preparation as a useful model for the equivalent region of the
mammalian CNS. So long as the limitations of the preparation are
clearly appreciated its many practical advantages, discussed in
Section I, make the lamprey eminently suitable for the study of the
- 157 -
pharmacology of anaesthetics. Not only are experiments of the type
reported herein feasible using identified cells, but it seems likely
that the use of more sophisticated techniques, such as the patch
clamp, will be possible also. These will give some insight into the
mechanisms underlying the observed effects.
I conclude, with Davy (1800):
... from the difficulty of discovering every possible mode
of examination, and from the modification of perception by
the state of feeling, it appears nearly impossible that all
the relations of a series of phaenomena can be discovered
by a single investigation, particularly when these
relations are complicated, and many of the agents unknown.
Fortunately for the active and progressive nature of the
human mind, even experimental research is only a method of
approximation to truth ... early experience has taught me
the folly of hasty generalization...
and, with Porta (1561):
...if I have over-passed some things, or not spoken so
properly of them, as I might; I know there is nothing so
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APPENDIX I
The effects of anaesthetics on the responses to GABA and glycine
The numerical data from the experiments of Section V are
tabulated in Table A-l. Each figure represents are the percentage
change in response during application of an anaesthetic: mean ±s.e.
Numbers of observations in parentheses.
Significant effects indicated (unpaired t-test): * p < 0.05;
** p < 0.01; *** p < 0.001.
Saffan vehicle dilution equivalent to 10_s" to 10-A\M.
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TableA-l








Pentobarbitone Icf* 2-5x10"*- lor*- Ketamine 3.7xlor* 3.7x10~4 3.7xlO-5" Alphaxalone 1-3x0"*- 1-3x10'5" 1-3x0"fc Saffanvehicle Metomidate 1.8x0"5 1.8x0~4 1.8x0"?
-63±11(2) +13±5(13)* +9±11(6) -4±15(2) +16±14(9) +10±15(8) -58±17(6)* -56±10(8)*** -15±4(3) -23±6(10)** -100±0(3)*** -27±1 (5) -6±5(6)
-90±11(2) +25±10(11)*±7(8)** +36±17(8)71±30(8)* +108±49(2)233±0(2)*** +124±44( 0)*78±17(10)** +55±43(8) -69±30(4) -74±5(8)*** -22±11(2) -21±9(10)* -100±0(3)*** -1±17(5) +6±7(6)+29±17(8)
+8(1) -15±9(9) +27±34(5) -82±1(2)** -33±9(9)** -2±9(10) -39±9(4)* -36±8(7)** -5±5(6) -19±13(6)
+3(1) +4±16(8) -4±26(6) -86±3(2)* -23±13(10)82 9) -5±11(10)+ 08(10) -45±20( ) -45±11(7)** +22±18(3) 0±7(6)
-73±15(6)**-77±17(6)* -6±10(4)+2823(4) +5±9(7)+11±12(7)
APPENDIX II
The effects of anaesthetics on the responses to glutamate
The numerical data from the experiments of Section VI are
tabulated in Table A-2. Each figure represents the percentage
change in response during application of an anaesthetic: mean ±s.e.
Numbers of observations in parentheses.
N.B. Standard errors have been calculated and t-tests carried out
only for the peak measurements.
Significant effects indicated (unpaired t-tests): * p < 0.05;
** p < 0.01 - 2-tailed test; $ p < 0.05; $$ p < 0.01 - 1-tailed
test. If it be assumed that no anaesthetic potentiates the effect
of an excitatory transmitter, the 1-tailed test is appropriate.
Saffan vehicle dilution equivalent to 10-r to 10_/f~M.
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Table A-2




2-5 x 10~^ -39 ±10(6)** -41 (5)
10"^ -17 ±8(8)$ -25 (7)
3 x 10~s -17 ±1(2)*$$
Ketamine
3.7 x 10_3> -50 (1) -51 (1)
3.7 x 10"^ -12 ±10(7) -6 (3)
3.7 x 10~s -13 ±13(6) +1 (3)
3.7 x 10"6 -4 ±7(4) +8 (2)
Alphaxalone
1-3 x 10'^ -20 ±7(4)$ -9 (2)
1-3 x lorf -4 ±6(12) -3 (12)
1-3 x 10"fe -17 ±10(7) -12 (7)
Saffan vehicle -16 ±9(4) -30 (4)
Metomidate
1.8 x 10~3 -21 ±13(3) -20 (3)
1.8 x 10"'1- -18 ±3(4) -17 (4)
1.8 x 10_s" +22 ±17(3) +15 (3)
Term (2) represents the variance between "cells", and term (5) the
variance arising within "cells" (the "error").
The interaction represents the extent to which different neurones
are affected differently by the anaesthetic. The significance of
the interaction is assessed by testing (Cell x Test)/Error. Even if
it is significant, as in this example, the anaesthetic "main" effect
can validly be tested because the mean square representing the
anaesthetic effect ("Test") contains the variance component of the
interaction (see discussion by Sokal & Rohlf, 1973). The ratio
calculated to assess the significance of the anaesthetic effect is
Test/Error.
Table A-3
Table of Analysis of Variance for 5 neurones exposed to 10~4M
pentobarbitone
For each neurone (N) the areas of 2 control and 2 test responses to G,A,"5A
have been used:





The columns (control and test measurements) have been regarded as
fixed replicated variable; and the rows (neurones) as a random
variable. Each cell of the above table represents the mean
measurement of 2 responses •
Source of df Sum of Mean F
variation Squares Square
1.Total 1 43589.78 43589.784 16.25
2.Cell 4 10727.78 2681.895 230.85***
3.Test 1 1540.01 1540.012 5.42
4.Interaction 4 1137.50 284.375 24.48***
5.Residue 10 116.17 11.617
*** p < 0.001
To assess the statistical significance of an effect the
quantity "F" was calculated, F being the "variance ratio" of the two
populations considered. The ratios calculated were:
for the "main" (anaesthetic) row effect: Test/Interaction;
"interaction" Interaction/Residue.
The analysis was unsatisfactory in this particular study for
reasons that are related to its design. In brief, the absolute
magnitude of the anaesthetic effect on any individual cell was no
greater than the absolute magnitude of differences between the
responses of different cells. The "signal to noise ratio" was
therefore poor and effects that were dramatic turned out to be
insignificant (for example the depression of GABA and glycine
responses by the highest concentration of metomidate). This
variability in control response amplitude between cells could be
eliminated by normalising the responses but only at the cost of
removing all variance from the control readings and thereby
invalidating the analysis. Part of the variation in the case of
GABA and glycine responses was caused by the proximity of the
resting membrane potential to the reversal potentials of the
responses. Small changes in membrane potential were apt to produce
marked alterations in the response, because there was a relatively
large change in the driving force on the permeant ion (chloride).
This was true particularly when the conductance was high, as at the
peak of a response.
It is obvious from Tables A-4 to A-8 that in very many tests
the interaction was highly significant. Comparison of the tables
with Figures V-3,5,7,9 and VI-5 & 7 reveals that this was sometimes
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the result of an anaesthetic's having opposite effects on different
cells, but that in other cases all effects were in the same
direction (e.g. 3.7 x lCf^M ketamine tested against glycine-induced
resistance changes). These alternatives could not be
distinguished.
It was for all these reasons that Student's t-test was used
in preference, applied to normalised data and with the null
hypothesis that the mean % change in the response in the presence of
anaesthetic did not differ from zero. The t-test is in fact a
special form of one-way AOV in which there are no replicate values
(only one figure in each sub-unit of the table).
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TableA-4









Peak Area Area/Peak Resistance
<0.05 NS <0.01 <0.05 NS NS <0.05 NS
<0.00114 NS11 <0.0258 <0.00113 <0.001 <0.001 <0.001 <0.025
5 5
NS
NS NS NS NS
NS
















































































































































































































































AOV: The effects of anaesthetics on responses to qlutmate
Anaesthetic Measure
Pentobarbitone





3.7 x ICTVm Peak
3.7 x 1CT* Peak
Alphaxalone
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DISSIMILAR INFLUENCES OF SOME INJECTABLE
ANAESTHETICS ON THE RESPONSES OF RETICULO-SPINAL
NEURONES TO INHIBITORY TRANSMITTERS IN THE LAMPREY
K.D. CULLEN & R.J. MARTIN
Department of Veterinary Pharmacology, Royal (Dick) School of Veterinary Studies, Summerhall, Edinburgh EH9 1QH
1 Intracellular recordings were made from identified bulbar reticulo-spinal neurones in the
medulla of lamprey ammocoetes. Responses to iontophoretically applied inhibitory transmitters
were measured as changes in membrane potential and input resistance.
2 Dose-dependent alterations in the responses to y-aminobutyric acid (GABA) and glycine during
bath application of injectable anaesthetic drugs were measured; the compounds used were pen¬
tobarbitone, ketamine, metomidate and the steroid mixture alphaxalone/alphadolone (Saffan).
3 GABA responses were potentiated by pentobarbitone (1-3 x 10~4m) and prolonged by
ketamine (3.7 x 10~5m); but depressed by high concentrations (10~3m) of all drugs, as well as by
anaesthetic concentrations of alphaxalone (1-3 x 10~5 M).
4 Glycine responses were depressed by alphaxalone (1-3 x ICE5 M) and by supra-anaesthetic
concentrations of ketamine (3.7 x 10~4m) and metomidate (1.8 x 10"3m). No drug potentiated the
glycine responses.
5 In the absence of an effect common to the 4 anaesthetics, it is concluded that neither potentiation
nor inhibition of all GABA or glycine responses is an essential feature of anaesthesia. However,
effects comparable to those described here may contribute to the overall clinical picture during
anaesthesia of higher vertebrates. The findings do not support the notion that all anaesthetic agents
act on biological membranes by a single mechanism.
Introduction
Anaesthesia is thought to result from a reversible
drug-induced disruption of brain function. Since
Sherrington (1906) drew attention to the susceptibil¬
ity of reflex arcs, attention has focussed on the
synapse as the site of action of anaesthetic drugs. It
has become apparent that anaesthetics differ in their
actions at individual synapses (Larrabee & Poster-
nak, 1952) and that different central nervous path¬
ways have unequal sensitivities (Mark & Steiner,
1958). Indeed some such differential action is re¬
quired to explain the characteristic clinical states
which follow administration of the various drugs
(Vickers, Wood-Smith & Stweart, 1978).
In this study we have compared the abilities of four
injectable anaesthetic drugs to interfere with the
actions of the inhibitory transmitters y-aminobutyric
acid (GABA) and glycine. The drugs were applied to
bulbar reticulospinal neurones in the medulla of the
lamprey ammocoete, cells readily identifiable and
known to possess distinct GABA and glycine recep¬
tors (Martin, 1978; Matthews & Wickelgren, 1979).
Anatomical and pharmacological analogies have
been drawn between these cells and cells in the
central nervous systems of higher vertebrates
(Shapovalov, 1975; Martin, 1979a).
0007-1188/82/110493-12 $01.00
The anaesthetics, chosen to represent four classes
of compound used in clinical anaesthetic practice,
were bath-applied to the preparation in concentra¬
tions similar to those likely to obtain in the brain
during clinical anaesthesia (Richards, 1972; Min-
chin, 1981). Although anaesthetics could equally
interfere with synaptic transmission by a presynaptic
action, we have concentrated on postsynaptic
mechanisms, applying the putative transmitters di¬




Ammocoetes 8-15 cm long of the species Lampetra
fluviatilis and Lampetra planeri were anaesthetized
with neutralized tricaine methane sulphonate
(100 pg/1) and then transected caudal to the gills. The
rostral portion was divided in the ventral midline and,
after tissues covering the ventral notochord had been
removed, was pinned out on Sylgard in the experi¬
mental chamber, dorsal surface uppermost. A simple
© The Macmillan Press Ltd 1982
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dissection exposed the bulbar reticulo-spinal cells,
clustered on either side of the midline near the centre
of the 4th ventricle (Figure 1). The preparation was
continuously perfused with a cooled Ringer solution
at 6 ml/min, and the recorded temperature in the
chamber (capacity, 1ml) maintained at 8-10°C by
the circulation of cooled fluid through an outer
jacket.
Figure 1 Diagram of the preparation showing the
location of micropipettes. Bulbar reticulo-spinal cells lie
in the floor of the 4th ventricle between the sulcus
limitans of His (arrows) and the median longitudinal
sulcus (double arrow) of the ammocoete larva. Positions
of recording (V) and iontophoresis (T) electrodes are
indicated.
Ringer solutions
The usual composition of the Ringer solution was
(mm): NaCl 71, KCI 2.1, CaCl2 2.6, MgCl2 15,
NaHCC>3 20, NaH2PO.)0.18 and glucose 4.0. The pH
was adjusted to 7.1-7.2 with HC1 and the solution
gassed with a mixture of C02 5 % and 02 95%. The
high concentration of magnesium was used to block
the release of endogenous transmitter.
Recording system
Standard intracellular recording techniques were
used, with direct visual control of cell penetration.
The recording electrode was connected by an
Ag/AgCl wire to a high impedance pre-amplifier
which incorporated a bridge balance circuit enabling
current pulses to be injected for the measurement of
input impedance. When filled with 2 m potassium
methyl sulphate the glass micropipettes used had d.c.
resistances in the range 20-30 mD. An Ag/AgCl
reference electrode was connected to the bath.
Membrane potentials were displayed on a cathode
ray oscilloscope (Tektronix 5113 Dual Beam Storage
Oscilloscope) and a permanent record made by a
high speed pen recorder (Lectromed MX212). A
thermistor probe connected to the pen recorder pro¬
vided a continuous record of the temperature in the
experimental chamber.
Iontophoresis
Three-barrelled assemblies were used for ion¬
tophoresis. The micropipettes were back-filled with
GAB A (0.5 m, pH2.5), glycine (0.5 m, pH5.0), or
NaCl (0.5 m). GABA and glycine were ejected as
cations. NaCl was incorporated as a control in some
experiments; in others, application of current pulses
of reversed polarity served instead. In all experi¬
ments an Ag/AgCl indifferent electrode was placed
in the bath for the return of iontophoretic current.
Retaining currents were not routinely employed, any
leakage of drug was insufficient to cause detectable
changes in the membrane potential or resistance of
the cells.
The ejection cycle was controlled by a micro-
iontophoresis programmer (Model 160, W-P Instru¬
ments Inc.) driven by a Digitimer. The transmitters
were applied alternately by currents of the same
strength, usually in the range 50 to 90 nA. Pulses
lasting between 0.3 and 7.0 s were applied at intervals
of 1 or 3 min. The pulse duration was determined for
each transmitter individually and then kept constant
for the duration of an experiment.
In experiments testing the influence of transmitter
concentration on the anaesthetic effect only one
transmitter was used. To vary the agonist dose a cycle
of iontophoretic pulses of differing duration but the
same amplitude was employed. The quantity of drug
ejected by an iontophoretic pulse is affected by the
immediately preceding pulse, but the use of a fixed
pulse sequence ensured that this factor was un¬
changed during an experiment. Differences between
the amounts of the agonist delivered by the test
pulses were therefore constant although unknown, so
measurements of the responses are comparable but
only within an experiment.
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The effects of anaesthetics on transmitter responses
Anaesthetics were dissolved in the perfusing Ringer
solution and applied to the preparation. No applica¬
tion was continued after 25 min; this limit allowed the
responses to recover before cell deterioration super¬
vened. The sequence of iontophoretic pulses con¬
tinued during the perfusion with anaesthetic.
Changes in input resistance associated with the trans¬
mitter actions were monitored by the injection of
constant hyperpolarizing current pulses (strength
0.5-1.0nA, frequency 1Hz) whose duration was
long (30 ms) in relation to the time constant of the
cell (<10ms). Because of the possibility that
anaesthetic drugs may interact (Richards & White,
1981), only one was tested on any individual prep¬
aration. Most experiments were terminated within
10 h of dissection.
a
b i
tophoretic pulse of y-aminobutyric acid (GABA). Verti¬
cal deflections (downward) from the resting membrane
potential are in response to repeated injections of hyper¬
polarizing current pulses (InA, 30 ms). GABA was
applied during the period indicated by the horizontal
bar. Features measured: (1) peak change in membrane
potential (Vz — Vj), (2) membrane potential change in
response to hyperpolarizing current pulses before
(V3-Vj) and during (V4 — V2) action of GABA. The
height of each vertical deflection is directly proportional
to the input resistance. Because constant current pulses
were used, the fractional change in input resistance at
peak GABA effect is
(V3-V1) -(V4-V2) •
(V3-VO
(3) area (X) enclosed by the envelope of the membrane
potential response, (b) Diagram to illustrate use of
measurement of ratio area:peak. Control (—) and test
( ) responses are superimposed, (i) Simple poten¬
tiation of membrane potential response, (ii) Alteration
of response profile showing both delayed peak response
and slowed recovery. In both (i) and (ii) the area of the
response is increased from 9 mV.s (control) to 19 mV.s
(test); but whereas in (i) the ratio remains 3.5 s, that in
(ii) is increased from 3.5 s (control) to 7.2 s (test).
Drugs
The drugs used were GABA (Sigma), glycine
(BDH), tricaine methane sulphonate (MS-222, San-
doz), pentobarbitone (May & Baker), ketamine
(Vetalar, Parke-Davis), alphaxalone/alphadolone
(Saffan, Glaxovet) and metomidate (Hypnodil, Jans-
sen). The vehicle present in Saffan was kindly do¬
nated by Glaxovet. Although the product Saffan was
used in the experiments, it will be referred to hence¬
forth as alphaxalone because concentrations are ex¬
pressed in terms of this constituent.
Analysis of results
The responses to GABA and glycine were essentially
similar. Numerical values were obtained for the peak
resistance changes as indicated in Figure 2a. A video-
plan (Reichert-Jung) was used to measure the time
integral of the membrane potential response (area
'X'). Figure 2b shows how the ratio of this area to the
peak hyperpolarization distinguishes between an in¬
crease in area due solely to an altered peak amplitude
and one effected by prolongation of the response.
The ratio was calculated in experiments in which
pentobarbitone or ketamine were tested, because
these drugs altered the GABA response profile.
So that the results of different experiments could
be compared, the changes in GABA and glycine
responses measured during exposure to anaesthetics
were expressed as percentages. Student's t test was
applied to these standardized data to assess the statis¬
tical significance of the anaesthetic effects.
Results
Responses to y-aminobutyric acid and glycine
Most cells had resting potentials in the range —60 to
— 65 mV and input resistances > 3 Mfi. The usual
response to application of either GABA or glycine
was a transient hyperpolarization accompanied by
reduction in the input resistance to the cell. A small
minority of cells (4 out of 92) showed depolarizing
responses to both amino acids. High concentrations
of either agonist elicited biphasic hyperpolarizing/
depolarizing responses and were therefore avoided.
Effect of anaesthetics on the responses to
y-aminobutyric acid and glycine
Sixty-three ammocoetes were exposed to the
anaesthetics: pentobarbitone (19 ammocoetes),
ketamine (15), alphaxalone (19), metomidate (10);
10 ammocoetes were tested with the Saffan vehicle
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brane potential and only the highest concentrations
of pentobarbitone and metomidate (10~3 M) affected
the input resistance, causing a small reduction. The
alterations in the GABA and glycine responses
measured during exposure to the four anaesthetics
are displayed in Table 1.
Most experiments were carried out at 8-10°C but
the results were qualitatively similar at room temper¬
ature and at 2°C (not illustrated).
Pentobarbitone
(1-5 x 10~4m) potentiated the GABA responses in
some cells, but only in 8 out of 19 tests did the
potentiation exceed 10%. The remaining 11 tests
showed little change. Potentiated responses were
increased both in amplitude and duration (Table 1).
In two preparations the concentration was raised to
10~3 M: this caused a reduction in amplitude of the
GABA response.
No concentration of pentobarbitone significantly
affected the glycine responses (Table 1, and see
Figure 3).
The effects of pentobarbitone were complex and
dose-dependent. Records from typical experiments
are displayed in Figure 3. Low concentrations
Ketamine












Control 2.5 x 10 4m Wash
Pentobarbitone
Figure 3 Effects of pentobarbitone on y aminobutyrie acid (CABA) and glycine responses. Records from 2 colls
showing: (upper traces), GABA potentiation by 10~4 M pentobarbitone and antagonism by 10 "3 M pentobarbitone
M pentobarbitone on glycine responses. Durations
4 min. Preparations
60 nA; glycine 3 s,
(no intervening wash); (lower traces) lack of effect of 2.5 x 10
of exposures to pentobarbitone: (upper trace) 13 min (10~4m), 6 min (10~3m); (lower trace) 14 in.
washed for 8 min (upper trace), 14 min (lower trace). Iontophoretic pulses: GABA 0.5 s
200 nA. Hyperpolarizing current pulses: 1 nA (upper traces), 0.7 nA (lower traces).








3.7 x 10 m 3.7 x 10~3m
Control Ketamine Wash
Figure 4 Effects of kctaminc on y aminobutyric acid (GABA) and glycine responses. Records from 1 cell showing
GABA potentiation by 3.7 x 10~4 M ketamine and complex effect of 3.7 x 10 M (no intervening wash). In this cell
glycine responses were unaffected by 3.7 x 10-4 M ketamine but reversibly depressed by 3.7 x 10-3 M. Duration of
exposure to ketamine: 8 min (3.7 x 10~4 m), lOmin (3.7 x 10~3 m). Preparation washed for 10 min (upper trace),
11 min (lower trace). Iontophoretic pulses: GABA and glycine 3 s, 60 nA. Hyperpolarizing current pulses: 1 nA.
sponses (Figure 4), an effect consistently detectable
at 3.7 x 10"5M and reaching statistical significance at
3.7 x 10~4m Ketamine (Table 1). Unlike the poten¬
tiation by pentobarbitone, that due to ketamine was
almost entirely attributable to prolongation of the
response, as is shown by the respective area/peak
ratios. Slowing of the onset and offset of the GABA
response was most striking at high concentrations of
ketamine (3.7 x 10"3m).
In contrast, Table 1 records a dose-dependent an¬
tagonistic action of ketamine on glycine responses.
This effect was statistically significant at 3.7 x 10"4m
when the response was measured as the peak change
in resistance. Only two cells were tested with
ketamine at 3.7 x 10~3M but in both cases depres¬
sion of the response was dramatic. No effect of
ketamine on the response profile was detected for
glycine (e.g. Figure 4).
Alphaxalone
The action of alphaxalone (> 10~5m) was consis¬
tently to depress responses to both GABA and
glycine (Table 1, and see Figure 5). The commercial
vehicle, which contains poly-oxyethylated castor oil,
had an antagonistic action in some experiments (7
out of 10 tests using GABA and 3 out of 6 with
glycine showed a reduction in response amplitude
which exceeded 10%). This latter effect was small,
and statistically significant only in the case of resis¬
tance measurements on GABA responses.
Metomidate
Metomidate, too, had a dramatic depressant action
on both GABA and glycine responses (Figure 6), but
only at high concentration (1.8 x 10~3 m). There was









Figure 5 Effect of alphaxalone on y-aminobutyric acid (GABA) and glycine responses. Records from 2 cells
showing reversible depression of GABA (9min exposure to 2.7 x 10~5m alphaxalone) and of glycine responses
(8 min exposure to 1.4 x 10-5 m). Preparations washed for 22 min (upper trace), 8 min (lower trace). Iontophoretic
pulses: GABA 2 s, 30 nA; glycine 5 s, 500 nA. Hyperpolarizing current pulses: 1 nAin upper traces, 0.9 nA in lower
traces.
no evidence of potentiation at any concentration
(Table 1), nor of alteration in the response profile.
The effect of agonist dose on the modulating
influence of anaesthetics
It was recognized that the agonist concentration at
the receptors might affect the recorded influence of
the anaesthetic drugs. Experiments were therefore
performed in which different doses of a single trans¬
mitter were applied to a cell.
The same anaesthetic-transmitter combinations as
previously described were tested in these experi¬
ments, each combination receiving 2-8 tests in be¬
tween 2 and 4 preparations. Only the potentiation
effects were consistently affected by transmitter
dose, this being marked particularly with pentobar¬
bitone, which only consistently potentiated GABA
responses when short iontophoretic pulses were
used. Measurements of peak change in input resis¬
tance obtained in one such experiment are shown in
Figure 7. In this particular experiment 10"4 m pen¬
tobarbitone approximately doubled the response to a
0.5 s GABA pulse, whereas the response to a 2 s
pulse was increased by only about a quarter. Higher
concentrations of pentobarbitone caused a reversible
loss of this effect.
Discussion
The lamprey as a model for the study of
the effects of anaesthetics
The lamprey brainstem has several features that
make it a suitable preparation in which to study the
neuropharmacology of anaesthetic drugs. Intracellu¬
lar recording from identified neurones is practicable
and enables changes in input resistance and mem¬
brane potential to be measured. This is preferable to
500 K.D. CULLEN & R.J. MARTIN
GABA










Figure 6 Effect of metomidate on y-aminobutyric acid (GABA) and glycine responses. Records from 1 cell
showing lack of effect of 1.8 x 10-5 M metomidate on GABA and glycine responses. Antagonism by 1.8 x 10~3 M
metomidate is total in both cases. Duration of exposures to metomidate (no intervening wash): lOmin
(1.8x10~5m), 5 min (1.8x10_3m). Preparation washed for 18min (upper traces), 17min (lower trace). Ion-
tophoretic pulses: GABA and glycine 2 s, 300 nA. Hyperpolarizing current pulses: 1 nA.
the use of indirect measures of cell responses, such as
changes in spike frequency. The bulbar reticulo¬
spinal cells lie close to the surface of the 4th ventricle,
covered only by a single layer of ependymal cells;
thus the diffusion path for drugs applied in the per¬
fusing Ringer is short (Martin, 1979a, b). In the
lamprey brain, blood vessels are confined to the
periphery and so neither obscure nor impede access
to the cells; visualization is also aided by the absence
of myelin.
The neuro-biology of the lamprey has been studied
in some detail (for review see Rovainen, 1979).
Wickelgren (1977) described diverse sensory inputs
to the bulbar neurones and reported that these cells
constitute a major motor outflow to the somatic
musculature. Any stimulation of the neurones by
anaesthetics, effected either directly or via the re¬
moval of inhibitory influences, should therefore elicit
movements. A similar result is predicted in higher
vertebrates, where analogous cells are found
(Shapovalov, 1975).
Anaesthetics differ in their postsynaptic effects
We set out to compare the abilities of four anaesthe¬
tic drugs to interfere with the responses of reticulo¬
spinal neurones to the inhibitory amino acid trans¬
mitters GABA and glycine. Many workers have
stressed the GABA-potentiating properties of the
barbiturates in a range of preparations (e.g. Barker &
Ransom, 1978). In our study, as in that of Bowery &
Dray (1978), the GABA-potentiating action of pen¬
tobarbitone was evident only in a proportion of cells,
and showed marked dependence on the agonist dose,
being detectable only if low amplitude or short ion-
tophoretic currents were employed.
Ketamine also was found to potentiate GABA
responses selectively, but the effect differed from
that of pentobarbitone in that it was principally on
the time course of the response; both the onset and
offset of the GABA response were slowed by
ketamine (> 10-4m). Other studies, e.g. Minchin
(1981), suggest that this potentiation is not the re-









Figure 7 y-Aiuinobutyi'ic acid (GABA) induced resistance changes measured in a single cell before, during and
after application of Increasing coneeniiaiioiis of pentobarbitone. Oidiuate scale: G ABA-induced lesistanec change
(%); abscissa scale: time after pulse sequence started (min). GABA pulses (amplitude 60 nA) applied for0.5 s(B),
1,0 s (A) and 2.0 s (•) in repeated sequence. Pentobarbitone 10-4 M approximately doubled the response to a 0.5 s
GABA pulse whereas the response to a 2.0 s pulse increased by only about a quarter. Higher concentrations of
pentobarbitone reversibly eliminated the potentiation.
suit of altered GABA uptake mechanisms. We are
unaware of any other studies using ketamine that are
directly comparable with ours.
In contrast, neither alphaxalone nor metomidate
caused significant potentiation of GABA responses
at any concentration tested; instead, both drugs pro¬
duced parallel depressions of the responses to
GABA and glycine. There are no previous reports of
the effects of either anaesthetic on responses to the
inhibitory transmitters; but ctomidatc, an imidazole
derivative closely related to metomidate, has been
studied: it is reported to be similar in action to
pentobarbitone, selectively potentiating GABA re¬
sponses at low doses (10~5 M) but having a depressant
effect at high doses (10"3m). As with the barbitu¬
rates, the potentiating action has been reported to
show stereo-specificity (Hill & Taberner, 1975;
Huang & Barker, 1980). We have not tested the
optical isomers of metomidate separately, but those
of etomidate have been shown to differ in their
pharmacological actions (Hill & Taberner, 1975).
Although published information about the actions
of alphaxalone/alphadolone on inhibitory mechan¬
isms is lacking, Pennefather & Quastel (1980) de¬
scribed alterations in endplate currents recorded at
the neuromuscular junction; and Smaje (1976) and
Richards & Smaje (1976) reported depressed re¬
sponses to acetylcholine and glutamate in the olfac¬
tory cortex.
Relevance to clinical anaesthesia
Although the reticulo-spinal cells are not concerned
with consciousness, the effects we have described are
likely to operate during anaesthesia and may be
related to side effects produced by the drugs. Our
results arc hard to reconcile with a unitary biophysi
cal hypothesis of anaesthetic action. Such a
hypothesis predicts similarity of action of different
anaesthetic compounds (Metcalfe, Hoult & Colley,
1974), however exerted, and this we have not ob¬
served. The concentrations at which the anaesthetics
have been tested in this study include those likely to
obtain in the brain during clinical anaesthesia
(Table 3), and were themselves capable of inducing
anaesthesia in lamprey ammocoetes (Table 2, and
see appendix).
Our finding that neither GABA nor glycine re¬
sponses were potentiated by alphaxalone and
metomidate lends no support to the contention that
inhibitory mechanisms are enhanced during anaes¬
thesia. However, that idea derives largely from
studies in which barbiturates or volatile anaesthetic
agents have been used (e.g. Eccles, Schmidt & Willis,
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Table 2 The effects of injectable anaesthetic drugs when bath-applied to intact lampreys
Concentration Stage of anaesthesia reached after
Drug (M) various time intervals
2 min 5 min 10 min 30 min
Pentobarbitone 10"3 — I I
Ketamine 3.7 x 10~5 — I II-l II-l
3.7 x 10~4 I II-l II-2 II—2
3.7 x 10"3 II-l II—2 II—2 III/IV
Alphaxalone 2.7 x 10~6 — — I 11-2
2.7 x 10"5 II-l II—2 11-2
2.7 x 10"4 II—2 III III/IV
Metomidate 1.8 x 10"5 — — 1-2 1-2
1.8 x 10"4 — II-l II-2 II—2
1.8 x 10"3 II—2 11-2 11-2
Dtugs dissolved in jivei water (unbuffered); times measured trow moment of transfer of ainmocoetes to anaesthetic
solution. Classification of anaesthesia after McFarland (1959), tabulated stages are the averages for the group (3 8
ammocoetes).
1963), and those results are not contradicted by our
experiments. There is no evidence that GABA and
glycine receptors on the reticulo-spinal cells of the
lamprey differ pharmacologically from those in high
er vertebrates (Martin, 1979a; Nistri & Constanti,
1979).
Only with alphaxalone was depression of GABA
and glycine responses seen at concentrations likely to
be encountered during clinical anaesthesia in fish
(Table 3) and higher vertebrates. Should a compara¬
ble depression of inhibitory mechanisms underlie the
excitatory phenomena commonly observed during
anaesthesia with alphaxalone/alphadolone in mam¬
mals, a logical preventive treatment would be pre¬
medication with a GABA-potentiating agent. It is
interesting that there are clinical reports of a reduced
incidence of tremors and purposeless move¬
ments when diazepam is used as a pre-medicant
before anaesthesia with etomidate (Holdcroft,
Morgan, Whitwam & Lumley, 1976) or
alphaxalone/alphadolone (Vickers et al. 1978). The
benzodiazepines as a group are known to potentiate
the actions of GABA (Curtis, Lodge, Johnston &
Brand, 1976).
This work was made possible by the generous support of the
Wellcome Trust.
Appendix
Abilities of the drugs to anaesthetize lampreys
(Table 2)
Experiments were carried out to ensure that the
drugs used in the iontophoresis experiments were
capable of inducing anaesthesia in intact lampreys.
These experiments give an indication of the concent¬
rations required but do not provide an accurate esti¬
mate of the concentration any anaesthetic reached in
the brain. The behaviours of groups of 3 ammocoetes
immersed in anaesthetic solutions were compared
with that of an untreated group. Anaesthesia was
assessed according to the criteria of McFarland
Table 3 Estimated brain concentrations of anaesthetics during clinical use in fish
Brain Cone, (m)
Anaesthetic Dose (estimate) Effect on fish Ref.
Pentobarbitone 30mg/kgi.p. 1.1 x 10"4 Sedation 1
48 mg/kgi.p. 1.8 x 10"4 Apnoea 1
Alphaxalone 18 mg/kgi.p. 8.1 x 10"5 Surgical anaesthesia 1
Ketamine 130mg/kgi.m. 9.5 x 10"5* Surgical anaesthesia 1
Metomidate 7.5 mg/1 (bath) 2.8 x 10"5* Surgical anaesthesia 2
"Upper limit. Ref. 1 = Oswald (1978), 2 = Stuart (1981).
Assumptions(Minchin, 1981): rapidly acting compounds (alphaxalone, metomidate) distributed in E.C.F. (-30%
body weight); slowly acting compounds (pentobarbitone, ketamine) distributed in total body water (— 66% body
weight); protein binding 10% for alphaxalonc and pentobarbitone.
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(1959). The anaesthetics were dissolved in river
water to the same concentrations as were employed
in the iontophoresis experiments and each drug was
tested on a minimum of 6 ammocoetes. Most of the
experiments were conducted at room temperature
(water temperature 15-17°C); but alphaxalone was
also tested at 4°C, with similar results. It is recognized
that both the rate of induction and the depth of
anaesthesia in fishes are affected by temperature, the
induction time commonly being shorter at higher
temperature (discussed by McFarland, 1959).
Ketamine, alphaxalone and metomidate, when
used at concentrations that affected the transmitter
responses, induced similar behavioural states that
were comparable to those McFarland (1959) re¬
ported in fish. A transient period of intense hyperac¬
tivity immediately after the introduction of high con¬
centrations of metomidate or ketamine was attri¬
buted to the acid reaction of these solutions. A
similar reaction of fish to the anaesthetic tricaine
methane sulphonate has been described (e.g. Ohr,
1976). No such hyperactivity was noted following the
introduction of pentobarbitone or alphaxalone.
The anaesthetic effect of alphaxalone (> 10~5m)
stood out because of the rapidity of its onset coupled
with the slow recovery; after the ammocoetes were
removed from 2.7xlO"4M alphaxalone to fresh
water it was an hour before there was slight move¬
ment in response to tail squeezing. During recovery
there was a period when non-propulsive and rolling
movements were observed, but frank convulsions
were not elicited. In contrast, the lampreys were
swimming within 30 min of their removal from 10~3 M
metomidate. Recovery from high concentrations of
ketamine was also slow, but was quiet in comparison
to that of ammocoetes exposed to 3.7 x 10~5 M
ketamine which was characterized by a period of
apparent excitement.
The finding that bath application of even a high
concentration of pentobarbitone induced only mild
sedation, is consistent with reports that bath applica¬
tion of the barbiturates is an unsatisfactory method of
anaesthetizing fis(see McFarland, 1959).
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